UNITED STATES
(Mark One)
þ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) |
For the fiscal year ended December 31, 2002
OR
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) |
For the transition period from to .
Commission File Number 333-62989
CDRJ Investments (Lux) S.A.
Luxembourg | 98-0185444 | |
(State or other jurisdiction of Incorporation or organization) |
(I.R.S. Employer Identification Number) |
Securities registered pursuant to Section 12(b) of the Act:
Securities registered pursuant to Section 12(g) of the Act:
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes o No þ
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. þ
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes o No þ
The registrant does not have a class of equity securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 and there is no public market for voting stock of the registrant.
As of March 7, 2003, the registrant had outstanding 831,888 shares of common stock, par value $2.00 per share.
Documents incorporated by reference
CDRJ INVESTMENTS (LUX) S.A. AND SUBSIDIARIES
TABLE OF CONTENTS
Item | ||||||||
Description | ||||||||
Page | ||||||||
PART I | ||||||||
1. | Business | 1 | ||||||
2. | Properties | 8 | ||||||
3. | Legal Proceedings | 8 | ||||||
4. | Submission of Matters to a Vote of Security Holders | 8 | ||||||
PART II | ||||||||
5. | Market for Registrants Common Equity and Related Stockholder Matters | 9 | ||||||
6. | Selected Financial Data | 10 | ||||||
7. | Managements Discussion and Analysis of Financial Condition and Results of Operations | 12 | ||||||
7A. | Quantitative and Qualitative Disclosures About Market Risk | 29 | ||||||
8. | Financial Statements and Supplementary Data | 34 | ||||||
9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 108 | ||||||
PART III | ||||||||
10. | Directors, Executive Officers and Significant Employees of the Company | 109 | ||||||
11. | Executive Compensation | 112 | ||||||
12. | Security Ownership of Certain Beneficial Owners and Management | 114 | ||||||
13. | Certain Relationships and Related Transactions | 116 | ||||||
14. | Controls and Procedures | 117 | ||||||
PART IV | ||||||||
15. | Exhibits, Financial Statement Schedules and Reports on Form 8-K | 118 | ||||||
Signatures | 125 | |||||||
Certifications | 126 |
i
PART I
Item 1. Business
General
CDRJ Investments (Lux) S.A., a Luxembourg société anonyme (Parent) is a holding company that conducts all of its operations through its subsidiaries. Prior to the consummation of the acquisition (the Acquisition) by the Parent of the Jafra Business (as defined) from The Gillette Company (Gillette) in 1998, the terms Company and Jafra refer to the various subsidiaries and divisions of Gillette conducting the worldwide Jafra cosmetics business (the Jafra Business), and, following the consummation of the Acquisition, collectively to the Parent and its subsidiaries.
The Company is a manufacturer and marketer of premium skin and body care products, color cosmetics, fragrances, and other personal care products. The Company markets its products through a direct selling, multilevel distribution system comprised of self-employed consultants (who perform the duties of sales representatives). The Companys business is comprised of one industry segment, direct selling, with worldwide operations. Financial information relating to geographic areas is incorporated by reference to the analysis of net sales and operating income by geographic area in Note 11 to the consolidated financial statements included in Item 8. Financial Statements and Supplementary Data.
The Jafra Business was started in 1956, as a California corporation, by Jan and Frank Day and was purchased by Gillette in 1973. The Company expanded into Latin America in 1977 and into Europe in 1978. On April 30, 1998, the Parent completed the Acquisition of the Company from Gillette. The Parent was organized to effect the Acquisition. The Acquisition was sponsored by Clayton, Dubilier & Rice Fund V Limited Partnership (CD&R Fund V), a Cayman Islands exempted limited partnership managed by Clayton, Dubilier & Rice, Inc. (CD&R), a private investment firm specializing in acquisitions that involve management participation.
Strategy
The Companys strategy consists primarily of the following key initiatives:
Continue to Grow Consultant Base and Sales in Core Markets. The Companys market position and distribution network of approximately 269,000 consultants in Mexico positions the Company to continue to grow the business by capturing additional market share. The Company intends to continue to pursue the divisional strategy initiated in late 2000 in which operations in the United States were bifurcated to focus on the Hispanic population and the non-Hispanic population. The establishment of two distinct divisions (the Hispanic Division and the General Division) in the United States has allowed the Company to tailor distinct marketing strategies for those demographics as well as provide U.S. Spanish and non-Spanish speaking consultants with specialized recruiting programs, training, and product offerings tailored to the specific demographic. In the General Division the Company will continue to leverage e-commerce capabilities. In the Hispanic Division the Company will continue to leverage its market position in Mexico in areas of training, recruitment and marketing.
Continue to Provide Support to Consultants. The Company will continue its operational and cultural focus on providing consultants with superior customer service and effective marketing tools, including catalogues, sales brochures, new product demonstrations and training sessions, to grow their businesses. Additionally, the Company intends to continue to stimulate sales and new consultant recruitment efforts through recognition events, incentives, gifts and free travel for consultants.
Develop New and Enhanced Products. The Company intends to focus on the development of new and innovative products that capitalize on the face-to-face interaction between consultants and their clients. New product introductions are fundamental to the Companys direct selling business model in that they serve to motivate consultants and give them new and exciting products to demonstrate and market to their clients. The Company employs a fast follower product development strategy that minimizes research costs and focuses development efforts on products that have proven successful in the marketplace.
1
Leverage Economies of Scale. Since the acquisition in 1998, the Company increased gross profit and reduced selling, general and administrative expenses, primarily by reducing manufacturing and overhead costs, streamlining marketing efforts and improving inventory and working capital management. The Company believes that its direct selling business model will continue to generate significant organic growth and that the resulting scale will afford it increasing opportunities to leverage its fixed cost base and increase efficiencies in its purchasing, manufacturing, marketing, training and technology functions.
Exit Secondary Markets. Due to the challenging macroeconomic environment that has affected results in the non-core markets in which the Company currently operates, it has adopted a strategic plan to focus on the strengths of the core U.S. and Mexican markets. The Company may consider plans to exit certain non-core markets in some or all of South America, Thailand and Europe through either a sale or discontinuation of their operations.
Products
The Company continuously introduces new and revitalized products based on changes in consumer demand and technological advances in order to enhance the quality, image and price positioning of its products. During 2002, the Company launched 29 new products, excluding limited life products. In connection with the new color line, the Company launched 289 new products during 2001 and 2002. Research and development is conducted at the Jafra Skin, Body and Color Laboratory, located in the Westlake Village, California facility. Amounts incurred on research activities relating to the development of new products and improvement of existing products were $ 1.5 million in 2002, $1.8 million in 2001 and $1.9 million in 2000.
Employees in the Research and Development Department formulate products and analyze them for chemical purity and microbial integrity. A separate small scale pilot batch is always produced and tested prior to full scale manufacture. The Company continues to invest in upgrading of its product lines by adding new formulations and contemporary fragrances. Through product development, manufacturing and packaging, the Company believes that it has enhanced the consistency and quality of its products.
The following table sets forth the sales of the Companys principal product lines for the three years ended December 31, 2002, 2001 and 2000:
2002 | 2001 | 2000 | ||||||||||||||||||||||||
Sales by | Percentage | Sales by | Percentage | Sales by | Percentage | |||||||||||||||||||||
Product Line | of Total | Product Line | of Total | Product Line | of Total | |||||||||||||||||||||
($ in millions) | Sales | ($ in millions) | Sales | ($ in millions) | Sales | |||||||||||||||||||||
Skin care
|
$ | 68.8 | 18.2 | % | $ | 69.4 | 19.0 | % | $ | 65.8 | 21.0 | % | ||||||||||||||
Color cosmetics
|
99.5 | 26.2 | 94.3 | 25.8 | 82.4 | 26.2 | ||||||||||||||||||||
Fragrances
|
126.6 | 33.4 | 125.4 | 34.3 | 103.7 | 33.0 | ||||||||||||||||||||
Body care and personal care
|
42.1 | 11.1 | 37.0 | 10.1 | 29.6 | 9.4 | ||||||||||||||||||||
Other(1)
|
42.0 | 11.1 | 39.3 | 10.8 | 32.6 | 10.4 | ||||||||||||||||||||
Subtotal before shipping and other fees less
commissions
|
379.0 | 100.0 | % | 365.4 | 100.0 | % | 314.1 | 100.0 | % | |||||||||||||||||
Shipping and other fees less commissions
|
12.0 | 10.8 | 7.1 | |||||||||||||||||||||||
Total
|
$ | 391.0 | $ | 376.2 | $ | 321.2 | ||||||||||||||||||||
(1) | Includes sales aids (e.g., party hostess gifts, demonstration products, etc.) and promotional materials, which typically do not qualify for commissions or overrides. |
Skin Care. The Company sells personalized skin programs in a free matrix skincare system that allows individuals to select a regiment to meet individual needs. Skin care products include cleansers, masks, skin fresheners and moisturizers for day and night. In addition to basic skin care products, The Company offers specialty products to enhance skin texture and encourage cell revitalization, including its premier product, Royal Jelly Milk Balm Moisture Lotion, and products for maturing skin (Time Protector and Time
2
Color. The Companys range of color cosmetics for the face, eyes, lips, cheeks and nails contribute significantly to its results. The Company internally develops lipstick formulas, foundations and mascaras. In 1999, the Company implemented a new color palette strategy by introducing seasonal color products, through innovative fashion color statements in the spring and fall shade product offerings. This has been a consistent strategy for 2000, 2001 and 2002, and has continued to drive the sales of color products. In 2001, the Company undertook a major restage of its entire color line. The new line consists of 31 new products, including 13 new formulas. In total, the restage involved the repackaging of approximately 280 items. The new color line was launched in Mexico during the fourth quarter of 2001 and globally in the second quarter of 2002.
Fragrance. In 1996, the Company introduced Adorisse, a contemporary womens fragrance, and Fm Force Magnetique, a prestige mens fragrance. The Company further extended its fragrance line in 1997 with Le Moiré for women and Legend for Men. In 1998, the Company launched the following fragrances for women: Sensations, a youthful fragrance, Joie de Vivre, a lifestyle fragrance, and Reflections, a signature fragrance. The following fragrances were also launched for men in 1998, Epic, an aspirational fragrance, and JF9 Green, a sub-brand of the existing JF9. In 1999, The Company introduced Chosen, a prestige fragrance for women, as well as a special 20th anniversary fragrance for the Mexico market. The fragrance category includes line extensions such as body lotions, shower gels, deodorants, after-shave lotions and shave creams for some of the most popular fragrances. The Company has a continued strategy of introducing new fragrances each year. In 2001, Sphera was introduced for women and Victus was introduced for men. In 2002, multiple new fragrances were launched. Navigo was launched as a master brand and two fragrances were launched simultaneously for men and women. JF9 Black, a sub brand of JF9 was launched for a limited time.
Body Care and Personal Care. The Company markets a broad selection of body, bath, sun and personal care products, including deodorants and shampoos. The Companys premier body care product, Royal Jelly Body Complex, contains royal jelly (a substance produced by queen bees) in an oil-free deep moisturizing formula with natural botanical extracts and vitamins. Other offerings in the body care line include sunscreens, hand care lotions, revitalizing sprays, and bath products. While the Company varies its product offerings and continues to develop new products, Royal Almond and Precious Protein products remain popular sellers. In 2002, the Company leveraged the success of the Royal Almond brand by introducing Royal Ginger, a scent extension to the body care family. Also, the Company launched the Define Your Body line of four products, a complete line of technologically advanced body treatment products. The Company continued to build on the success of the Jafra Spa line with the launches of the Spa fragrances and the Scalp Massage and Hair Treatment. The Tender Moments Baby line was enhanced with the launch of pediatrician-tested Baby Bottom Balm, formulated with soothing ingredients. In a collaborative effort with Kevin Charles, founder of the Kevin Charles Salon Spa, the Company launched a new hair care line of salon quality products. Developed by the Company, tested by Kevin Charles in his salon, these products cleanse, nourish, protect and style hair. In 2003, the Company will continue to promote body and personal care products with fragrance-driven line extensions.
Other Products. The Company is considering expanding its product line to include nutritional and wellness products. Any decision to offer such products will include consideration of the attendant risks, including potential product liability.
3
Marketing
Strategy and Product Positioning. The Company positions its products to appeal to a relatively wide range of market categories, demographic groups and lifestyles. The Company products generally price at the higher end of the mass market category, but slightly below prestige brands.
Product Strategy. The Companys product strategy is to provide customers with exciting and prestige quality product lines that fit into the Companys value-added demonstration sales techniques and promote the sale of multiple products per home visit. To that end, the Company develops integrated products and actively promotes cross-selling among categories, thus encouraging multi-product sales and repeat purchases. Product variety and modernization are keys to the Companys success. The Company continues to look for ways to expand product offerings and broaden its appeal in the marketplace. This led to the development of the Retinol capsules and the new color line.
Marketing Material & Corporate Image. The company supports its identity and corporate image through its energetic network of consultants and word-of-mouth. The Company uses a sophisticated and integrated promotional approach that includes meetings, marketing literature, and the Internet to create strong corporate imagery and support corporate identity.
Independent Sales Force
Jafras self-employed sales force is composed of approximately 416,000 consultants worldwide as of December 31, 2002. Approximately 80,000 of these consultants are in the United States and the Dominican Republic, 269,000 are in Mexico and 67,000 are in other markets. These consultants are not agents or employees of the Company; they are independent contractors or dealers. They purchase products directly from the Company and sell them directly to their customers.
More seasoned senior consultants, who have experience managing their own consultant networks, recruit and train the Companys field level organization. The Company sells substantially all of its products directly to its consultants. Each consultant conducts her Jafra sales operations as a stand-alone business, purchasing Jafra goods and reselling them to customers, as well as offering free personal care consultations. The Companys independent sales force constitutes its primary marketing contact with the general public.
Selling. The primary role of a Jafra consultant is to sell Jafra products. Although sales occur as a result of person-to-person sales, the Company also encourages its consultants to arrange sales parties at customers homes. Sales parties permit a more efficient use of a consultants time, allowing the consultant to offer products and cosmetic advice to multiple potential customers at the same time, and provide a comfortable selling environment in which clients can learn about skin care and sample the Jafra product line. Such parties also provide an introduction to potential recruits and the opportunity for referrals to other potential clients, party hostesses and recruits.
The Company does not require consultants to maintain any inventory. Instead, Jafra consultants can wait to purchase products from the Company until they have a firm customer order to fill. Consultants generally personally deliver orders to their customers within one week of placement of an order. By delivering products directly to the customer, the Jafra consultant creates an additional sales opportunity. The short-term delivery requirements and the nature of the Companys business preclude any significant backlog.
Recruiting. The Company believes that the lower start-up costs and policy of providing retail discounts to consultants even on small orders helps recruit consultants. Other major attractions to prospective recruits include flexible hours, increased disposable income, an attractive incentive program (including international travel, national and regional meetings, awards and free products), personal and professional recognition, social interaction, product discounts and career development opportunities.
The Company also emphasizes a commitment to consultants personal and professional training, thereby building consultants management and entrepreneurial skills.
Consultant Management and Training. To become a manager, a consultant must sponsor a specified number of recruits and meet certain minimum sales levels. Once a consultant becomes a manager, she is
4
Training for new consultants focuses first on the personalized selling of the Jafra product line, beginning with skin care and the administration of a Jafra business. Training is conducted primarily by the Companys consultant managers. Managers train their downline consultants at monthly meetings using materials prepared by the Company. In training managers, the Company seeks to improve leadership and management skills, while teaching managers to motivate downline consultants to higher sales levels.
Income Opportunities and Recognition. Consultants earn income by purchasing products from the Company at retail discounts and selling to consumers at suggested retail prices. Once a consultant becomes a manager, her compensation also includes overrides on the wholesale value of paid sales made by herself and her recruits. The overrides are paid to motivate and compensate the managers to train, recruit and develop downline consultants. Additionally, managers often perform collection efforts on the Companys behalf as the overrides paid on a consultants downline productivity are paid only upon the collection of payment for the underlying product sale.
The Company believes that public recognition of sales accomplishments serves the dual purpose of identifying successful role models and boosting consultant morale. Each year the Company sponsors major events in most geographic markets to recognize and reward sales and recruiting achievements and strengthen the bond between the independent sales force and the Company. Consultants and managers must meet certain qualification levels to receive invitation to attend these events.
International Operations
The Companys international operations are subject to certain customary risks inherent in carrying on business abroad, including the risk of adverse currency fluctuations, the effect of regulatory and legal restrictions imposed by foreign governments, and unfavorable economic and political conditions.
Due to the challenging macroeconomic environment that has effected the Companys results in the non-core markets in which the Company operates, the Company recently adopted a strategic plan to focus on the strengths of the core U.S. and Mexican markets. The Company may consider plans to exit certain non-core markets, including some or all of South America, Thailand and Europe through either a sale or discontinuation of their operations.
The most important markets to date are Mexico and the United States, which represented approximately 64% and 24%, respectively, of total 2002 consolidated sales. See Note 11 of the consolidated financial statements appearing in Item 8. Financial Statements and Supplementary Date. The Company has entered into foreign currency contracts to help mitigate the risk that a potential currency devaluation in Mexico would have on operations and liquidity. See Managements Discussion and Analysis of Financial Condition and Results of Operations Quantitative and Qualitative Disclosures About Market Risk Foreign Currency Risk.
Manufacturing
The Company has a manufacturing facility in Naucalpan, Mexico, which is near Mexico City. This facility produces color cosmetics and most of the Companys fragrances. Until June of 1999, the Company produced skin care and personal use products at the Westlake Village, California manufacturing facility. In June of 1999, the Company outsourced the U.S. product manufacturing functions to a third-party contractor.
The Company and the third-party contractor (the contractor) entered into a manufacturing agreement, dated as of June 10, 1999. Subject to the terms and conditions of the manufacturing agreement, the contractor has agreed to manufacture all of the Companys requirements for certain cosmetic and skin care products for
5
Beginning in 2001, the Company began manufacturing, through a third-party, a limited number of items in Brazil, for sale in South America.
The Company purchases from other third-party suppliers certain finished goods and raw materials for use in its manufacturing operations. In general, the Company does not have written contracts with other suppliers. Finished goods and raw materials used in the Companys products, such as glass, plastics, and chemicals, generally are available stock items or can be obtained to the Companys specifications from more than one potential supplier.
Distribution
As of December 31, 2002, the Company uses three distribution centers in the United States and Mexico and various other distribution centers globally. The U.S. warehouses in Bridgeport, New Jersey and Westlake Village, California currently stock the entire Jafra product line. In Mexico, the Company has historically outsourced virtually all of its distribution to third-parties. However, in January 2002, the Company opened a distribution center in Mexico and terminated the third-party distribution function. This distribution center services all consultants in Mexico. Management believes that its facilities are adequate to meet demand in its existing markets for the foreseeable future.
Typically, owned or leased distribution centers are located in an area that allows for direct delivery to consultants by either post or carrier. Maintaining a short delivery cycle in direct selling is an important competitive advantage.
Competition
The Company sells all of its products in highly competitive markets. The principal bases of competition in the cosmetics direct selling industry are price, quality and range of product offerings. Several direct sales companies compete with the Company in sales of cosmetic products, and at least two such competitors, Mary Kay and Avon, are substantially larger than the Company in terms of total independent salespersons, sales volume and resources. In addition, the Companys products compete with cosmetics and toiletry items manufactured by cosmetic companies that sell their products in retail or department stores. Several of such competitors are substantially larger than the Company in terms of sales and have substantially more resources. The Company also faces competition in recruiting independent salespersons from other direct selling organizations whose product lines may or may not compete with the Companys products.
The Company believes that its senior management team with a strong direct selling track record, motivated direct sales force, prestige quality product lines, product development capabilities, geographic diversification, short delivery cycle, and manufacturing technology are significant factors in establishing and maintaining its competitive position.
Patents and Trademarks
The Companys operations do not depend to any significant extent upon any single trademark other than the Jafra trademark and one of its most significant line of products, Royal Jelly, is not protected by any registered trademark. Some of the trademarks Jafra uses, however, are identified with and important to the
6
In 1998, a former employee of Gillette filed applications to register the Jafra trademark in Algeria, Bangladesh, China, Cyprus, Egypt, Gambia, Ghana, Guyana, India, Kenya, Malawi, Morocco, Nigeria, OAPI, Pakistan, Sierra Leone, Syria, Sudan, Surinam, Tanzania, Tunisia, Zambia, and Zimbabwe, jurisdictions in which the Company does not currently operate. In 1998, Gillette obtained a court order prohibiting this employee from transferring or licensing such trademark applications and registrations and requiring that the trademark applications and registrations be assigned to Gillette. The relevant documentation relating to the transfer of these trademarks to the Company has been completed. The Company has filed the documents obtained from this former employee in those jurisdictions in which the documentation will be accepted in order to secure the abandonment and cancellation of this employees applications and registrations. If the Company is not able to secure cancellation or abandonment of the applications and registrations in these jurisdictions, it may be prohibited from distributing its products in these jurisdictions.
Management Information Systems
During 2001, the Company redefined its Internet strategy and continued to develop and implement an expanded e-commerce system. The expanded e-commerce platform became operational in the United States during June 2001, with the consultant adoption rate averaging 24% of order volume by year end 2002. In Mexico, an e-commerce platform was launched during the second half of 2001. The Company also selected a new platform to run its core operations in the United States. The U.S. business will replace the order entry, fulfillment, commission and override processing and financial system software with Enterprise Resource Planning (ERP) software from JD Edwards. Wave one of this implementation of the financial systems was implemented in April of 2002. Waves two and three, which relate to the order entry and remaining commercial systems, will be implemented in the second quarter of 2003. The Company anticipates that this new system may be leveraged to improve computer operations in Mexico, Puerto Rico and the Dominican Republic during 2004.
Seasonality
The Companys net sales, as measured in local currencies, during the fourth quarter of the year are typically slightly higher than in the other three quarters of the year due to seasonal holiday purchases.
Environmental Matters
The Companys operations are subject to various federal, state, local and foreign laws or regulations governing environmental, health and safety matters. Some of its operations require environmental permits and controls and these permits are subject to modification, renewal and revocation by issuing authorities. Violations of or liabilities under environmental laws could result in fines or penalties, obligations to clean up contaminated properties or claims for property damage or personal injury. The Company believes that it is in material compliance with all such laws, regulations and permits, and under present conditions, it does not foresee that such laws and regulations will have a material adverse effect on its capital expenditures, earnings or competitive position.
7
Employees
As of December 31, 2002, the Company had 1,016 full-time employees, of which 267 were employed in the United States and 749 in other countries. The Company also had 427 outside contract employees.
Item 2. Properties
The Company is headquartered and maintains a warehouse and distribution facility in Westlake Village, California, 40 miles north of Los Angeles. Manufacturing is done on a global basis for the color and fragrance product lines at the Companys facility in Naucalpan, Mexico. The Westlake Village, California and Naucalpan, Mexico facilities are owned by the Company, except for a small portion of the Naucalpan facility that is leased. In addition, the Company leases certain distribution facilities, sales offices and service centers to facilitate its operations globally. As of January 1, 2002, the Company began utilizing a leased distribution center in Lerma, Mexico. The Companys properties are suitable and adequate to meet its current and anticipated requirements.
Item 3. Legal Proceedings
The Company is subject from time to time to various litigation and claims arising in the ordinary course of its business. The Company does not believe that any known litigation or claims pending against it would, if determined in a manner adverse to it, have a material adverse effect on its business, financial condition or results of operations.
Item 4. Submission of Matters to a Vote of Security Holders
No matters were submitted to a vote of the security holders of the Company during the fourth quarter of 2002.
8
PART II
Item 5. Market for Registrants Common Equity and Related Stockholder Matters
There is no established public trading market for Parent common stock (the Common Stock). The number of holders of record of the Companys Common Stock on March 7, 2003 was 32. On July 11, 2000, a member of management purchased 316 shares of Common Stock for a purchase price of $150 per share, or a total of $47,400; on July 27, 2000, a former member of management exercised options to purchase 158 shares of Common Stock for a purchase price of $100 per share, or a total of $15,800, and then sold a total of 632 shares of Common Stock back to the Company at $210 per share, or a total of $132,720; on August 9, 2000, certain members of management purchased an aggregate of 4,108 shares of Common Stock for a purchase price of $210 per share, or a total of $862,860; on November 6, 2000, a former member of management sold 316 shares of Common Stock back to the Company at $210 per share, or a total of $66,360; on February 10, 2001, certain members of management purchased an aggregate of 474 shares of Common Stock for a purchase price of $210 per share, or a total of $99,540; on June 14, 2001, a former member of management and a former director, sold an aggregate total of 2,563 shares of Common Stock back to the Company at $250 per share, or a total of $640,750; on September 19, 2001, a former member of management exercised options to purchase 210 shares of Common Stock for a purchase price of $150 per share, or a total of $31,500, and then sold a total of 526 shares of Common Stock back to the Company at $250 per share, or a total of $131,500. All of these transactions were exempt from the registration requirements of the Securities Act of 1933, as amended, as either offerings to accredited investors under Regulation D or offerings to employees under Rule 701. See Item 12. Security Ownership of Certain Beneficial Owners and Management. The parent has not paid in the past, and does not expect to pay for the foreseeable future, regular dividends on shares of its Common Stock. The declaration and payment of future dividends, if any, will be at the sole discretion of the Board of Directors of the Parent, subject to the restrictions set forth in the senior credit agreement and the Indenture for its senior subordinated notes (the Indenture), which currently restrict the payment of cash dividends to stockholders, and restrictions, if any, imposed by other indebtedness outstanding from time to time. See Item 7. Managements Discussion and Analysis of Financial Conditions and Results of Operations Liquidity and Capital Resources.
9
Item 6. Selected Financial Data
The following is a summary of selected financial data of the Company (amounts in millions except for consultant and consultant productivity data). The selected financial data as of December 31, 2002 and 2001 and for the years ended December 31, 2002, 2001 and 2000 are derived from the audited financial statements which appear in Item 8. Financial Statements and Supplementary Data. The related selected financial data should be read in conjunction with such financial statements and notes thereto and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations. All other financial data presented has been derived from audited financial statements of the Company which are not included herein. The financial data for the four months ended April 30, 1998 reflects the Jafra Business prior to the Acquisition and are referred to as the Predecessor operations.
Predecessor | |||||||||||||||||||||||||
Four | |||||||||||||||||||||||||
Eight Months | Months | ||||||||||||||||||||||||
Years Ended December 31, | Ended | Ended | |||||||||||||||||||||||
December 31, | April 30, | ||||||||||||||||||||||||
2002 | 2001 | 2000 | 1999 | 1998 | 1998 | ||||||||||||||||||||
Statement of Operations Data:
|
|||||||||||||||||||||||||
Net sales(a)
|
$ | 391.0 | $ | 376.2 | $ | 321.2 | $ | 296.4 | $ | 174.5 | $ | 79.2 | |||||||||||||
Cost of sales(b)
|
92.4 | 87.0 | 79.5 | 82.3 | 56.3 | 22.7 | |||||||||||||||||||
Gross profit
|
298.6 | 289.2 | 241.7 | 214.1 | 118.2 | 56.5 | |||||||||||||||||||
Selling, general and administrative expenses(a)
|
240.9 | 232.9 | 196.6 | 180.7 | 110.9 | 51.1 | |||||||||||||||||||
Restructuring and impairment charges(c)
|
| | 2.6 | 4.8 | | | |||||||||||||||||||
Loss (gain) on sale of assets
|
(0.1 | ) | 0.1 | 0.1 | (1.0 | ) | 0.2 | | |||||||||||||||||
Income from operations
|
57.8 | 56.2 | 42.4 | 29.6 | 7.1 | 5.4 | |||||||||||||||||||
Other income (expense):
|
|||||||||||||||||||||||||
Exchange (loss) gain, net
|
(11.2 | ) | (9.7 | ) | (11.7 | ) | 3.3 | (1.8 | ) | 1.4 | |||||||||||||||
Interest (expense) income, net
|
(11.4 | ) | (13.3 | ) | (15.7 | ) | (16.9 | ) | (11.5 | ) | 0.1 | ||||||||||||||
Other income (expense), net
|
0.1 | (0.1 | ) | 1.6 | 0.1 | (0.1 | ) | 0.1 | |||||||||||||||||
Income (loss) before income taxes,
extraordinary item and cumulative effect of accounting change
|
35.3 | 33.1 | 16.6 | 16.1 | (6.3 | ) | 7.0 | ||||||||||||||||||
Income tax expense
|
16.3 | 17.4 | 10.0 | 10.9 | 1.7 | 2.9 | |||||||||||||||||||
Income (loss) before extraordinary item and
cumulative effect of accounting change
|
19.0 | 15.7 | 6.6 | 5.2 | (8.0 | ) | 4.1 | ||||||||||||||||||
Extraordinary loss on early extinguishment of
debt, net of income tax benefit of $0.2 in 2000 and $0.2 in 1999.
|
| | 0.3 | 0.6 | | | |||||||||||||||||||
Income (loss) before cumulative effect of
accounting change
|
19.0 | 15.7 | 6.3 | 4.6 | (8.0 | ) | 4.1 | ||||||||||||||||||
Cumulative effect of accounting change, net of
income tax expense of $0 in 2002 and $0.1 in 2001(e)
|
(0.2 | ) | 0.1 | | | | | ||||||||||||||||||
Net income (loss)
|
$ | 18.8 | $ | 15.8 | $ | 6.3 | $ | 4.6 | $ | (8.0 | ) | $ | 4.1 | ||||||||||||
Balance Sheet Data (at end of
period):
|
|||||||||||||||||||||||||
Cash and cash equivalents
|
$ | 27.2 | $ | 6.7 | $ | 5.8 | $ | 4.9 | $ | 18.4 | |||||||||||||||
Working capital
|
31.9 | 14.2 | 19.2 | 34.2 | 22.9 | ||||||||||||||||||||
Property and equipment, net
|
60.7 | 59.6 | 51.4 | 50.6 | 56.2 | ||||||||||||||||||||
Total assets
|
288.3 | 291.1 | 276.9 | 278.4 | 288.6 | ||||||||||||||||||||
Total debt(d)
|
84.4 | 93.1 | 109.0 | 133.5 | 141.5 | ||||||||||||||||||||
Stockholders equity
|
$ | 108.5 | $ | 96.0 | $ | 81.2 | $ | 75.8 | $ | 75.4 |
10
Predecessor | ||||||||||||||||||||||||
Four | ||||||||||||||||||||||||
Eight Months | Months | |||||||||||||||||||||||
Years Ended December 31, | Ended | Ended | ||||||||||||||||||||||
December 31, | April 30, | |||||||||||||||||||||||
2002 | 2001 | 2000 | 1999 | 1998 | 1998 | |||||||||||||||||||
Other Financial Data:
|
||||||||||||||||||||||||
Net cash provided by (used in) operating
activities
|
43.1 | 30.1 | 32.5 | (1.6 | ) | 18.1 | (8.0 | ) | ||||||||||||||||
Net cash provided by (used in) investing
activities
|
(11.3 | ) | (11.7 | ) | (7.2 | ) | (3.1 | ) | (211.1 | ) | 2.6 | |||||||||||||
Net cash provided by (used in) financing
activities
|
(8.7 | ) | (16.6 | ) | (23.5 | ) | (7.4 | ) | 211.7 | (8.8 | ) | |||||||||||||
Depreciation and amortization
|
5.6 | 7.7 | 7.6 | 7.1 | 5.1 | 1.4 | ||||||||||||||||||
Amortization of deferred financing fees
|
1.4 | 1.4 | 1.4 | 1.8 | 1.4 | | ||||||||||||||||||
Capital expenditures
|
$ | 11.0 | $ | 11.4 | $ | 7.1 | $ | 5.8 | $ | 6.4 | $ | 6.1 | ||||||||||||
Total ending consultants
|
416,000 | 369,000 | 310,000 | 292,000 | 247,600 | 220,000 | ||||||||||||||||||
Average ending consultants(f)
|
394,000 | 362,000 | 307,000 | 275,000 | 238,000 | 215,000 | ||||||||||||||||||
Consultant productivity(f)
|
$ | 992 | $ | 1,039 | $ | 1,046 | $ | 1,078 | $ | 1,103 | $ | 1,103 |
(a) | In connection with the adoption of Emerging Issues Task Force Issue No. 01-9, Accounting for Consideration Given by a Vendor to a Customer or a Reseller of the Vendors Products, on January 1, 2002, reclassifications have been made to all periods ending prior to that date to reflect commissions on personal sales paid to consultants, previously reported as selling, general and administrative expenses, as a reduction of net sales and selling, general and administrative expenses. The amounts that have been reclassified as a reduction to net sales and selling, general and administrative expenses are $3.9 million, $3.4 million, $3.2 million, $1.9 million and $0.8 million for the years ended December 31, 2001, 2000 and 1999, the eight- months ended December 31, 1998, the four-months ended April 30, 1998, respectively. |
(b) | Cost of sales for the eight months ended December 31, 1998 includes a $2.7 million charge relating to the sale of certain inventories that were revalued to fair value in conjunction with the Acquisition. |
(c) | Restructuring and impairment charges include the following: for 2000, approximately $1.6 million of restructuring charges and approximately $1.0 million of asset impairment charges and for 1999, approximately $3.7 million of restructuring charges and approximately $1.1 million of asset impairment charges. |
(d) | Total debt consists of borrowings under the subordinated notes, term loan, revolving loan and unsecured foreign bank loan. |
(e) | In connection with the adoption of Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and other Intangible Assets, on January 1, 2002, the Company recorded a net loss of $0.2 million (net of a tax effect of $0) as a cumulative transition adjustment to earnings. In connection with the adoption of SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities, on January 1, 2001, the Company recorded a net gain of $0.1 million (net of a tax effect of $0.1 million) as a cumulative transition adjustment to earnings. |
(f) | The average consultant base is calculated based on the total ending consultant base for each of the prior twelve months. A consultant is included in the total ending consultant base if she places an order within the past four months. Consultant productivity is defined as net sales in U.S. dollars divided by the annual average number of consultants. Full year 1998 consultant productivity is shown for comparability. |
11
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations
The following discussion of the results of operations, financial condition and liquidity of the Company should be read in conjunction with the information contained in the consolidated financial statements and notes thereto included in Item 8. Financial Statements and Supplementary Data in this Form 10-K. These statements have been prepared in conformity with accounting principles generally accepted in the United States of America and require management to make estimates and assumptions that affect amounts reported and disclosed in the financial statements and related notes. Actual results could differ from these estimates.
Results of Operations
The following table represents selected components of the Companys results of operations, in millions of dollars and as percentages of net sales. The table reflects the operations of the Company for the years ended December 31, 2002, 2001 and 2000.
Years Ended December 31, | ||||||||||||||||||||||||
2002 | 2001 | 2000 | ||||||||||||||||||||||
($ in millions) | ||||||||||||||||||||||||
Net sales(1)
|
$ | 391.0 | 100.0 | % | $ | 376.2 | 100.0 | % | $ | 321.2 | 100.0 | % | ||||||||||||
Cost of sales
|
92.4 | 23.6 | 87.0 | 23.1 | 79.5 | 24.8 | ||||||||||||||||||
Gross profit
|
298.6 | 76.4 | 289.2 | 76.9 | 241.7 | 75.2 | ||||||||||||||||||
Selling, general and administrative expenses(1)
|
240.9 | 61.6 | 232.9 | 62.0 | 196.6 | 61.2 | ||||||||||||||||||
Restructuring and impairment charges
|
| | | | 2.6 | 0.8 | ||||||||||||||||||
Loss (gain) on sale of assets
|
(0.1 | ) | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | |||||||||||||||||
Income from operations
|
57.8 | 14.8 | 56.2 | 14.9 | 42.4 | 13.2 | ||||||||||||||||||
Exchange loss, net
|
(11.2 | ) | (2.9 | ) | (9.7 | ) | (2.6 | ) | (11.7 | ) | (3.6 | ) | ||||||||||||
Interest expense, net
|
(11.4 | ) | (2.9 | ) | (13.3 | ) | (3.5 | ) | (15.7 | ) | (4.9 | ) | ||||||||||||
Other income (expense), net
|
0.1 | 0.0 | (0.1 | ) | 0.0 | 1.6 | 0.5 | |||||||||||||||||
Income before income taxes, extraordinary item
and cumulative effect of accounting change
|
35.3 | 9.0 | 33.1 | 8.8 | 16.6 | 5.2 | ||||||||||||||||||
Income tax expense
|
16.3 | 4.1 | 17.4 | 4.6 | 10.0 | 3.1 | ||||||||||||||||||
Income before extraordinary item and cumulative
effect of accounting change
|
19.0 | 4.9 | 15.7 | 4.2 | 6.6 | 2.1 | ||||||||||||||||||
Extraordinary loss on early extinguishment of
debt, net of income tax benefit of $0.2 million
|
| | | | 0.3 | 0.1 | ||||||||||||||||||
Income before cumulative effect of accounting
change
|
19.0 | 4.9 | 15.7 | 4.2 | 6.3 | 2.0 | ||||||||||||||||||
Cumulative effect of accounting change, net of
income tax expense of $0 in 2002 and $0.1 million in 2001.
|
(0.2 | ) | (0.1 | ) | 0.1 | 0.0 | | | ||||||||||||||||
Net income
|
$ | 18.8 | 4.8 | % | $ | 15.8 | 4.2 | % | $ | 6.3 | 2.0 | % | ||||||||||||
(1) | In connection with the adoption of Emerging Issues Task Force Issue No. 01-9, Accounting for Consideration Given by a Vendor to a Customer or a Reseller of the Vendors Products, on January 1, 2002, reclassifications have been made to periods ending prior to that date to reflect commissions on personal sales paid to consultants, previously reported as selling, general and administrative expenses, as a reduction of net sales and selling, general and administrative expenses. The amounts that have been reclassified as a reduction of net sales and selling, general and administrative expenses are $3.9 million and $3.4 million, for the years ended December 31, 2001 and 2000, respectively. |
12
The following tables represent selected components of the consolidated results of operations by market. Management evaluates market performance based on segment operating income, excluding reorganization and restructuring charges, unusual gains and losses, and amortization of goodwill and other intangible assets. Results for subsidiaries in South America, the Dominican Republic, and Thailand are combined and included in the following tables under the caption All Others. Corporate expenses, reorganization and restructuring charges, unusual gains and losses and amortization of goodwill and other intangible assets are included under the caption Corporate, Unallocated and Other.
Corporate, | ||||||||||||||||||||||||||||
United | Total | Unallocated | Consolidated | |||||||||||||||||||||||||
Mexico | States | Europe | All Others | Segments | and Other | Total | ||||||||||||||||||||||
(Dollars in millions) | ||||||||||||||||||||||||||||
Year Ended December 31, 2002
|
||||||||||||||||||||||||||||
Net sales
|
$ | 251.6 | $ | 92.1 | $ | 26.9 | $ | 20.4 | $ | 391.0 | $ | | $ | 391.0 | ||||||||||||||
Cost of sales
|
60.6 | 21.2 | 6.3 | 6.2 | 94.3 | (1.9 | ) | 92.4 | ||||||||||||||||||||
Gross profit
|
191.0 | 70.9 | 20.6 | 14.2 | 296.7 | 1.9 | 298.6 | |||||||||||||||||||||
Selling, general and administrative expenses
|
124.8 | 55.3 | 19.4 | 20.3 | 219.8 | 21.1 | 240.9 | |||||||||||||||||||||
Gain on sale of assets
|
(0.1 | ) | | | | (0.1 | ) | | (0.1 | ) | ||||||||||||||||||
Income (loss) from operations
|
$ | 66.3 | $ | 15.6 | $ | 1.2 | $ | (6.1 | ) | $ | 77.0 | $ | (19.2 | ) | $ | 57.8 | ||||||||||||
Year Ended December 31, 2001
|
||||||||||||||||||||||||||||
Net sales
|
$ | 247.5 | $ | 79.6 | $ | 26.4 | $ | 22.7 | $ | 376.2 | $ | | $ | 376.2 | ||||||||||||||
Cost of sales
|
59.4 | 18.3 | 5.5 | 6.4 | 89.6 | (2.6 | ) | 87.0 | ||||||||||||||||||||
Gross profit
|
188.1 | 61.3 | 20.9 | 16.3 | 286.6 | 2.6 | 289.2 | |||||||||||||||||||||
Selling, general and administrative expenses
|
116.8 | 49.7 | 19.1 | 22.2 | 207.8 | 25.1 | 232.9 | |||||||||||||||||||||
Loss on sale of assets
|
| 0.1 | | | 0.1 | | 0.1 | |||||||||||||||||||||
Income (loss) from operations
|
$ | 71.3 | $ | 11.5 | $ | 1.8 | $ | (5.9 | ) | $ | 78.7 | $ | (22.5 | ) | $ | 56.2 | ||||||||||||
Year Ended December 31, 2000
|
||||||||||||||||||||||||||||
Net sales
|
$ | 199.8 | $ | 74.1 | $ | 26.9 | $ | 20.4 | $ | 321.2 | $ | | $ | 321.2 | ||||||||||||||
Cost of sales
|
48.8 | 16.5 | 6.3 | 6.9 | 78.5 | 1.0 | 79.5 | |||||||||||||||||||||
Gross profit
|
151.0 | 57.6 | 20.6 | 13.5 | 242.7 | (1.0 | ) | 241.7 | ||||||||||||||||||||
Selling, general and administrative expenses
|
86.6 | 46.9 | 20.3 | 19.5 | 173.3 | 23.3 | 196.6 | |||||||||||||||||||||
Restructuring and impairment charges
|
| | | | | 2.6 | 2.6 | |||||||||||||||||||||
Loss on sale of assets
|
| | 0.1 | | 0.1 | | 0.1 | |||||||||||||||||||||
Income (loss) from operations
|
$ | 64.4 | $ | 10.7 | $ | 0.2 | $ | (6.0 | ) | $ | 69.3 | $ | (26.9 | ) | $ | 42.4 | ||||||||||||
Year Ended December 31, 2002 Compared to Year Ended December 31, 2001
Net Sales. Net sales for 2002 increased to $391.0 million from $376.2 million in 2001, an increase of $14.8 million, or 3.9%. In local currencies, net sales increased 7.6% in 2002 compared to 2001. The average number of ending consultants worldwide increased 8.8% to approximately 394,000 consultants in 2002, an increase of 32,000 consultants over the 2001 average number of consultants. A consultant is included in the total ending consultant base if she places an order within the four months immediately preceding the period end date. The average consultant base is calculated based on the total ending number of consultants for each of the prior twelve months. Consultant activity decreased approximately 1.6%, with 49.0% of all consultants considered active in 2002, compared to 49.7% in 2001. In general, consultants are considered to be active ordering consultants if they place an order within the month. Consultant productivity decreased 4.5% in 2002 compared to 2001, due primarily to weaker local currencies, partially offset by increased productivity in the
13
In Mexico, net sales, excluding intersegment sales, for 2002 increased to $251.6 million from $247.5 million in 2001, an increase of $4.1 million, or 1.7%. In local currency, net sales in Mexico increased 5.5% over net sales during 2001. The year-to-year increase was due to an increase in the average number of consultants, partially offset by reduced productivity. The reduction in productivity was partially due to weaker average exchange rates of the Mexican peso. In Mexico, the average number of consultants in 2002 increased to approximately 252,000, 9.9% over the 2001 average number of consultants. Consultant productivity decreased 7.5% in 2002 compared to 2001.
In the United States, net sales, excluding intersegment sales, for 2002 increased to $92.1 million from $79.6 million in 2001, an increase of $12.5 million, or 15.7%. The U.S. selling market has established two distinct selling divisions to focus on the individual characteristics of the Hispanic Division and the General Division. The establishment of two distinct selling divisions allows the Company to focus on independent marketing strategies and to provide specialized recruiting, training and product offerings, which has contributed to the increased net sales. Sales in the Hispanic Division increased 19.7% to $61.2 million and sales in the General Division increased 8.6% to $30.9 million during 2002 compared to net sales in 2001. In the Hispanic Division, the year-to-year increase was driven by increases in the number of consultants, the number of active consultants and consultant productivity. In the General Division, the year-to-year increase was driven by an increase in consultant productivity, partially offset by a smaller consultant base. In the United States, the increased productivity was due to certain productivity-related changes in the program during the second quarter of 2002. In the Hispanic Division, the average number of consultants increased 12.1% to 39,000 compared to the 2001 average. Hispanic Division consultant productivity increased 6.8% in 2002 compared to 2001 productivity. Additionally, in 2002, consultant activity increased 6.3% in the Hispanic Division compared to 2001, with 60.7% of all consultants considered to be active in 2002. The Hispanic Division also reported increases in the number of leaders. A leader is defined as a consultant who sponsors a specified number of recruits and meets certain minimum sales levels. In the General Division, consultant productivity increased 16.5% and the average number of consultants decreased 6.8% to approximately 29,000 consultants in 2002.
In Europe, net sales, excluding intersegment sales, for 2002 increased to $26.9 million from $26.4 million in 2001, an increase of $0.5 million, or 1.9%. Measured in local currencies, net sales in 2002 decreased 3.6% compared to net sales in 2001. The increase in net sales measured in U.S. dollars was the result of the strengthening of the euro and Swiss Franc compared to the U.S. dollar, partially offset by a decrease in the average number of consultants, and reduced consultant productivity in local currencies. In Europe, the average number consultants decreased 2.6% to approximately 16,000 consultants. Consultant productivity increased 5.0% in 2002, compared to 2001, due to the strengthening of local currencies compared to the U.S. dollar. Measured in local currencies, consultant productivity decreased 1.1% in 2002 compared to 2001 productivity.
Gross Profit. Gross profit in 2002 increased to $298.6 million from $289.2 million in 2001, an increase of $9.4 million, or 3.3%. Gross profit as a percentage of net sales (gross margin) decreased to 76.4% from 76.9%.
In Mexico, gross margin decreased nominally to 75.9% in 2002 compared to 76.0% in 2001 due primarily to incrementally greater charges related to the reserve for slow moving inventory in 2002 (excluding Mexico manufacturing operations), the weakening of the peso compared to the U.S. dollar, partially offset by a more favorable product mix. Excluding charges for the reserve for slow moving inventory in 2002, gross margin would have been approximately 76.3% in 2002, compared to 76.1% in 2001. The percentage of resale sales compared to total sales remained constant at 91.2%.
In the United States, gross margin remained constant at 77.0% between 2002 and 2001. In 2002, sales of new products contributed a greater gross margin compared to 2001. This was offset by a lower gross margin contribution from non-resale sale products. Charges for the reserve for slow moving inventory were relatively constant between 2002 and 2001.
14
In Europe, gross margin in 2002 decreased to approximately 76.6% compared to 79.2% in 2001 primarily due to a more aggressive product mix implemented in an effort to generate sales.
Selling, General and Administrative Expenses. SG&A expenses in 2002 increased to $240.9 million from $232.9 million in 2001, an increase of $8.0 million, or 3.4%. SG&A expenses, as a percentage of net sales, decreased to 61.6% in 2002 from 62.0% in 2001, primarily due to the discontinuation of amortization of goodwill and trademarks pursuant to SFAS No. 142 (See New Accounting Pronouncements). In 2001, the Company recorded $3.5 million of charges related to amortization of intangible assets.
In Mexico, SG&A expenses increased to $124.8 million in 2002, from $116.8 million in 2001. As a percentage of net sales, SG&A expenses increased to 49.6% in 2002 compared to 47.2% in 2001. The primary factors for the increase in SG&A expenses as a percentage of net sales were selling expenses, variable freight expenses and administrative expenses. Selling expenses increased due primarily to an increase in the number of regional sales managers. As a percentage of sales, variable freight expenses increased 1.1% due to increased orders and higher average packaging costs. Administrative expenses increased primarily due an additional $3.4 million of bad debt expense in 2002, compared to 2001, due to declining consultant liquidity as a result of the general economic condition. Excluding the charges for bad debt expense, administrative expense was relatively constant as a percentage of sales in 2002 and 2001.
In the United States, SG&A expenses increased to $55.3 million in 2002 from $49.7 million in 2001, an increase of $5.6 million, or 11.3%. However, as a percentage of net sales, SG&A expenses decreased to 60.0% from 62.4% primarily due to decreases in sales promotional expenses and administrative expenses. Sales promotional expenses decreased as a percentage of net sales due to the mix of events. Administrative expenses decreased as a percentage of net sales due to an increase in net sales as most of these expenses are fixed in nature. However, administrative expenses were relatively constant in total. Certain other variable expenses, such as period distribution and freight out, increased in total, but were relatively constant as a percentage of net sales.
In Europe, SG&A expenses increased to $19.4 million in 2002 from $19.1 million in 2001, an increase of $0.3 million. As a percentage of net sales, SG&A expenses decreased to 72.1% in 2002 from 72.3% in 2001. Administrative expenses increased as a percentage of net sales and in total due to larger charges related to the reserve for uncollectible accounts in Italy and incrementally higher information technology expenses in Germany in 2002 compared to 2001. The increase in administrative expenses, as a percentage of net sales, was offset by reduced sales promotional and override expenses, in 2002 compared to 2001.
SG&A expenses in the other selling markets (South America, Dominican Republic and Thailand) decreased to $20.3 million in 2002, compared to $22.2 million in 2001, primarily due to the favorable impact on expenses of currency devaluation of the South American currencies compared to the U.S. dollar, and decreased incremental charges related to the reserve for uncollectible accounts in the Companys Brazilian subsidiary in 2002 compared to 2001. SG&A expenses in the corporate, unallocated and other categories decreased $4.0 million in 2002, compared to 2001, primarily due to the discontinuation of intangible amortization pursuant to SFAS No. 142 and administrative cost savings in the Companys corporate headquarters.
Exchange Loss. The Companys net foreign exchange loss in 2002 was $11.2 million compared to $9.7 million in 2001, an increase in exchange losses of $1.5 million, or 15.5%. The Companys foreign exchange gains and losses primarily result from the Companys operations in Mexico and South America. The net exchange loss has three primary elements: gains or losses on forward currency and option contracts, unrealized and realized gains or losses on the remeasurement of U.S. dollar-denominated debt, and gains or losses on transactions denominated in foreign currencies.
In 2002, the Company continued to use forward contracts to protect against potential devaluation of the Mexican peso by selling Mexican pesos and buying U.S. dollars. Additionally, during 2002, the Company modified its hedging program to include the use of foreign currency option contracts (option contracts or options) to hedge foreign currency exposures to the Mexican peso. In order to execute the option contracts and to offset the current outstanding forward contracts to sell Mexican pesos, the Company entered into
15
During the year ended December 31, 2002, the Company recognized $2.6 million of exchange losses related to forward contracts and $0.9 million of exchange gains related to option contracts (including the reclassification of other comprehensive loss into exchange loss). As the Company utilizes hedge accounting pursuant to SFAS No. 133 for forward and option contracts to hedge certain forecasted transactions, certain losses and gains are deferred as a separate component of other comprehensive loss and are recognized in income at the same time that the underlying hedged exposure is recognized in income. As of December 31, 2001, the Company had deferred losses of $3.7 million as a component of other comprehensive loss. During 2002, the Company deferred an additional $1.8 million of losses on forward exchange contracts and $1.3 million of exchange gains on option contracts as a component of other comprehensive loss. During the year ended December 31, 2002, the Company reclassified $1.6 million of losses on forward contracts and $0.5 million of exchange gains on option contracts from other comprehensive loss into exchange loss on the consolidated statement of income. Additionally, during the year ended December 31, 2002, the Company reclassified $3.1 million of losses on forward contracts and $0.4 million of exchange gains on option contracts from other comprehensive loss into cost of sales in the consolidated statements of income.
During the year ended December 31, 2002, the Mexican peso devalued 13.5%, which resulted in a $5.2 million loss on the remeasurement of U.S. dollar-denominated debt, most of which was unrealized. The Company recognized $4.3 million of other exchange losses on other foreign currency transactions, most of which was unrealized, primarily due to the weakening of the South American currencies.
During 2001, the Company recognized a total of $12.2 million of exchange losses related to forward contracts (including the reclassification of other comprehensive loss into exchange loss). During 2001, the Company deferred $5.5 million of losses as a component of other comprehensive loss, pursuant to SFAS No. 133. Of this $5.5 million, $0.8 million was recognized as a component of exchange loss and $1.0 million was recognized as cost of sales, in the consolidated statements of income, resulting in $3.7 million of exchange losses deferred as a component of other comprehensive loss at December 31, 2001. As the Mexican peso strengthened in 2001, the Company recognized $2.8 million of exchange gains on the remeasurement of U.S. dollar-denominated debt in 2001. Additionally, the Company recognized $0.3 million of net exchange losses on other transactions denominated in foreign currencies.
Interest Expense. Interest expense decreased to $11.4 million in 2002 from $13.3 million in 2001, a decrease of $1.9 million, or 14.3%. The decrease was due to a lower debt balance, as total debt decreased approximately $8.7 million in 2002 from 2001, and lower average interest rates. Interest rates on Libor based borrowings decreased from 3.6% at December 31, 2001 to 3.1% at December 31, 2002.
Income Tax Expense. Income tax expense decreased to $16.3 million in 2002 from $17.4 million in 2001, a decrease of $1.1 million, or 6.3%. The Companys effective income tax rate decreased to 46.4% in 2002 from 52.5% in 2001. The reduced effective income tax rate was primarily the result of the release of valuation allowances against certain deferred income tax assets in the United States and the impact of the enactment of changes in Mexicos future corporate statutory rates on net deferred income tax liabilities partially offset by valuation allowances against certain pretax expenses in the United States. Excluding the impact of the release of the valuation allowance of $2.3 million and the impact of the enactment of changes in the Mexico rate of $1.2 million, the effective tax rate would have been 56.4% in 2002.
Net Income. Net income increased to $18.8 million in 2002 from $15.8 million in 2001, an increase of $3.0 million, or 19.0%. The increase was due to a $9.4 million increase in gross profit, a $0.2 million favorable change in loss (gain) on sale of assets, a $1.9 million decrease in interest expense, a $0.2 million favorable change in other income (expense), a $1.1 million decrease in tax expense, offset by a $8.0 million increase in
16
Year Ended December 31, 2001 Compared to Year Ended December 31, 2000
Net Sales. Net sales for 2001 increased to $376.2 million from $321.2 million in 2000, an increase of $55.0 million, or 17.1%. The Companys average ending number of consultants worldwide increased 17.9% to approximately 362,000 consultants in 2001, an increase of 55,000 consultants over the 2000 average. The Companys consultant productivity decreased 0.6% between 2001 and 2000. Consultant productivity in Mexico increased 3.5%.
In Mexico, net sales, excluding intersegment sales, for 2001 increased to $247.5 million from $199.8 million in 2000, an increase of $47.7 million, or 23.9%. Sales in Mexico in local currency increased by 22.3% over 2000 net sales. The year-to-year increase was driven by an increase in the average number of consultants, an increase in consultant productivity and an increase in average consultant branches, or leaders. Mexico defines a branch or leader as a consultant with twelve or more active consultants in her downline. The average number of leaders in 2001 increased 20.4% compared to the 2000 average. In Mexico, the average number of consultants in 2001 increased to approximately 229,000, or 19.6% over the 2000 average.
In the United States, net sales, excluding intersegment sales, for 2001 increased to $79.6 million from $74.1 million in 2000, an increase of $5.5 million, or 7.4%. During the later part of 2000, the U.S. established two distinct selling divisions to focus on the individual characteristics of the Hispanic Division and the General Division. The focus on the distinct needs of the consultants in each of the selling divisions contributed to the overall sales increase. Net sales in the Hispanic Division increased 8.1% and net sales in the General Division increased 6.4% compared to 2000 sales. The year-to-year increase was also driven by an overall increase in the number of consultants and an increase in the percentage of active consultants, partially offset by a decrease in productivity. In the U.S., the average number of consultants in 2001 increased to approximately 66,000, or 7.8% above the 2000 average. The percent of ordering consultants increased to 53.5% of all consultants, as compared to 49.6% in 2000. Consultant productivity decreased 6.1% over consultant productivity in 2000.
In Europe, net sales, excluding intersegment sales, for 2001 decreased to $26.4 million from $26.9 million in 2000, a decrease of $0.5 million, or 1.9%. The decline in net sales was primarily attributed to unfavorable exchange rates due to the weakening of local currency compared to the U.S. dollar. If exchange rates remained constant between 2000 and 2001, net sales would have increased nominally. In Europe, the average number of consultants was relatively constant at an average of 17,000 consultants each year.
Gross Profit. Gross profit in 2001 increased to $289.2 million from $241.7 million in 2000, an increase of $47.5 million, or 19.7%. Gross profit as a percentage of sales (gross margin) increased to 76.9% in 2001 from 75.2% in 2000.
In Mexico, gross margin improved primarily due to reduced product costs, while prices increased in line with inflation. During 2001, the peso strengthened 5.2% compared to the U.S. dollar in 2000. The strengthening of the peso resulted in reduced product costs as the Company benefited from foreign currency gains as some inventory and components are purchased in U.S. dollar-denominated transactions. These gains were partially offset by derivative losses on forward contracts used to purchase inventory and accounted for using hedge accounting. Mexicos fourth quarter 2000 gross margin included certain adjustments related to changes in cost accounting estimates, totaling $3 million. These changes resulted in increased margins of 76.3% in the fourth quarter of 2001 compared to 67.3% in the fourth quarter of 2000 and 76.0% for the year ended December 31, 2001 compared to 75.6% for the year ended December 31, 2000.
In the United States, the gross margin decreased as a result of a more aggressive promotional mix. In 2001, the U.S. sold less regular resale items and more promotional and non-resale items. In 2001, 53.3% of resale items sold were promotional products, compared to 45.0% in 2000. Regular resale items typically contribute a greater margin than promotional or non-resale items.
17
In Europe, gross margin in 2001 increased to approximately 79.2% compared to 76.6% in 2000 primarily due to the favorable impact of exchange rates on product costs.
Selling, General and Administrative Expenses. SG&A expenses in 2001 increased to $232.9 million from $196.6 million in 2000, an increase of $36.3 million, or 18.5%. SG&A expenses as a percentage of net sales increased in 2001 to 62.0% from 61.2% in 2000.
In Mexico, SG&A expenses as a percentage of net sales increased to 47.2% for 2001 compared to 43.3% in 2000. The primary factors for the increase in SG&A expenses as a percentage of net sales were sales promotional expenses, distribution costs and administrative expenses. Sales promotional expenses increased because there was additional promotional activity in 2001 in an effort to generate sales. Distribution costs increased proportionally more than sales due to the shipment of more small packages. Administrative expense increased primarily due to additional expenses related to reserves for uncollectible accounts receivable. Due to declining consultant liquidity, Mexico charged $7.7 million to bad debt expense during 2001, of which $3.8 million was charged during the fourth quarter.
In the United States, SG&A, as a percentage of net sales, decreased to 62.4% from 63.3%. Selling expenses increased proportionally more than sales due to the implementation of the expanded e-commerce platform in 2001. In 2001, there was approximately $1.2 million of increased incremental e-commerce related expenses. The percentage increase in selling expenses is partially offset by a decrease in sales promotional expense and administrative expense, as a percentage of net sales. Expenditures on major events were scaled back, which resulted in a decrease in sales promotional expenses, and cost savings measures were employed in 2001 in an effort to reduce administrative expense.
In Europe, SG&A expenses in 2001 decreased to 72.3% of net sales compared to 75.5% in 2000, primarily as a result of the Companys repositioning and restructuring activities in Europe in the second half of 2000.
Developing markets, particularly Brazil, incurred additional SG&A expenses in 2001 compared to 2000 due to the growing nature of the business and an increase in the allowance for bad debts as a result of declining consultant liquidity and economic difficulties. Corporate expenses increased $1.8 million because of increased compensation expenses in 2001, primarily related to bonuses, compared to 2000 and increased infrastructure expenses to support the growing business.
Restructuring and Impairment Charges. There were no restructuring and impairment charges for 2001 compared to $2.6 million for 2000. In 2000, the Company recorded approximately $1.6 million of restructuring charges and approximately $1.0 million of asset impairment charges. The restructuring charges in 2000 related to the Companys repositioning activities in Europe, and consisted primarily of severance costs. The asset impairment charges consisted of approximately $0.3 million related to the Companys repositioning activities in Europe and approximately $0.7 million relating to the writedown of certain capitalized computer software costs in the United States. In 2000, the Company consolidated the sales support and administrative functions for Austria, Italy, and the Netherlands in Germany. Field sales personnel continue to perform sales and marketing functions in those locations. The Company closed its Poland operation, and began serving that territory through a distributor in 2001.
Exchange Loss. The Companys net foreign exchange loss in 2001 was $9.7 million compared to $11.7 million in 2000, a decrease in exchange loss of $2.0 million. The Companys foreign exchange gains and losses primarily result from its operations in Mexico. The net exchange loss has three primary elements: gains or losses on forward currency contracts, unrealized and realized gains or losses on the remeasurement of U.S. dollar-denominated debt, and gains or losses on transactions denominated in foreign currencies.
Effective January 1, 2001, the Company adopted SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. SFAS No. 133, as amended and interpreted, establishes accounting and reporting standards for derivative instruments and hedging activities and requires such instruments to be measured and recorded at fair value. The derivative instruments the Company utilized did not qualify for hedge accounting under applicable standards prior to adoption of SFAS No. 133, and accordingly such instruments were marked-to-market with gains and losses included as a component of exchange loss in the statement of operations for the year ended December 31, 2000. Under SFAS No. 133, certain derivative contracts do not
18
In 2001, the Company continued to use forward contracts to protect against potential devaluation of the Mexican peso by selling Mexican pesos and buying U.S. dollars. Throughout 2001, the forward currency contract pricing reflected the markets expectation that the peso would devalue relative to the dollar. However, in 2001, the peso to U.S. dollar exchange rate strengthened, resulting in exchange losses of $12.2 million related to forward contracts. Upon implementation of SFAS 133 on January 1, 2001, the Company had certain forward contracts not designated as hedges. During 2001, the Company recognized foreign exchange losses totaling $11.4 million on certain forward contracts not designated as hedges under SFAS No. 133. As the Company utilized hedge accounting pursuant to SFAS No. 133 for forward contracts to hedge certain forecasted transactions, certain losses were deferred as a separate component of other comprehensive income and recognized in income at the same time that the underlying hedged exposure was recognized in income. During 2001, $5.5 million of losses were deferred and $0.8 million was recognized as a component of exchange loss and $1.0 million was recognized as cost of sales, resulting in $3.7 million of exchange losses deferred as a component of other comprehensive income at December 31, 2001. The contracts were remeasured each month and the fair value of the contracts was included in current liabilities. As the Mexican peso strengthened in 2001, the Company recognized $2.8 million of exchange gains on the remeasurement of U.S. dollar-denominated debt in 2001. Additionally, the Company recognized $0.3 million of net unrealized and realized exchange losses on other transactions denominated in foreign currencies.
In 2000, the peso to U.S. dollar exchange rate was stable, resulting in $10.0 million of exchange losses on forward contracts. The remeasurement of U.S. dollar-denominated debt in 2000 resulted in an exchange loss of $0.7 million, as the peso weakened against the U.S. dollar at year-end. Net realized and unrealized losses on other foreign currency transactions were $0.6 million.
Interest Expense. Interest expense decreased to $13.3 million in 2001 from $15.7 million in 2000, a decrease of $2.4 million, or 15.3%. The decrease was due to a lower debt balance, as total debt decreased approximately $15.9 million from 2000 to 2001, and lower average interest rates.
Other Income (Expense). Other expense in 2001 was nominal compared to other income for 2000 of $1.6 million, which consisted primarily of income related to the recovery of the effect of inflation from a receivable due from the Mexican government related to taxes.
Income Tax Expense. Income tax expense increased to $17.4 million in 2001 from $10.0 million in 2000, an increase of $7.4 million, or 74.0%. The increase in income tax expense is the result of increased income generated by the Companys Mexico and U.S. subsidiaries in 2001 compared to 2000 and approximately $0.6 million of tax provision related to certain tax adjustments in Europe. In 2001, the Companys effective income tax rate decreased to 52.5% from a 59.9% effective income tax rate in 2000. The decrease in the effective income tax rate was driven by taxable income generated by the Companys European subsidiary in 2001, compared to a tax loss without any tax benefit in 2000. This decrease in the effective income tax rate was partially offset by higher effective income tax rates in the Companys Mexico and U.S. subsidiaries.
Net Income. Net income increased to $15.8 million in 2001 from $6.3 million in 2000, an increase of $9.5 million, or 150.8%. The increase was due to a $47.5 million increase in gross profit, a $2.6 million decrease in restructuring and impairment charges, a $2.0 million decrease in exchange loss, a $2.4 million decrease in interest expense, a $0.3 million decrease in extraordinary loss on early extinguishment of debt, net of tax, and a $0.1 million gain on the cumulative effect of accounting change, net of tax, partially offset by a $36.3 million increase in selling, general and administrative expenses, a $1.7 million decrease in other income (expense), and a $7.4 million increase in income tax expense.
19
New Accounting Pronouncements
In June 2001, the Financial Accounting Standards Board (FASB) approved two new statements: SFAS No. 141, Business Combinations and SFAS No. 142, Goodwill and Other Intangible Assets. SFAS No. 141 requires combinations entered into after June 30, 2001 to be accounted for using the purchase method of accounting. SFAS No. 142 requires that goodwill not be amortized, but be tested for impairment at least annually. SFAS No. 142 was effective for fiscal years beginning after December 15, 2001 to all goodwill and other intangible assets recognized in an entitys statement of financial position at that date, regardless of when those assets were initially recognized. The Company adopted SFAS No. 142 on January 1, 2002. In accordance with such adoption, the Company identified all reporting units in conjunction with the provisions of SFAS No. 142 and allocated all goodwill accordingly. Prior to June 30, 2002, the Company completed the transitional goodwill impairment test required by SFAS No. 142. Due to general market uncertainty in Colombia, the Company revised its projections and recorded an impairment loss of $0.2 million associated with its Colombia reporting unit. The impairment loss has been recorded as a cumulative effect of accounting change in the accompanying consolidated statements of income. No other impairment was identified in connection with the annual impairment test. The changes in the carrying amount of goodwill for the year ended December 31, 2002 were as follows (in millions):
United | All | Consolidated | ||||||||||||||||||
Goodwill | States | Mexico | Europe | Others | Total | |||||||||||||||
Balance as of December 31, 2001
|
$ | 32.2 | $ | 32.4 | $ | 5.9 | $ | 0.6 | $ | 71.1 | ||||||||||
Translation effect
|
| (3.9 | ) | (0.6 | ) | (0.1 | ) | (4.6 | ) | |||||||||||
Impairment losses
|
| | | (0.2 | ) | (0.2 | ) | |||||||||||||
Balance as of December 31, 2002
|
$ | 32.2 | $ | 28.5 | $ | 5.3 | $ | 0.3 | $ | 66.3 | ||||||||||
The Companys other intangible assets consist of trademarks. During the year ended December 31, 2002, the Company determined trademarks to have an indefinite life and performed the transitional impairment test as required under SFAS No. 142. Based upon the transitional and annual test, the Company determined that there was no impairment of trademarks. The carrying value of trademarks was $44.6 million as of December 31, 2002.
In accordance with SFAS No. 142, the Company discontinued amortization of goodwill and other intangible assets with an indefinite life. A reconciliation of previously reported net income to amounts adjusted for the exclusion of goodwill and trademark amortization, net of the related income tax effects, where applicable, is as follows (in millions):
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Net income
|
$ | 18.8 | $ | 15.8 | $ | 6.3 | ||||||
Goodwill amortization, net of tax
|
| 1.8 | 1.9 | |||||||||
Trademark amortization, net of tax
|
| 0.8 | 0.9 | |||||||||
Adjusted net income
|
$ | 18.8 | $ | 18.4 | $ | 9.1 | ||||||
In November 2001, the Emerging Issues Task Force (EITF) issued EITF Issue No. 01-9, Accounting for Consideration Given by a Vendor to a Customer or a Reseller of the Vendors Products. This new guidance provides that consideration from a vendor to a reseller is generally presumed to be a reduction of the selling prices of the vendors products, and, therefore, should be characterized as a reduction of revenue when recognized in the vendors income statement. On January 1, 2002, the Company adopted EITF Issue No. 01-9 and reclassified commissions paid to consultants of $3.9 million and $3.4 million on their personal sales, previously reported as a component of selling, general and administrative expenses, as a reduction in net sales and selling, general and administrative expenses for the years ended December 31, 2001 and 2000, respectively.
20
On January 1, 2002, the Company adopted SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets. SFAS No. 144 supersedes SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed of. SFAS No. 144 retains substantially all of the requirements of SFAS No. 121, while resolving certain implementation issues and addressing the accounting for a component of a business accounted for as a discontinued operation. SFAS No. 144 was adopted with no significant impact on the Companys financial position or results of operations.
In April 2002, the FASB issued SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections. This Statement rescinds or modifies existing authoritative pronouncements including FASB Statement No. 4 Reporting Gains and Losses from Extinguishment of Debt. As a result of the issuance of SFAS No. 145, gains and losses from extinguishment of debt should be classified as extraordinary items only if they meet the criteria in Accounting Principles Board (APB) Opinion No. 30, Reporting the Results of Operations-Reporting the Effects of Disposal of a Segment of a business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions. Applying the provisions of APB Opinion No. 30 will distinguish transactions that are part of an entitys recurring operations from those that are unusual or infrequent or that meet the criteria for classification as an extraordinary item. The provisions of this Statement related to the rescission of SFAS No. 4 shall be applied in fiscal years beginning after May 15, 2002. Any gain or loss on extinguishment of debt that was classified as an extraordinary item in prior periods presented that does not meet the criteria in APB Opinion No. 30 for classification as an extraordinary item shall be reclassified. The Company is currently evaluating the impact that this statement may have on any potential future extinguishments of debt. Upon adoption of SFAS No. 145, the Company will reclassify items previously reported as extraordinary items as a component of operating income on the accompanying consolidated statements of income.
In June 2002, the FASB approved SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities. This statement addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. The provisions of this statement are effective for exit or disposal activities that are initiated after December 31, 2002, with early application encouraged. The Company is currently evaluating the impact that this statement may have on any potential future exit or disposal activities.
During 2002, the FASB issued SFAS No. 148, Accounting for Stock Based Compensation Transaction and Disclosure, an amendment to FASB Statement No. 123. This Statement requires more extensive disclosure, including interim disclosure, related to stock based compensation for all companies and permits additional transition methods for companies that elect to use the fair value method for employee stock compensation. This statement is effective for fiscal years ending after December 15, 2002. The Company adopted the disclosure requirements of SFAS No. 148.
Critical Accounting Policies and Estimates
Managements Discussion and Analysis of Financial Condition and Results of Operations are based on the Companys consolidated financial statements, which have been prepared in conformity with accounting principles generally accepted in the United States of America. These principles require the appropriate application of certain accounting policies, many of which require management to make estimates and assumptions about future events and their impact on amounts reported in the Companys consolidated financial statements and related notes. Since future events and their impact cannot be determined with certainty, the actual results may differ from managements estimates. Such differences could be material to the consolidated financial statements.
Management believes that the application of accounting policies, and the estimates inherently required therein, are reasonable. These accounting policies and estimates are constantly reevaluated, and adjustments are made when facts and circumstances dictate a change. Historically, the application of accounting policies has been appropriate, and actual results have not differed materially from those determined using necessary estimates.
21
The Companys accounting policies are more fully described in Note 2 to the audited consolidated financial statements included in Item 8. Financial Statements and Supplementary Data. Certain critical accounting policies are described below.
Accounts Receivable. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of consultants to make payments. An allowance is calculated based on historical experience and the age of the outstanding receivables. If the financial condition of consultants were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.
Inventory Obsolescence. The Company writes down its inventory to provide for estimated obsolete or unsalable inventory based on assumptions about future demand for its products. If future demand is less favorable than managements assumptions, additional inventory write-downs may be required. Likewise, favorable future demand and market conditions could positively impact future operating results if inventory that has been written-down is sold.
Foreign Currency Contracts. The Company enters into foreign currency forward and option contracts to reduce the effect of adverse exchange rate fluctuations in the exchange rate of the Mexican peso to the U.S. dollar. The Company places forward and option contracts based on its forecasted U.S. dollar cash outflows from Jafra S.A. over a rolling twelve-month period and does not hedge transactions that are not included in the twelve-month forecast on the date the forward or option contract is initiated. As a matter of policy, the Company does not hold or issue forward or option contracts for trading or speculative purposes nor does it enter into contracts or agreements containing embedded derivative features or involving leveraged derivatives. If the Mexican peso were to significantly strengthen during the year compared to the U.S. dollar, the Company may incur additional losses on option contracts open as of the balance sheet date. See Item 7A. Quantitative and Qualitative Disclosures about Market Risk.
Contingencies. The Company accounts for contingencies in accordance with Statement of Financial Accounting Standards (SFAS) No. 5, Accounting for Contingencies. SFAS No. 5 requires that the Company record an estimated loss from a loss contingency when information available prior to issuance of the Companys financial statements indicates that it is probable that an asset has been impaired or a liability has been incurred at the date of the financial statements and the amount of the loss can be reasonably estimated. Accounting for contingencies such as legal and income tax matters requires management to use judgment. Many of these legal and tax contingencies can take years to be resolved. Generally, as the time period increases over which the uncertainties are resolved, the likelihood of changes to the estimate of the ultimate outcome increases. Management believes that the accruals for these matters are adequate.
Income Taxes. Deferred income tax assets have been established for net operating loss carryforwards of certain foreign subsidiaries and foreign tax credits originating in the United States, which are reduced by a valuation allowance. The net operating loss carryforwards expire in varying amounts over a future period of time. Realization of the income tax carryforwards are dependent on generating sufficient taxable income prior to expiration of the carryforwards. Although realization is not assured, management believes it is more likely than not that the net carrying value of the income tax carryforwards will be realized. The amount of the income tax carryforwards that is considered realizable, however, could change if estimates of future taxable income during the carryforward period are adjusted.
Impairment of Long-Lived Assets and Goodwill. Long-lived assets are reviewed for impairment, based on undiscounted cash flows, whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. If this review indicates that the carrying amount of the long-lived assets is not recoverable, the Company will recognize an impairment loss, measured by the future discounted cash flow method. Goodwill is evaluated for impairment based on SFAS No. 142, Goodwill and Other Intangible Assets. SFAS No. 142 requires that goodwill not be amortized, but be tested for impairment annually.
22
Liquidity and Capital Resources
The Acquisition was consummated on April 30, 1998. As part of the financing for the Acquisition, $100.0 million of notes were issued, $41.5 million of borrowings were initially drawn down under the senior credit agreement ($25.0 million under the term loan facility and $16.5 million under the revolving credit facility), and $82.9 million of cash was contributed as an equity investment by CD&R Fund V, certain members of management, certain directors and other persons. The purchase price for the Jafra Business, after final adjustments determined in 1999, was approximately $212.4 million (excluding $12.0 million of financing fees and expenses), consisting of $202.5 million in cash and $9.9 million of Acquisition fees.
The Companys liquidity needs arise primarily from principal and interest payments under the notes, the term loan facility and the revolving credit facility. The notes represent several obligations of Jafra Cosmetics International, Inc. (JCI) and Jafra Cosmetics International, S.A. de C.V. (Jafra S.A.) in the initial amount of $60 million and $40 million (subsequently reduced in 1999 and 2000 by the repurchases), respectively, with each participating on a pro rata basis upon redemption. The notes mature in 2008 and bear a fixed interest rate of 11.75% payable semi-annually.
Borrowings under the senior credit agreement are payable in quarterly installments of principal and interest through April 30, 2004. Scheduled term loan principal payments under the term loan facility will be approximately $5.9 million and $2.5 million for each of the years from 2003 through 2004, respectively. Borrowings under the revolving credit facility (zero as of December 31, 2002) mature on April 30, 2004. Borrowings under the senior credit agreement currently bear interest at an annual rate of LIBOR plus a margin of 1.625% or an alternate base rate (the higher of the prime rate or federal funds rate plus 0.5%, plus an applicable margin of 0.625%). The interest rate in effect at December 31, 2002 was approximately 3.1% for the LIBOR-based borrowings. At December 31, 2002, the Company did not have any prime-based borrowings. If the Company had prime-based borrowings at December 31, 2002, the rate would have been approximately 4.9%. Borrowings under the senior credit agreement are secured by substantially all of the assets of JCI and Jafra S.A. Interest expense in 2002 was $11.4 million, including approximately $1.4 million of non-cash amortization of deferred financing fees. During 2002, cash paid for interest was approximately $10.2 million.
Both the Indenture, dated as of April 30, 1998, under which the notes were issued, and the senior credit agreement contain certain covenants that limit the Companys ability to incur additional indebtedness, pay cash dividends and make certain other payments. The Indenture and the senior credit agreement also require the Company to maintain certain financial ratios including a minimum EBITDA to cash interest expense coverage ratio and a maximum debt to EBITDA ratio. At December 31, 2002, the Company was in compliance with all covenants. As of December 31, 2002, the Company had irrevocable standby letters of credit outstanding totaling $2.8 million.
The notes are unsecured and are generally non-callable for five years from the date of issuance. Thereafter, the notes will be callable at premiums declining to par in the eighth year.
Consents and waivers, dated June 30, 2001 and November 19, 1999, to the senior credit agreement allow the Company to repurchase the notes in the open market from time to time, with the aggregate purchase prices for all such notes repurchased not to exceed $50.0 million. Aggregate repurchases as of December 31, 2002 were $24.8 million.
As of December 31, 2002, the Company had outstanding $84.4 million of debt, consisting of approximately $75.2 million (face amount) of notes, $8.4 million of term loans due under the credit agreement, and $0.8 million of foreign bank borrowings.
During the year ended December 31, 2001, Jafra S.A. repaid the balance remaining under a one-year term originally due on August 16, 2001, and entered into an unsecured foreign bank loan agreement. Under this agreement, Jafra S.A. had the peso equivalent of $0.8 million at a weighted average fixed interest rate of 18.5% outstanding at December 31, 2002. Principal and interest payments are due monthly through January 25, 2005.
23
The following schedule details the payment schedule for debt and lease obligations as of December 31, 2002:
Payments Due by Period
Contractual Obligations | Total | 2003 | 2004 - 2005 | 2006 - 2007 | Thereafter | |||||||||||||||
(Dollars in thousands) | ||||||||||||||||||||
11 3/4% senior subordinated notes due 2008
|
$ | 75,180 | $ | | $ | | $ | | $ | 75,180 | ||||||||||
Term loan
|
8,375 | 5,875 | 2,500 | | | |||||||||||||||
Unsecured foreign bank loan agreement
|
828 | 614 | 214 | | | |||||||||||||||
Lease obligations
|
$ | 18,848 | $ | 3,481 | $ | 7,663 | $ | 7,177 | $ | 167 |
The Company believes, but no assurance can be given, that its existing cash, cash flow from operations and availability under the senior credit agreement will provide sufficient liquidity to meet the Companys cash requirements and working capital needs over the next year. The Company has experienced reduced consultant liquidity in certain foreign subsidiaries. Reduced consultant liquidity could result in future reduced cash flows from operations, which may require the Company to use available funds under the Senior Credit Agreement.
Outsourcing of Manufacturing Functions
The Company entered into a manufacturing agreement, dated as of June 10, 1999, with a third-party contractor (the contractor). Subject to the terms and conditions of the manufacturing agreement, the contractor has agreed to manufacture all of the Companys requirements for certain cosmetic and skin care products for an initial term of five years expiring in 2004. Following the expiration of the initial five-year term, the manufacturing agreement will be automatically extended for additional one-year terms unless terminated by six months prior written notice by either party. The manufacturing agreement provides for price renegotiations by the contractor if the Companys quarterly or annual purchase volume falls below specified minimums. The manufacturing agreement requires the contractor to maintain insurance to cover costs associated with any product liability or product recall caused by the acts or omissions of the contractor. In addition, the Company is obligated to purchase materials acquired by the contractor based upon product forecasts provided by the Company if the contractor is unable to sell such materials to a third party. There have been no such repurchases to date. The contractor is solely responsible for obtaining the inventories, manufacturing the inventories at its current location in Chino, California, complying with applicable laws and regulations, and performing quality assurance functions.
During the fourth quarter of 2000, the contractor obtained $1.0 million of advances from the Company in exchange for an unsecured promissory note. The note bears interest at an annual rate of 9% and is payable in monthly installments commencing on February 15, 2001. On April 15, 2002, the unsecured promissory note was amended to advance an additional $0.3 million to the contractor. At December 31, 2002, approximately $0.1 million of the note was outstanding and was included in receivables in the accompanying consolidated balance sheets.
Restructuring Activities
During 2001, the Company paid out approximately $1.0 million in charges related to year 2000 repositioning activities in Europe consisting primarily of severance costs. During 2002, the remaining $0.2 million was paid out against the remaining accrual.
Cash Flows
Net cash provided by operating activities was $43.1 million in 2002, consisting of $48.0 million provided by net income adjusted for depreciation, and other non-cash items included in net income, less $4.9 million used in changes in operating assets and liabilities. The significant elements of the net cash used in changes in
24
Net cash used in investing activities was $11.3 million in 2002, compared to $11.7 million in 2001, a decrease of $0.4 million. In 2002, investing activities consisted primarily of capital expenditures of $11.0 million, primarily in the Companys United States and Mexico subsidiaries. A significant portion of the 2002 capital expenditures related to information technology and production equipment. In 2001, investing activities consisted primarily of capital expenditures of $4.5 million in the Companys U.S. subsidiary, $6.0 million in the Companys Mexico subsidiaries, and $0.9 million in other subsidiaries.
Capital expenditures in 2003 are expected to be approximately $13.0 million, comprised of approximately $4.5 million of information technology expenditures and $5.9 million of production equipment expenditures. These capital expenditures will be funded by cash from operations or borrowings under the revolving credit facility.
Net cash used in financing activities was $8.7 million in 2002 compared to $16.6 million in 2001, a decrease of $7.9 million. In 2002, the Company made net repayments of $6.1 million under the term loan facility, $1.8 million under the revolving credit facility and $0.8 million repayment of the foreign bank debt. In 2001, the Company made net repayments of $12.7 million under the existing revolving credit facility and $4.5 million under the existing term loan facility and paid $0.8 million for the repurchase of common stock. In 2001, the cash used in financing activities was partially offset by net proceeds of $1.3 million from an unsecured foreign bank loan agreement at Jafra S.A.
The effect of exchange rate changes on cash was $2.6 million in 2002 compared to $1.0 million for 2001 relating to fluctuations in the exchange rate of the Mexican peso and South American currencies, primarily the Brazilian real and the Argentine peso.
Foreign Operations
Net sales outside of the United States aggregated 76%, 79% and 77% of the Companys total net sales for the fiscal years 2002, 2001 and 2000, respectively. In addition, as of December 31, 2002, international subsidiaries comprised approximately 71% of the Companys consolidated total assets. Accordingly, the Company has experienced and continues to be exposed to foreign exchange risk. The Company has implemented a hedging program to protect against potential devaluation of the Mexican peso. See Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
The Companys subsidiary in Mexico, Jafra S.A. generated approximately 64% of the Companys net sales for 2002 compared to 66% for 2001, substantially all of which was denominated in Mexican pesos. During 2002, the peso weakened against the U.S. dollar. Net sales in Mexico for 2002 would have increased $9.4 million, or 3.7%, from the reported amounts if average exchange rates in 2002 remained the same as in 2001.
Mexico has experienced periods of high inflation in the past and has been considered a hyperinflationary economy. As of January 1, 1999, the Company has accounted for its Mexican operations using the peso as its functional currency. Because the functional currency in Mexico is the Mexican peso, gains and losses of remeasuring debt to the U.S. dollar from the peso are included as a component of net income. In 2002, the remeasurement of U.S. dollar-denominated debt resulted in an exchange loss of $5.2 million, most of which was unrealized. Jafra S.A. had $32.4 million of U.S. dollar-denominated third-party debt and $21.9 million of U.S. dollar-denominated intercompany current payables as of December 31, 2002.
25
The Company is also exposed to foreign exchange risk due to its operations in South America. During 2002, most South American currencies devalued against the U.S. dollar. Measured in U.S. dollars, South America sales decreased 11% in 2002 compared to 2001. If currencies remained stable between 2002 and 2001, South America net sales would have increased 16%.
European Economic and Monetary Union
On January 1, 1999, eleven of the fifteen member countries of the European Union established fixed conversion rates between their existing sovereign currencies and the euro. The participating countries adopted the euro as their common legal currency on that date. The euro traded on currency exchanges and was available for non-cash transactions during the transition period between January 1, 1999 and January 1, 2002. During this transition period, the existing currencies remained legal tender in the participating countries as denominations of the euro and public and private parties paid for goods and services using either the euro or the participating countries existing currencies.
During the transition period, the Company utilized the respective countrys existing currency as the functional currency. During 2001, the Company modified its current systems to achieve a euro compliant system. The system modifications were conducted without significant cost and did not have any adverse affects on the business or operations. Effective January 1, 2002, the Company adopted the euro as its functional currency for its European subsidiaries, except for Switzerland, without any material adverse affects on the business or operations.
Business Trends and Initiatives
The Company has experienced sales growth in Mexico, due primarily to increases in the number of consultants. Additionally, the Mexico subsidiary contributes a significant portion of the Companys consolidated net sales. In 2002, the Companys Mexican subsidiary generated 64% of the Companys consolidated net sales, compared to 66% in 2001 and 62% in 2000. In local currency, net sales growth was 5% in 2002, compared to 22% in 2001. The Mexico peso devalued 13% between December 31, 2001 and December 31, 2002. The weakening of the Mexico peso during 2002 resulted in 2% net sales growth measured in US dollars compared to 5% sales growth measured in local currency in 2002.
The Companys U.S. subsidiary has experienced significant sales growth in the past two years. In 2000, the U.S. subsidiary employed a strategy to bifurcate its operations into two distinct divisions, the Hispanic Division and the General Division. The two distinct divisions allow management to tailor programs and product offerings to meet the needs of each division. In 2002, the U.S. subsidiary also initiated certain program changes to focus on consultant productivity. The U.S. subsidiary contributed 24% to total 2002 net sales. U.S. net sales increased 16% in 2002, compared to 7% in 2001 and 1% in 2000.
Due to the favorable exchange rate impact, net sales in Europe for 2002 increased 2% compared to net sales in 2001. In local currencies, European net sales decreased in 2002 compared to 2001. Except for the favorable impact of exchange in 2002, European net sales have declined over the past three years. Europe has also experienced declines in both the number and productivity of consultants (except for the favorable impact of exchange on 2002 productivity). European sales have declined from approximately 11% of the Companys business in 1999 to approximately 7% of the Companys business in 2002. The Company is also considering certain plans to minimize losses in the European markets, which may include exiting some or all of the European markets through sale or discontinuation of operations.
Since 1999, the Company has made significant investments in new markets in South America. During 2002, South American countries in which the Company operates faced challenging macroeconomic environments. The South American operations were unfavorably impacted by exchange rates in 2002 compared to
26
Information Concerning Forward-Looking Statements
This Form 10-K may contain forward-looking statements which include assumptions about future market conditions, operations and results. These statements are based on current expectations and are subject to risks and uncertainties. They are made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Among those forward-looking statements, are, without limitation, (i) the statements in Business Strategy concerning (a) the Companys belief that its market position and distribution network of approximately 269,000 consultants in Mexico positions the Company to continue to grow the business by capturing additional market share, (b) the Companys belief that in the General Division the Company will to continue to leverage e-commerce capabilities, (c) the Companys belief that in the Hispanic Division the Company will continue to leverage its market position in Mexico in areas of training, recruitment and marketing, (d) the Companys intent to continue to stimulate sales and new consultant recruitment efforts through recognition events, incentives, gifts and free travel for consultants, (e) the Companys belief that new product introductions are fundamental to the Companys direct selling business model in that they serve to motivate consultants and give them new and exciting products to demonstrate and market to their clients (f) the Companys belief that its direct selling business model will continue to generate significant organic growth, (g) the Company may consider plans to exit certain non-core markets, in Thailand, and some or all of South America and Europe through either a sale or discontinuation of their operations; (ii) the statements in Business Products concerning (a) the Companys plan to launch new products that address skin pigmentation in 2003, (b) the Companys consideration of expanding its product line to include nutritional and wellness products (iii) the statements in Business Independent Sales Force that the Company believes that public recognition of sales accomplishments serves the dual purpose of identifying successful role models and boosting consultant morale, (iv) the statements in Business International Operations that the Company may consider plans to exit certain non-core markets, including Thailand and some or all of South America and Europe through either a sale or discontinuation of their operations; (v) the statement in Business Manufacturing that finished goods and raw materials used in the Companys products generally are available or can be obtained to Company specifications from more than one potential supplier; (vi) the statement in Business Distribution that management believes its facilities are adequate to meet demand in its existing markets for the foreseeable future; (vi) the statements in Business Competition that the Company believes that the senior management team with a strong direct selling track record, motivated direct sales force, prestige quality product lines, product development capabilities, geographic diversification, short delivery cycle, and manufacturing technology are significant factors in establishing and maintaining its competitive position; (vii) Business Management Information Systems concerning (a) the Companys expectation that waves two and three, which relate to the order entry and remaining commercial systems, will be implemented in the second quarter of 2003, (b) the Companys anticipation that this new system may be leveraged to improve computer operations in Mexico, Puerto Rico and the Dominican Republic during 2004; (viii) the statement in Business Environmental Matters that the Company believes that environmental laws and regulations will not have a material adverse effect on its capital expenditures, earnings or competitive position; (ix) other statements as to managements or the Companys expectations, intentions and beliefs presented in Business; (x) the statement in Properties that the Companys properties are suitable to meet its anticipated requirements; (xi) the statement in Legal Proceedings that the Company believes that the resolution of the routine legal matters in which it is involved will not have a material adverse effect on the Companys business, financial condition or results of operations; (xii) the statement in Market for Registrants Common Equity and Related Stockholder Matters that the Parent does not expect to pay for the foreseeable future, regular dividends on shares of its Common Stock; (xiii) the statement in Critical
27
Forward-looking statements are based upon managements current expectations and beliefs concerning future developments and their potential effects upon the Company. There can be no assurance that future developments will be in accordance with managements expectations or that the effect of future developments on the Company will be those anticipated by management. The following important factors, and those important factors described elsewhere in this report (including, without limitation, those discussed in Business Strategy, International Operations, Distribution, Manufacturing, Management Information Systems, Environmental Matters, Properties, Legal Proceedings and Managements Discussion and Analysis of Financial Condition and Results of Operations Results of Operations, New Accounting Pronouncements, Critical Accounting Policies and Estimates, Liquidity and Capital Resources, Foreign Operations, European Economic and Monetary Union and Business Trends and Initiatives), or in other Securities and Exchange Commission filings, could affect (and in some cases have affected) the Companys actual results and could cause such results to differ materially from estimates or expectations reflected in such forward-looking statements:
| The Companys high degree of leverage could have important consequences to the Company, including but not limited to the following: (i) the Companys ability to obtain additional financing for working capital, capital expenditures, acquisitions, general corporate purposes or other purposes may be impaired in the future; (ii) a substantial portion of the Companys cash flow from operations must be dedicated to the payment of principal and interest on its indebtedness, thereby reducing the funds available to the Company for other purposes; (iii) certain of the Companys borrowings will be at variable rates of interest, which could cause the Company to be vulnerable to increases in interest rates and (iv) the Company may be more vulnerable to economic downturns and be limited in its ability to withstand competitive pressures. | |
| The Companys ability to make scheduled payments or to refinance its obligations with respect to its indebtedness, and to comply with the covenants and restrictions contained in the instruments governing such indebtedness, will depend on its financial and operating performance, which, in turn, is subject to prevailing economic and competitive conditions and to certain financial, business and other factors beyond its control, including operating difficulties, increased operating costs, market cyclicality, product prices, the response of competitors, regulatory developments, and delays in implementing strategic projects. | |
| The Companys ability to meet its debt service and other obligations will depend in significant part on the extent to which the Company can successfully implement its business strategy. The components of |
28
the Companys strategy are subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond the control of the Company. | ||
| The Companys ability to conduct and expand its business outside the United States and the amount of revenues derived from foreign markets are subject to the risks inherent in international operations. The Companys international operations may be adversely affected by import duties or other legal restrictions on imports, currency exchange control regulations, fluctuations in currency exchange rates, transfer pricing regulations, the possibility of hyperinflationary conditions and potentially adverse tax consequences, among other things. Given the balance of payment deficits and shortages in foreign exchange reserves that many such economies, including the Mexican economy, have suffered in recent years, there can be no assurance that the governments of nations in which the Company operates, or intends to expand, will not take actions that materially adversely affect the Company and its business. | |
| The direct selling cosmetics and personal care products business is highly competitive. A number of the Companys competitors, including Avon and Mary Kay, are significantly larger and have substantially greater resources and less leverage than the Company, which may provide them with greater flexibility to respond to changing business and economic conditions than the Company. An increase in the amount of competition faced by the Company, or the inability of the Company to compete successfully, could have a material adverse effect on the Companys business, financial condition and results of operations. | |
| The Companys ability to anticipate changes in market and industry trends and to successfully develop and introduce new and enhanced products on a timely basis will be a critical factor in its ability to grow and to remain competitive. There can be no assurance that new products and product enhancements will be completed on a timely basis or will enjoy market acceptance following their introduction. In addition, the anticipated development schedules for new or improved products are inherently difficult to predict and are subject to delay or change as a result of shifting priorities in response to customers requirements and competitors new product introductions. | |
| The Company is subject to or affected by governmental regulations concerning, among other things, (i) product formulation, (ii) product claims and advertising, whether made by the Company or its consultants, (iii) fair trade and distributor practices and (iv) environmental, health and safety matters. In addition, new regulations could be adopted or any of the existing regulations could be changed at any time in a manner that could have a material adverse effect on the Companys business and results of operations. Present or future health or safety or food and drug regulations could delay or prevent the introductions of new products into a given country or marketplace or suspend or prohibit the sale of existing products in such country or marketplace. The Company believes that it is in compliance in all material respects with such laws and regulations now in effect. |
While the Company periodically reassesses material trends and uncertainties affecting the Companys results of operations and financial condition in connection with its preparation of managements discussion and analysis of results of operations and financial condition contained in its quarterly and annual reports, the Company does not intend to review or revise any particular forward-looking statement referenced in this report in light of future events.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
The Company is exposed to certain market risks arising from transactions in the normal course of its business, and from debt incurred in connection with the Acquisition. Such risk is principally associated with interest rate and foreign exchange fluctuations, as well as changes in the Companys credit standing.
Interest Rate Risk
The Company has U.S. dollar-denominated debt obligations in both the United States and Mexico that have fixed and variable interest rates and mature on various dates. The Company also has Mexican peso
29
Debt Obligation Information at December 31, 2002
Expected Year of Maturity | Fair Value | ||||||||||||||||||||||||||||||||
December 31, | |||||||||||||||||||||||||||||||||
2003 | 2004 | 2005 | 2006 | 2007 | Thereafter | Total | 2002(1) | ||||||||||||||||||||||||||
Senior subordinated notes, term loan, revolving
credit facility
and unsecured bank debt, |
|||||||||||||||||||||||||||||||||
Fixed rate (US$)
|
$ | 614 | $ | 214 | $ | | $ | | $ | | $ | 75,180 | $ | 76,008 | $ | 77,888 | |||||||||||||||||
Average Interest Rate
|
18.47 | % | 18.47 | % | | | | 11.75 | % | ||||||||||||||||||||||||
Variable Rate (US$)
|
$ | 5,875 | $ | 2,500 | $ | | $ | | $ | | $ | | $ | 8,375 | $ | 8,375 | |||||||||||||||||
Average Interest Rate
|
3.1 | % | 3.1 | % | | | | |
Debt Obligation Information at December 31, 2001
Expected Year of Maturity | Fair Value | ||||||||||||||||||||||||||||||||
December 31, | |||||||||||||||||||||||||||||||||
2002 | 2003 | 2004 | 2005 | 2006 | Thereafter | Total | 2001(1) | ||||||||||||||||||||||||||
Senior subordinated notes, term loan, revolving
credit facility and unsecured bank debt
|
|||||||||||||||||||||||||||||||||
Fixed Rate (US$)
|
$ | 688 | $ | 688 | $ | 233 | $ | | $ | | $ | 75,180 | $ | 76,789 | $ | 82,052 | |||||||||||||||||
Average Interest Rate
|
18.66 | % | 18.66 | % | 18.66 | % | | | 11.75 | % | |||||||||||||||||||||||
Variable Rate (US$)
|
$ | 5,500 | $ | 6,500 | $ | 4,300 | $ | | $ | | $ | | $ | 16,300 | $ | 16,300 | |||||||||||||||||
Average Interest Rate
|
4.25 | % | 4.25 | % | 4.72 | % | | | |
(1) | The Companys estimate of the fair value of its senior subordinated notes was based on discussions with one of the Companys largest bondholders, and an analysis of current market interest rates and the Companys credit rating. The Companys revolving credit facilities and the term loan are variable rate debt, and the interest rate spread paid by the Company is adjusted for changes in certain financial ratios of the Company. The fair value of the revolving credit facilities, the term loan and the unsecured bank agreement approximated their carrying amounts at December 31, 2002 and 2001. |
As of December 31, 2002, the Company had $8.4 million of variable interest rate debt outstanding. If variable interest rates had increased by 10%, the Company would have incurred $0.1 million of additional interest expense during 2002.
Foreign Currency Risk
The Company operates globally, with manufacturing facilities in Mexico and distribution facilities in various locations around the world. With the exception of most intercompany product sales between European subsidiaries, all intercompany product sales are denominated in U.S. dollars, as are some expenses, including interest payments with respect to almost all of its outstanding indebtedness. In addition, 76% of the Companys 2002 revenue was generated in countries with a functional currency other than the U.S. dollar. As a result, the Companys earnings and cash flows are exposed to fluctuations in foreign currency exchange rates.
As part of its overall strategy to reduce the risk of adverse exchange rate fluctuations in Mexico, the Company entered into foreign currency exchange contracts. Prior to March 2002, the Company purchased forward exchange contracts (forward contracts or forwards) to hedge its foreign currency exposures to the Mexican peso. In March 2002, in accordance with previously approved policies, the Company modified its hedging program to include the use of foreign currency option contracts (option contracts or options). In order to offset its current outstanding forward contracts to sell Mexican pesos, the Company entered into forward contracts to buy Mexican pesos. Also, on that date, the Company entered into a series of U.S. dollar
30
The Company places forward contracts and option contracts based on forecasted U.S. dollar cash outflows from Jafra S.A. over a rolling twelve-month period and does not hedge transactions that are not included in the twelve-month forecast on the date the forward contract is initiated. As a matter of policy, the Company does not hold or issue forward contracts or option contracts for trading or speculative purposes, nor does it enter into contracts or agreements containing embedded derivative features nor is the Company a party to leveraged derivatives. The Company regularly monitors its foreign currency exposures and ensures that contract amounts do not exceed the amounts of the underlying exposures. In addition, as the Company generally purchases hedging instruments on a rolling twelve-month basis, there can be no assurance that instruments protecting it to the same or a similar extent will be available in the future on reasonable terms, if at all. Unprotected declines in the value of the Mexican peso against the U.S. dollar will adversely affect the Companys ability to pay its dollar-denominated expenses.
Prior to adoption of SFAS No. 133, the forward contracts the Company utilized did not qualify for hedge accounting under the applicable accounting standards, and accordingly such instruments were marked-to-market with gains and losses included as a component of exchange loss in the statements of income for the year ended December 31, 2000. However, under SFAS No. 133, the Companys use of forward and option contracts to hedge certain forecasted transactions does qualify for hedge accounting. Gains and losses from such derivative instruments arising subsequent to January 1, 2001 are deferred as a separate component of other comprehensive loss, and are recognized in income at the same time that the underlying hedged exposure is recognized in income. This accounting treatment results in the matching of gains and losses from such forward and option contracts with the corresponding gains and losses generated by the underlying hedged transactions. Under SFAS No. 133, certain of the Companys forward and option contracts do not qualify for hedge accounting and, therefore, are remeasured based on fair value, with gains and losses included as a component of net income. As of December 31, 2002, the Company had no outstanding forward contracts. As of December 31, 2002, the fair value of the option contracts is included in other receivables in current assets in the accompanying consolidated balance sheets.
The outstanding foreign currency option contracts had a notional value denominated in Mexican pesos of $523,000,000 in put and call positions at December 31, 2002 and mature at various dates through December 31, 2003. The outstanding foreign currency forward contracts had notional values denominated in Mexican pesos of $688,873,000 at December 31, 2001 and matured in 2002. Notional amounts do not quantify the Companys market or credit exposure or represent the Companys assets or liabilities, but are used in the calculation of cash settlements under the contracts.
31
The following table provides information about the details of the Companys option contracts as of December 31, 2002 (in thousands):
Coverage in | ||||||||||||||||
Mexican | Average Strike | Fair Value in | ||||||||||||||
Foreign Currency | Pesos | Price | U.S. Dollars(1) | Maturity Date | ||||||||||||
At December, 2002:
|
||||||||||||||||
Purchased puts (Company may sell peso/buy USD)
|
||||||||||||||||
Mexican peso
|
$ | 149,000 | 10.31-10.48 | $ | (113 | ) | Jan.-Mar. 2003 | |||||||||
Mexican peso
|
100,000 | 11.05-12.19 | 77 | Apr.-June 2003 | ||||||||||||
Mexican peso
|
150,000 | 11.76-12.79 | 131 | July-Aug 2003 | ||||||||||||
Mexican peso
|
124,000 | 12.51-12.91 | 21 | Oct.-Dec. 2003 | ||||||||||||
$ | 523,000 | $ | 116 | |||||||||||||
Written calls (Counterparty may buy peso/sell USD)
|
||||||||||||||||
Mexican peso
|
$ | 149,000 | 9.01-9.02 | $ | (207 | ) | Jan.-Mar. 2003 | |||||||||
Mexican peso
|
100,000 | 9.50-9.84 | (144 | ) | Apr.-June 2003 | |||||||||||
Mexican peso
|
150,000 | 9.69-10.19 | (112 | ) | July-Aug 2003 | |||||||||||
Mexican peso
|
124,000 | 10.15-10.19 | (55 | ) | Oct.-Dec. 2003 | |||||||||||
$ | 523,000 | $ | (518 | ) | ||||||||||||
(1) | The Fair Value of the option contracts presented above, an unrealized loss of $402,000 at December 31, 2002, represents the carrying value and was recorded in other receivables in the consolidated balance sheets. |
The tables below describe the forward contracts that were outstanding at December 31, 2001 (in thousands):
December 31, 2001:
Forward Position | Weighted | |||||||||||||||
In Mexican | Maturity | Average | Fair Value in | |||||||||||||
Foreign Currency | Pesos(1) | Date | Contract Rate | U.S. Dollars(1) | ||||||||||||
Buy US dollar/sell Mexican peso
|
$ | 108,715 | 1/31/02 | 10.19 | $ | 1,128 | ||||||||||
Sell Mexican peso/buy US dollar
|
(20,000 | ) | 1/31/02 | 9.35 | (34 | ) | ||||||||||
Buy US dollar/sell Mexican peso
|
71,787 | 2/28/02 | 10.26 | 756 | ||||||||||||
Sell Mexican peso/buy US dollar
|
(20,000 | ) | 2/28/02 | 9.47 | (48 | ) | ||||||||||
Buy US dollar/sell Mexican peso
|
94,371 | 3/27/02 | 10.46 | 1,102 | ||||||||||||
Sell Mexican peso/buy US dollar
|
(40,000 | ) | 3/27/02 | 9.48 | (80 | ) | ||||||||||
Buy US dollar/sell Mexican peso
|
85,000 | 4/30/02 | 10.23 | 748 | ||||||||||||
Sell Mexican peso/buy US dollar
|
(30,000 | ) | 4/30/02 | 9.62 | (84 | ) | ||||||||||
Buy US dollar/sell Mexican peso
|
81,000 | 5/31/02 | 10.11 | 559 | ||||||||||||
Sell Mexican peso/buy US dollar
|
(25,000 | ) | 5/31/02 | 9.71 | (75 | ) | ||||||||||
Buy US dollar/sell Mexican peso
|
80,000 | 6/28/02 | 9.95 | 375 | ||||||||||||
Sell Mexican peso/buy US dollar
|
(30,000 | ) | 6/28/02 | 9.78 | (88 | ) | ||||||||||
Buy US dollar/sell Mexican peso
|
48,000 | 7/31/02 | 10.07 | 242 | ||||||||||||
Buy US dollar/sell Mexican peso
|
100,000 | 8/30/02 | 10.05 | 410 | ||||||||||||
Buy US dollar/sell Mexican peso
|
45,000 | 9/30/02 | 10.09 | 169 | ||||||||||||
Buy US dollar/sell Mexican peso
|
110,000 | 10/31/02 | 10.09 | 338 | ||||||||||||
Buy US dollar/sell Mexican peso
|
30,000 | 11/29/02 | 10.27 | 122 | ||||||||||||
$ | 688,873 | $ | 5,540 | |||||||||||||
(1) | The Fair Value of the forward positions presented above, an unrealized loss of $5,540,000 at December 31, 2001 represents the carrying value of the forward contracts and was recorded in accrued liabilities in the accompanying consolidated balance sheets. |
32
Prior to entering into foreign currency hedging contracts, the Company evaluates the counter parties credit ratings. Credit risk represents the accounting loss that would be recognized at the reporting date if counter parties failed to perform as contracted. The Company does not currently anticipate non-performance by such counter parties.
Based upon the outstanding option contracts at December 31, 2002, if the peso to U.S. dollar exchange rate strengthened by 10%, a $2.5 million foreign currency loss on the settlement of option contracts would result. However, gains would be realized on the Companys underlying hedged transactions.
The Companys Mexican subsidiary, Jafra S.A. had U.S. dollar-denominated debt of $32.4 million and $35.6 million at December 31, 2002 and 2001, respectively. During 2002, the value of the peso to the U.S. dollar decreased by 13.5%, and Jafra S.A. incurred a $5.2 million foreign currency transaction loss related to the remeasurement and repayment of U.S. dollar-denominated debt.
Based upon the $32.4 million of outstanding debt at December 31, 2002, a 10% decline in the peso to U.S. dollar exchange rate would result in a $3.2 million foreign currency exchange loss.
33
Item 8. Financial Statements and Supplementary Data
INDEX TO FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCHEDULES*
Page | |||||
Consolidated Financial Statements
CDRJ Investments (Lux) S.A. and Subsidiaries
|
|||||
Independent Auditors Reports
|
35 | ||||
Consolidated Balance Sheets As of
December 31, 2002 and 2001
|
37 | ||||
Consolidated Statements of Income For
the years ended December 31, 2002 , 2001 and 2000
|
38 | ||||
Consolidated Statements of Stockholders
Equity For the years ended December 31, 2002,
2001 and 2000
|
39 | ||||
Consolidated Statements of Cash Flows
For the years ended December 31, 2002, 2001 and 2000
|
40 | ||||
Notes to Consolidated Financial Statements
|
41 | ||||
Consolidated Financial Statements
Jafra Cosmetics International, Inc. and Subsidiaries
|
|||||
Independent Auditors Reports
|
63 | ||||
Consolidated Balance Sheets As of
December 31, 2002 and 2001
|
65 | ||||
Consolidated Statements of Income For
the years ended December 31, 2002, 2001 and 2000
|
66 | ||||
Consolidated Statements of Stockholders
Equity For the years ended December 31, 2002,
2001 and 2000
|
67 | ||||
Consolidated Statements of Cash Flows
For the years ended December 31, 2002, 2001 and 2000
|
68 | ||||
Notes to Consolidated Financial Statements
|
69 | ||||
Consolidated Financial Statements
Jafra Cosmetics International, S.A. de C.V. and
Subsidiaries
|
|||||
Independent Auditors Reports
|
86 | ||||
Consolidated Balance Sheets As of
December 31, 2002 and 2001
|
88 | ||||
Consolidated Statements of Income For
the years ended December 31, 2002, 2001 and 2000
|
89 | ||||
Consolidated Statements of Stockholders
Equity For the years ended December 31, 2002,
2001 and 2000
|
90 | ||||
Consolidated Statements of Cash Flows
For the years ended December 31, 2002, 2001 and 2000
|
91 | ||||
Notes to Consolidated Financial Statements
|
92 | ||||
Schedule II Valuation and
Qualifying Accounts
|
107 |
* | Schedules other than those listed above have been omitted because they are not applicable. |
34
INDEPENDENT AUDITORS REPORT
To the Board of Directors and Stockholders of
We have audited the accompanying consolidated balance sheet of CDRJ Investments (Lux) S.A. and subsidiaries (the Company) as of December 31, 2001, and the related consolidated statements of income, stockholders equity, and cash flows for each of the two years in the period ended December 31, 2001. These financial statements and the financial statement schedule are the responsibility of the Companys management. Our responsibility is to express an opinion on these financial statements and the financial statement schedule based on our audits.
We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements referred to above present fairly, in all material respects, the financial position of CDRJ Investments (Lux) S.A. and subsidiaries as of December 31, 2001, and the results of their operations and their cash flows for each of the two years in the period ended December 31, 2001, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the financial statement schedule referred to above, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
DELOITTE & TOUCHE, LLP
Los Angeles, California
35
INDEPENDENT AUDITORS REPORT
To the Board of Directors and Stockholders of
We have audited the accompanying consolidated balance sheets of CDRJ Investments (Lux) S.A. and subsidiaries (the Company) as of December 31, 2002, and the related consolidated statement of income, stockholders equity, and cash flows for the year then ended. Our audit also included the financial statement schedule for the year ended December 31, 2002 listed at Item 15(a)(2). These financial statements and schedule are the responsibility of the Companys management. Our responsibility is to express an opinion on these financial statements and schedule based on our audit.
We conducted our audit in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.
In our opinion, such consolidated financial statements referred to above present fairly, in all material respects, the financial position of CDRJ Investments (Lux) S.A. and subsidiaries as of December 31, 2002, and the results of their operations and their cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States. Also, in our opinion, the related financial statement schedule for the year ended December 31, 2002, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
As discussed in Note 2 to the consolidated financial statements, effective January 1, 2002, the Company adopted Statement of Financial Accounting Standards No. 142.
/s/ Ernst & Young, LLP |
Los Angeles, California
36
CDRJ INVESTMENTS (LUX) S.A. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
ASSETS
December 31, | December 31, | |||||||||
2002 | 2001 | |||||||||
Current assets:
|
||||||||||
Cash and cash equivalents
|
$ | 27,206 | $ | 6,748 | ||||||
Receivables, less allowances for doubtful
accounts of $8,396 in 2002 and $7,267 in 2001
|
41,126 | 43,898 | ||||||||
Inventories
|
35,286 | 40,515 | ||||||||
Prepaid income taxes
|
258 | | ||||||||
Prepaid expenses and other current assets
|
4,977 | 7,851 | ||||||||
Deferred income taxes
|
| 55 | ||||||||
Total current assets
|
108,853 | 99,067 | ||||||||
Property and equipment, net
|
60,722 | 59,598 | ||||||||
Other assets:
|
||||||||||
Goodwill
|
66,305 | 71,148 | ||||||||
Trademarks
|
44,570 | 50,560 | ||||||||
Deferred financing fees and other, net
|
7,840 | 10,763 | ||||||||
Total
|
$ | 288,290 | $ | 291,136 | ||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
Current liabilities:
|
||||||||||
Current portion of long-term debt
|
$ | 6,489 | $ | 6,188 | ||||||
Accounts payable
|
18,636 | 26,516 | ||||||||
Accrued liabilities
|
44,824 | 40,916 | ||||||||
Income taxes payable
|
4,939 | 7,130 | ||||||||
Deferred income taxes
|
2,073 | 4,094 | ||||||||
Total current liabilities
|
76,961 | 84,844 | ||||||||
Long-term debt
|
77,894 | 86,901 | ||||||||
Deferred income taxes
|
21,186 | 20,311 | ||||||||
Other long-term liabilities
|
3,787 | 3,088 | ||||||||
Total liabilities
|
179,828 | 195,144 | ||||||||
Commitments and contingencies
|
| | ||||||||
Stockholders equity:
|
||||||||||
Common stock, par value $2.00; authorized,
1,020,000 shares; issued and outstanding,
831,888 shares in 2002 and 2001
|
1,664 | 1,664 | ||||||||
Additional paid-in capital
|
81,921 | 81,921 | ||||||||
Retained earnings
|
37,145 | 18,373 | ||||||||
Accumulated other comprehensive loss
|
(12,268 | ) | (5,966 | ) | ||||||
Total stockholders equity
|
108,462 | 95,992 | ||||||||
Total
|
$ | 288,290 | $ | 291,136 | ||||||
See accompanying notes to consolidated financial statements.
37
CDRJ INVESTMENTS (LUX) S.A. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
Years Ended December 31, | ||||||||||||||
2002 | 2001 | 2000 | ||||||||||||
Net sales
|
$ | 390,978 | $ | 376,153 | $ | 321,228 | ||||||||
Cost of sales
|
92,434 | 86,996 | 79,559 | |||||||||||
Gross profit
|
298,544 | 289,157 | 241,669 | |||||||||||
Selling, general and administrative expenses
|
240,869 | 232,865 | 196,561 | |||||||||||
Restructuring and impairment charges
|
| | 2,626 | |||||||||||
Loss (gain) on sale of assets
|
(76 | ) | 69 | 150 | ||||||||||
Income from operations
|
57,751 | 56,223 | 42,332 | |||||||||||
Other income (expense):
|
||||||||||||||
Exchange loss, net
|
(11,148 | ) | (9,658 | ) | (11,652 | ) | ||||||||
Interest expense, net
|
(11,437 | ) | (13,308 | ) | (15,659 | ) | ||||||||
Other, net
|
119 | (123 | ) | 1,563 | ||||||||||
Income before income taxes, extraordinary item
and cumulative effect of accounting change
|
35,285 | 33,134 | 16,584 | |||||||||||
Income tax expense
|
16,269 | 17,420 | 9,934 | |||||||||||
Income before extraordinary item and cumulative
effect of accounting change
|
19,016 | 15,714 | 6,650 | |||||||||||
Extraordinary loss on early extinguishment of
debt, net of income tax benefit of $195
|
| | 315 | |||||||||||
Income before cumulative effect of accounting
change
|
19,016 | 15,714 | 6,335 | |||||||||||
Cumulative effect of accounting change, net of
income tax expense of $0 in 2002 and $82 in 2001
|
(244 | ) | 126 | | ||||||||||
Net income
|
$ | 18,772 | $ | 15,840 | $ | 6,335 | ||||||||
See accompanying notes to consolidated financial statements.
38
CDRJ INVESTMENTS (LUX) S.A. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
Years Ended December 31, | ||||||||||||||||||||||||||
2002 | 2001 | 2000 | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | |||||||||||||||||||||
Common Stock:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
831,888 | $ | 1,664 | 834,293 | $ | 1,669 | 830,659 | $ | 1,661 | |||||||||||||||||
Issuance of common stock
|
| | 474 | 1 | 4,424 | 9 | ||||||||||||||||||||
Exercise of stock options
|
| | 210 | | 158 | 1 | ||||||||||||||||||||
Repurchase of common stock
|
| | (3,089 | ) | (6 | ) | (948 | ) | (2 | ) | ||||||||||||||||
Balance, end of year
|
831,888 | 1,664 | 831,888 | 1,664 | 834,293 | 1,669 | ||||||||||||||||||||
Additional Paid-in Capital:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
81,921 | 82,128 | 81,381 | |||||||||||||||||||||||
Issuance of common stock
|
| 99 | 912 | |||||||||||||||||||||||
Exercise of stock options
|
| 52 | 32 | |||||||||||||||||||||||
Repurchase of common stock
|
| (358 | ) | (197 | ) | |||||||||||||||||||||
Balance, end of year
|
81,921 | 81,921 | 82,128 | |||||||||||||||||||||||
Retained Earnings:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
18,373 | 2,942 | (3,393 | ) | ||||||||||||||||||||||
Net income
|
18,772 | 15,840 | 6,335 | |||||||||||||||||||||||
Repurchase of common stock
|
| (409 | ) | | ||||||||||||||||||||||
Balance, end of year
|
37,145 | 18,373 | 2,942 | |||||||||||||||||||||||
Accumulated Other Comprehensive
Loss:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
(5,966 | ) | (5,572 | ) | (3,855 | ) | ||||||||||||||||||||
Net unrealized and deferred realized losses on
derivatives
|
(264 | ) | (3,746 | ) | | |||||||||||||||||||||
Tax benefit on unrealized and deferred realized
losses on derivatives
|
92 | 1,311 | | |||||||||||||||||||||||
Currency translation adjustments
|
(6,130 | ) | 2,041 | (1,717 | ) | |||||||||||||||||||||
Balance, end of year
|
(12,268 | ) | (5,966 | ) | (5,572 | ) | ||||||||||||||||||||
Total Stockholders Equity
|
831,888 | $ | 108,462 | 831,888 | $ | 95,992 | 834,293 | $ | 81,167 | |||||||||||||||||
Comprehensive Income:
|
||||||||||||||||||||||||||
Net income
|
$ | 18,772 | $ | 15,840 | $ | 6,335 | ||||||||||||||||||||
Unrealized and deferred realized losses on
derivatives
|
(4,192 | ) | (5,504 | ) | | |||||||||||||||||||||
Reclassified to exchange loss
|
1,167 | 797 | | |||||||||||||||||||||||
Reclassified to cost of sales
|
2,761 | 961 | | |||||||||||||||||||||||
Tax benefit on unrealized and deferred realized
losses on derivatives
|
92 | 1,311 | | |||||||||||||||||||||||
Currency translation adjustments
|
(6,130 | ) | 2,041 | (1,717 | ) | |||||||||||||||||||||
Total Comprehensive Income
|
$ | 12,470 | $ | 15,446 | $ | 4,618 | ||||||||||||||||||||
See accompanying notes to consolidated financial statements.
39
CDRJ INVESTMENTS (LUX) S.A. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years Ended December 31, | ||||||||||||||||
2002 | 2001 | 2000 | ||||||||||||||
Cash flows from operating
activities:
|
||||||||||||||||
Net income
|
$ | 18,772 | $ | 15,840 | $ | 6,335 | ||||||||||
Extraordinary loss on early extinguishment of
debt, net of taxes
|
| | 315 | |||||||||||||
Cumulative effect of accounting change, net of
taxes
|
244 | (126 | ) | | ||||||||||||
Income before extraordinary item and cumulative
effect of accounting change
|
19,016 | 15,714 | 6,650 | |||||||||||||
Adjustments to reconcile income before
extraordinary item and cumulative effect of accounting change to
net cash provided by operating activities:
|
||||||||||||||||
Loss (gain) on sale of property and equipment
|
(76 | ) | 69 | 150 | ||||||||||||
Depreciation and amortization
|
5,611 | 7,749 | 7,632 | |||||||||||||
Provision for uncollectible accounts receivable
|
12,376 | 9,464 | 5,958 | |||||||||||||
Amortization of deferred financing fees
|
1,405 | 1,434 | 1,430 | |||||||||||||
Asset impairment charge
|
| | 1,019 | |||||||||||||
Unrealized foreign exchange and derivative losses
(gains)
|
8,857 | (683 | ) | 2,918 | ||||||||||||
Deferred realized foreign exchange gains (losses)
|
181 | (827 | ) | | ||||||||||||
Deferred income taxes
|
587 | 3,913 | 3,430 | |||||||||||||
Changes in operating assets and liabilities:
|
||||||||||||||||
Receivables
|
(14,296 | ) | (15,839 | ) | (10,536 | ) | ||||||||||
Inventories
|
720 | (917 | ) | (7,856 | ) | |||||||||||
Prepaid expenses and other current assets
|
5,688 | 2,795 | (1,688 | ) | ||||||||||||
Other assets
|
1,787 | 192 | (927 | ) | ||||||||||||
Accounts payable and accrued liabilities
|
1,716 | (1,033 | ) | 12,065 | ||||||||||||
Income taxes payable/prepaid
|
(1,141 | ) | 7,376 | 12,156 | ||||||||||||
Other long-term liabilities
|
699 | 722 | 57 | |||||||||||||
Net cash provided by operating activities
|
43,130 | 30,129 | 32,458 | |||||||||||||
Cash flows from investing
activities:
|
||||||||||||||||
Proceeds from sale of property and equipment
|
225 | 93 | 675 | |||||||||||||
Purchases of property and equipment
|
(11,011 | ) | (11,372 | ) | (7,105 | ) | ||||||||||
Other
|
(531 | ) | (408 | ) | (760 | ) | ||||||||||
Net cash used in investing activities
|
(11,317 | ) | (11,687 | ) | (7,190 | ) | ||||||||||
Cash flows from financing
activities:
|
||||||||||||||||
Repurchase of subordinated notes
|
| | (10,597 | ) | ||||||||||||
Repayments under term loan facility
|
(6,125 | ) | (4,500 | ) | (3,500 | ) | ||||||||||
Net repayments under revolving credit facility
|
(1,800 | ) | (12,700 | ) | (10,500 | ) | ||||||||||
Net (repayments) borrowings of bank debt
|
(781 | ) | 1,263 | 346 | ||||||||||||
Net issuance of common stock
|
| 152 | 954 | |||||||||||||
Repurchase of common stock
|
| (773 | ) | (199 | ) | |||||||||||
Net cash used in financing activities
|
(8,706 | ) | (16,558 | ) | (23,496 | ) | ||||||||||
Effect of exchange rate changes on cash
|
(2,649 | ) | (974 | ) | (840 | ) | ||||||||||
Net increase in cash and cash equivalents
|
20,458 | 910 | 932 | |||||||||||||
Cash and cash equivalents at beginning of year
|
6,748 | 5,838 | 4,906 | |||||||||||||
Cash and cash equivalents at end of year
|
$ | 27,206 | $ | 6,748 | $ | 5,838 | ||||||||||
Supplemental disclosure of cash flow
information
|
||||||||||||||||
Cash paid (received) during the year for:
|
||||||||||||||||
Interest
|
$ | 10,173 | $ | 11,538 | $ | 15,027 | ||||||||||
Income Taxes
|
8,327 | 5,319 | (5,652 | ) |
At December 31, 2002, the Company had deferred net gains of $0.4 million on foreign currency option contracts recorded as other comprehensive loss and other receivables. At December 31, 2001, the Company had deferred losses of $2.9 million on foreign currency forward contracts recorded in accrued liabilities and other comprehensive income. Additionally, the related deferred income tax benefit of $1.3 million related to the deferred losses was recorded as a component of the net deferred income tax liability and other comprehensive income.
See accompanying notes to consolidated financial statements.
40
CDRJ INVESTMENTS (LUX) S.A. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(1) | Basis of Presentation and Description of Business |
Basis of Presentation
CDRJ Investments (Lux) S.A., a Luxembourg société anonyme (the Parent), Jafra Cosmetics International, Inc., a Delaware corporation (JCI), Jafra Cosmetics International, S.A. de C.V., a sociedad anonima de capital variable organized under the laws of the United Mexican States (Jafra S.A.) and certain other subsidiaries of the Parent were organized by Clayton, Dubilier & Rice Fund V Limited Partnership, a Cayman Islands exempted limited partnership managed by Clayton, Dubilier & Rice, Inc. (CD&R) to acquire (the Acquisition) the worldwide Jafra Cosmetics business (the Jafra Business) of The Gillette Company (Gillette). JCI and Jafra S.A. are indirect, wholly owned subsidiaries of the Parent. The Parent is a holding company that conducts all its operations through its subsidiaries. The Parent and its subsidiaries are collectively referred to as the Company. The Acquisition was completed on April 30, 1998.
The accompanying consolidated financial statements for the years ended December 31, 2002, 2001 and 2000 reflect the operations of the Parent and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Description of Business
The Company is an international manufacturer and marketer of premium skin and body care products, color cosmetics, fragrances, and other personal care products. The Company markets its products primarily in 15 countries, 14 outside the United States, and a number of additional countries through distributors, through a direct selling, multilevel distribution system comprised of self-employed salespersons (known as consultants).
(2) | Summary of Significant Accounting Policies |
Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents. Cash and cash equivalents include cash, time deposits and all highly liquid debt instruments purchased with a maturity of three months or less.
Inventories. Inventories are stated at the lower of cost, as determined by the first-in, first-out basis, or market.
Property and Equipment. Property and equipment are stated at cost. Depreciation of property and equipment is provided for over the estimated useful lives of the respective assets using the straight-line method. Estimated useful lives are 20 or 40 years for buildings, the lesser of 20 or 40 years or the term of the lease for improvements, 5 to 15 years for machinery and equipment and 3 to 8 years for hardware and software. Maintenance and repairs, including cost of minor replacements, are charged to operations as incurred. Costs of additions and betterments are added to property and equipment accounts provided that such expenditures increase the useful life or the value of the asset.
Intangible Assets. Intangible assets principally consist of goodwill and trademarks. On January 1, 2002, the Company adopted Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and other Intangible Assets which requires the Company to not amortize goodwill and certain other indefinite life intangible assets, but to test those intangible assets for impairment at least annually. Prior to adoption of SFAS No. 142, goodwill and other intangible assets were amortized using the straight-line method over a period of 40 years. Goodwill of $77.9 million and trademarks of $53.8 million, resulted from the Companys
41
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
acquisition of the Jafra Business from Gillette. The book value of goodwill and trademarks was $66,305,000 and $44,570,000 at December 31, 2002, respectively. (See New Accounting Standards).
Deferred Financing Costs. In connection with the acquisition of the Jafra Business, the Company incurred approximately $12.0 million of costs related to the 11.75% Senior Subordinated Notes due 2008 (the Notes), the revolving credit facility and the term loan facility (see Note 6). Such costs are being amortized on a basis that approximates the interest method over the expected term of the related debt. Accumulated amortization at December 31, 2002 and 2001 was $6,554,000 and $5,566,000, respectively.
Impairment of Long-Lived Assets and Goodwill. Long-lived assets are reviewed for impairment, based on undiscounted cash flows, whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. If this review indicates that the carrying amount of the long-lived assets is not recoverable, the Company will recognize an impairment loss, measured by the future discounted cash flow method. Goodwill is tested for impairment annually, or whenever events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable based on the provisions of SFAS No. 142. (see New Accounting Standards).
Foreign Currency Forward and Option Contracts. During 2002 and 2001, the Company entered into foreign currency forward contracts. In 2002, the Company entered into forward currency option contracts. The Company enters into these contracts to reduce the effect of potentially adverse exchange rate fluctuations in the exchange rate of the Mexican peso to the U.S. dollar. Effective January 1, 2001, the Company adopted SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. SFAS No. 133, as amended and interpreted, establishes accounting and reporting standards for derivative instruments and hedging activities and requires that all derivative instruments be recorded based on fair value. In connection with the adoption of SFAS No. 133, at January 1, 2001, the Company recorded a net gain of $126,000 (net of a tax effect of $82,000) as a cumulative transition adjustment to earnings. This adjustment relates to derivatives not designated as hedges prior to adoption of SFAS No. 133, and represents the difference between the carrying value and the fair value of such instruments.
As a matter of policy, the Company does not hold or issue foreign currency forward contracts or foreign currency option contracts for trading or speculative purposes. The forward contracts utilized by the Company did not qualify for hedge accounting under the applicable accounting standards prior to adoption of SFAS No. 133 on January 1, 2001, and accordingly such instruments were marked-to-market each month based upon the change in the spot rate from the date of contract inception to the balance sheet date. The premium on such contracts was amortized to expense over the life of the contracts. However, under SFAS No. 133, the Companys use of forward contracts and option contracts to hedge certain forecasted transactions qualifies for hedge accounting. Gains and losses from qualifying hedged derivative instruments are deferred as a separate component of other comprehensive loss, and are recognized in income at the same time that the underlying hedged exposure is recognized in income. This accounting treatment results in the matching of gains and losses from such forward contracts and option contracts with the corresponding gains and losses generated by the underlying hedged transactions. Under SFAS No. 133, certain of the Companys foreign currency forward contracts and option contracts do not qualify for hedge accounting and therefore, are remeasured based on fair value, with gains and losses included as a component of net income. At December 31, 2001, the carrying value of the forward contracts was $5,540,000 and was included in accrued liabilities in the accompanying consolidated balance sheets. At December 31, 2002, the carrying value of the option contracts was $402,000 and was included in other receivables in the accompanying consolidated balance sheets.
Fair Value of Financial Instruments. The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value because of the short-term maturities of these instruments. The fair value of the Notes and other fixed rate long-term debt at December 31, 2002 and 2001 was $77,888,000 and $82,052,000, respectively, based upon discussions with one of the Companys largest bondholders and an analysis of current market interest rates and the Companys credit rating. As the
42
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Companys revolving credit facility and the term loan are variable rate debt, and the interest rate spread paid by the Company is adjusted for changes in certain financial ratios of the Company, the fair value of the revolving credit facility and the term loan approximated their carrying amounts at December 31, 2002 and 2001.
Revenue Recognition. The Company recognizes revenue when title passes at shipment in accordance with its shipping terms. Amounts billed to consultants for shipping and handling costs are included in net sales. Sales are reduced by commissions paid to consultants on their personal sales.
Shipping and Handling Costs. Shipping and handling costs of $32,119,000, $28,736,000 and $24,716,000 for the years ended December 31, 2002, 2001 and 2000, respectively, are included in selling, general and administrative expenses.
Research and Development. Research and development costs are expensed as incurred. Total research and development expense aggregated $1,469,000, $1,842,000 and $1,901,000 for the years ended December 31, 2002, 2001 and 2000, respectively.
Income Taxes. The Company accounts for income taxes under the balance sheet approach that requires the recognition of deferred income tax assets and liabilities for the expected future consequences of events that have been recognized in the Companys financial statements or income tax returns. Management provides a valuation allowance for deferred income tax assets when it is more likely than not that a portion of such deferred income tax assets will not be realized.
Foreign Currency Translation. The functional currency for foreign subsidiaries is generally the local currency. Assets and liabilities of such foreign subsidiaries are translated into U.S. dollars at current exchange rates, and related revenues and expenses are translated at average exchange rates in effect during the period. Resulting translation adjustments are recorded as a component of other comprehensive loss.
Approximately 76%, 79% and 77% of the Companys net sales for the years ended December 31, 2002, 2001 and 2000, respectively, were generated by operations located outside of the United States. Mexico is the Companys largest foreign operation, accounting for 64%, 66% and 62% of the Companys net sales for the years ended December 31, 2002, 2001 and 2000, respectively. As such, the Companys results of operations are subject to fluctuations in the exchange rate of the Mexican peso to the U.S. dollar.
Additionally, Jafra S.A. had outstanding U.S. dollar-denominated debt of $32,447,000 and $35,572,000 at December 31, 2002 and 2001, respectively. This debt is remeasured at each reporting date, subjecting the Company to additional foreign exchange risk.
New Accounting Standards. Effective January 1, 2001, the Company adopted SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. SFAS No. 133, as amended and interpreted, established accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. All derivatives, whether designated in hedging relationships or not, are required to be recorded on the balance sheet at fair value. If the derivative is designated in a fair-value hedge, the changes in the fair value of the derivative and the underlying hedged item are recognized concurrently in earnings. If the derivative is designated in a cash-flow hedge, changes in the fair value of the derivative are recorded in other comprehensive income (loss) (OCI) and are recognized in the statement of operations when the hedged item affects earnings. SFAS No. 133 defined new requirements for designation and documentation of hedging relationships as well as ongoing effectiveness assessments in order to use hedge accounting. For a derivative that does not qualify as a hedge, changes in fair value are recognized concurrently in earnings. As of January 1, 2001, the Company recorded a net gain of $126,000 (net of a tax effect of $82,000) as a cumulative transition adjustment to earnings. This adjustment relates to derivatives not designated as hedges prior to adoption of SFAS No. 133, and represents the difference between the carrying
43
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
value as measured by the difference in the spot rate to the forward rate and the fair value as determined by forward rates of such instruments at January 1, 2001.
In June 2001, the Financial Accounting Standards Board (FASB) approved two new statements: SFAS No. 141, Business Combinations and SFAS No. 142, Goodwill and Other Intangible Assets. SFAS No. 141 requires business combinations entered into after June 30, 2001 to be accounted for using the purchase method of accounting. SFAS No. 142 requires that goodwill not be amortized, but be tested for impairment at least annually. SFAS No. 142 was effective for fiscal years beginning after December 15, 2001 to all goodwill and other intangible assets recognized in an entitys statement of financial position at that date, regardless of when those assets were initially recognized. The Company adopted SFAS No. 142 on January 1, 2002. In accordance with such adoption, the Company identified all reporting units in conjunction with the provisions of SFAS No. 142 and allocated all goodwill accordingly. Prior to June 30, 2002, the Company completed the transitional goodwill impairment test required by SFAS No. 142. Due to general market uncertainty in Colombia, the Company revised its projections and recorded an impairment loss of $244,000 associated with its Colombia reporting unit. The impairment loss has been recorded as a cumulative effect of accounting change in the accompanying consolidated statements of income. No other impairment was identified in connection with the annual impairment test. The changes in the carrying amount of goodwill for the year ended December 31, 2002 are as follows (in thousands):
United | All | Consolidated | ||||||||||||||||||
Goodwill | States | Mexico | Europe | Others | Total | |||||||||||||||
Balance as of December 31, 2001
|
$ | 32,188 | $ | 32,401 | $ | 5,937 | $ | 622 | $ | 71,148 | ||||||||||
Translation effect
|
| (3,853 | ) | (637 | ) | (109 | ) | (4,599 | ) | |||||||||||
Impairment losses
|
| | | (244 | ) | (244 | ) | |||||||||||||
Balance as of December 31, 2002
|
$ | 32,188 | $ | 28,548 | $ | 5,300 | $ | 269 | $ | 66,305 | ||||||||||
The Companys other intangible assets consist of trademarks. During the year ended December 31, 2002, the Company determined trademarks to have an indefinite life and performed the transitional and annual impairment test as required under SFAS No. 142. Based upon the transitional and annual test, the Company determined that there was no impairment of trademarks. The carrying value of trademarks was $44,570,000 as of December 31, 2002.
In accordance with SFAS No. 142, the Company discontinued amortization of goodwill and other intangible assets with an indefinite life. A reconciliation of previously reported net income to amounts adjusted for the exclusion of goodwill and trademark amortization, net of the related income tax effects, where applicable, is as follows (in thousands):
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Net income
|
$ | 18,772 | $ | 15,840 | $ | 6,335 | ||||||
Goodwill amortization, net of tax
|
| 1,717 | 1,876 | |||||||||
Trademark amortization, net of tax
|
| 822 | 882 | |||||||||
Adjusted net income
|
$ | 18,772 | $ | 18,379 | $ | 9,093 | ||||||
In November 2001, the Emerging Issues Task Force (EITF) issued EITF Issue No. 01-9, Accounting for Consideration Given by a Vendor to a Customer or a Reseller of the Vendors Products. This new guidance provides that consideration from a vendor to a reseller is generally presumed to be a reduction of the selling prices of the vendors products, and, therefore, should be characterized as a reduction of revenue when recognized in the vendors income statement. On January 1, 2002, the Company adopted EITF Issue No. 01-9 and reclassified commissions paid to consultants of $3,928,000 and $3,460,000 on their personal sales,
44
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
previously reported as a component of selling, general and administrative expenses, as a reduction in net sales and selling, general and administrative expenses for the years ended December 31, 2001 and 2000, respectively.
On January 1, 2002, the Company adopted SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets. SFAS No. 144 supersedes SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed of. SFAS No. 144 retains substantially all of the requirements of SFAS No. 121, while resolving certain implementation issues and addressing the accounting for a component of a business accounted for as a discontinued operation. SFAS No. 144 was adopted with no significant impact on the financial position or results of operations of the Company.
In April 2002, the FASB issued SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections. This Statement rescinds or modifies existing authoritative pronouncements including SFAS No. 4 Reporting Gains and Losses from Extinguishment of Debt. As a result of the issuance of SFAS No. 145, gains and losses from extinguishment of debt should be classified as extraordinary items only if they meet the criteria in Accounting Principles Board (APB) Opinion 30, Reporting the Results of Operations-Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions. Applying the provisions of APB Opinion 30 will distinguish transactions that are part of an entitys recurring operations from those that are unusual or infrequent or that meet the criteria for classification as an extraordinary item. The provisions of this Statement related to the rescission of SFAS No. 4 shall be applied in fiscal years beginning after May 15, 2002. Any gain or loss on extinguishment of debt that was classified as an extraordinary item in prior periods presented that does not meet the criteria in APB Opinion 30 for classification as an extraordinary item shall be reclassified. The Company is currently evaluating the impact that this statement may have on any potential future extinguishments of debt. Upon adoption of SFAS No. 145, the Company will reclassify items previously reported as extraordinary items as a component of operating income in the accompanying statements of income.
In June 2002, the FASB approved SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities. This statement addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. The provisions of this statement are effective for exit or disposal activities that are initiated after December 31, 2002, with early application encouraged. The Company is currently evaluating the impact that this statement may have on any potential future exit or disposal activities.
During 2002, the FASB issued SFAS No. 148, Accounting for Stock Based Compensation Transaction and Disclosure, an amendment to FASB Statement No. 123. This Statement requires more extensive disclosure, including interim disclosure, related to stock based compensation for all companies and permits additional transition methods for companies that elect to use the fair value method for employee stock compensation. This statement is effective for fiscal years ending after December 15, 2002, with early adoption regarding annual disclosures encouraged. The Company adopted the disclosure requirements of SFAS No. 148. (See Note 13).
Reclassifications. Certain reclassifications were made to the prior year financial statements to conform to current year presentation.
45
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(3) Inventories
Inventories consist of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | ||||||||
Raw materials and supplies
|
$ | 5,239 | $ | 5,923 | |||||
Finished goods
|
30,047 | 34,592 | |||||||
Total inventories
|
$ | 35,286 | $ | 40,515 | |||||
(4) Property and Equipment
Property and equipment consist of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Land
|
$ | 16,448 | $ | 17,833 | ||||
Buildings and improvements
|
17,452 | 18,523 | ||||||
Machinery equipment and other
|
42,153 | 34,640 | ||||||
76,053 | 70,996 | |||||||
Less accumulated depreciation
|
15,331 | 11,398 | ||||||
Property and equipment, net
|
$ | 60,722 | $ | 59,598 | ||||
(5) Accrued Liabilities
Accrued liabilities consist of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Sales promotions, commissions and overrides
|
$ | 15,104 | $ | 14,230 | ||||
Accrued restructuring charges (Note 10)
|
| 201 | ||||||
Accrued interest
|
1,498 | 1,549 | ||||||
Compensation and other benefit accruals
|
8,633 | 8,311 | ||||||
State and local sales taxes and other taxes
|
12,644 | 4,912 | ||||||
Unrealized losses on forward contracts
|
| 5,540 | ||||||
Other
|
6,945 | 6,173 | ||||||
Total accrued liabilities
|
$ | 44,824 | $ | 40,916 | ||||
46
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(6) Debt
Debt consists of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | ||||||||
Subordinated Notes, unsecured, interest payable
semi-annually at 11.75% due in 2008
|
$ | 75,180 | $ | 75,180 | |||||
Term loan, secured, principal and interest due in
quarterly installments through April 30, 2004, interest
rates at 3.1% and 4.3% at December 31, 2002 and 2001,
respectively
|
8,375 | 14,500 | |||||||
Revolving loan, secured, due April 30, 2004,
weighted average interest rates of 5.4% at December 31, 2001
|
| 1,800 | |||||||
Unsecured foreign bank loan agreement, principal
and interest due in monthly installments through
January 25, 2005, weighted average interest rates of 18.5%
and 18.7% at December 31, 2002 and 2001, respectively
|
828 | 1,609 | |||||||
Total debt
|
84,383 | 93,089 | |||||||
Less current maturities
|
6,489 | 6,188 | |||||||
Long-term debt
|
$ | 77,894 | $ | 86,901 | |||||
The Companys long-term debt matures as follows (in thousands): $6,489 in 2003, $2,714 in 2004, $0 in 2005, 2006 and 2007, and $75,180 thereafter.
On April 30, 1998, JCI and Jafra S.A. borrowed $125 million by issuing $100 million aggregate principal amount of 11.75% Subordinated Notes due 2008 (the Notes) pursuant to an Indenture dated April 30, 1998 (the Indenture) and $25 million under a senior credit agreement.
At the date of issuance, the Notes represented the several obligations of JCI and Jafra S.A. in the amount of $60 million and $40 million, respectively, with each participating on a pro rata basis upon redemption. The Notes mature in 2008 and bear a fixed interest rate of 11.75% payable semi-annually.
Each of JCI and Jafra S.A. is an indirect, wholly owned subsidiary of the Parent and has fully and unconditionally guaranteed the obligations under the Notes of the other on a senior subordinated basis, subject to a 30-day standstill period prior to enforcement of such guarantees. In addition, the Parent has fully and unconditionally guaranteed the Notes on a senior subordinated basis. JCI currently has no U.S. subsidiaries. Each acquired or organized U.S. subsidiary of JCI will also be required to fully and unconditionally guarantee the Notes jointly and severally, on a senior subordinated basis. Each existing subsidiary of Jafra S.A. fully and unconditionally guarantees the Notes jointly and severally, on a senior subordinated basis, and each subsequently acquired or organized subsidiary of Jafra S.A. will fully and unconditionally guarantee the Notes jointly and severally, on a senior subordinated basis. The nonguarantor entities are the Parents indirect European subsidiaries in Austria, Germany, Italy, the Netherlands, Poland, and Switzerland; its indirect South American subsidiaries in Argentina, Brazil, Chile, Colombia, Peru, and Venezuela; and its indirect subsidiaries in the Dominican Republic and Thailand. All guarantor and nonguarantor entities are either direct or indirect wholly owned subsidiaries of the Parent. The Notes were registered in a registered exchange offer, effective as of January 25, 1999, under the Securities Act of 1933, as amended.
The Notes are unsecured and are generally non-callable for five years. Thereafter, the Notes will be callable at premiums declining to par in the eighth year.
Consents and waivers, dated June 30, 2001 and November 19, 1999, to the senior credit agreement, as described below, allow the Company to repurchase the Notes in the open market from time to time, with the aggregate purchase price for all such Notes repurchased not to exceed $50 million. Aggregate repurchases as of December 31, 2002 were $24.8 million. During 2000, the Company retired Notes of JCI and Jafra S.A.,
47
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
prior to maturity, with a face value of $6.5 million and $4.3 million, respectively. The debt repurchases in 2000 resulted in an extraordinary loss of $315,000, net of an income tax benefit of $195,000. In connection with the early retirement of the Notes as described above, a portion of the unamortized deferred financing costs was written off and included in the determination of the extraordinary loss on early extinguishment of debt. In 2000, $733,000 of the unamortized deferred financing fees were written off.
In addition, JCI and Jafra S.A. entered into a senior credit agreement that provides for senior secured credit facilities in an aggregate principal amount of $90 million, consisting of a multicurrency revolving credit facility of $65 million and a term loan facility of $25 million. Borrowings under the term loan facility are payable in quarterly installments of principal and interest over six years through April 30, 2004. Borrowings under the revolving credit facility mature on April 30, 2004. Borrowings under the senior credit agreement currently bear interest at an annual rate of LIBOR plus a margin of 1.625% or an alternate base rate (the higher of the prime rate or federal funds rate plus 0.5%, plus an applicable margin of 0.625%). The interest rate in effect at December 31, 2002 was approximately 3.1% for the LIBOR-based borrowings. Borrowings under the senior credit agreement are secured by substantially all of the assets of JCI and Jafra S.A. No amounts were outstanding under the revolving credit facility at December 31, 2002.
Both the Indenture and the senior credit agreement contain certain covenants that limit the Companys ability to incur additional indebtedness, pay cash dividends and make certain other payments. These debt agreements also require the Company to maintain certain financial ratios including a minimum EBITDA to cash interest expense coverage ratio and a maximum debt to EBITDA ratio.
During the year ended December 31, 2001, Jafra S.A. repaid the balance remaining under a one-year term loan originally due on August 16, 2001, and entered into an unsecured foreign bank loan agreement. Under this agreement, Jafra S.A. had the peso equivalent of $828,000 outstanding at December 31, 2002 at a weighted average fixed interest rate of 18.5%. Principal and interest payments are due monthly through January 25, 2005.
As of December 31, 2002, the Company had irrevocable standby letters of credit outstanding totaling $2.8 million. These letters of credit, expiring on various dates through February 17, 2003, collateralize the Companys obligation to a third-party in connection with certain lease agreements.
(7) Income Taxes
The Companys income before income taxes consists of the following (amounts in thousands):
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Income before income taxes, extraordinary item
and cumulative effect of accounting change:
|
||||||||||||
United States
|
$ | 12,859 | $ | 13,530 | $ | 9,741 | ||||||
Foreign
|
22,426 | 19,604 | 6,843 | |||||||||
$ | 35,285 | $ | 33,134 | $ | 16,584 | |||||||
48
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Actual income tax expense differs from the expected tax expense (computed by applying the U.S. Federal corporate rate of 35% to income before income taxes) as a result of the following:
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Provision for income taxes at federal statutory
rate
|
$ | 12,350 | $ | 11,597 | $ | 5,804 | ||||||
Foreign income subject to tax other than at
federal statutory rate
|
3,461 | 4,270 | 2,339 | |||||||||
Foreign tax and other credits
|
(2,312 | ) | (3,230 | ) | (1,724 | ) | ||||||
State income taxes
|
548 | 544 | 243 | |||||||||
Valuation allowance domestic
|
19 | 944 | (616 | ) | ||||||||
Valuation allowance foreign
|
2,270 | 2,939 | 3,794 | |||||||||
Other
|
(67 | ) | 356 | 94 | ||||||||
Income tax expense
|
$ | 16,269 | $ | 17,420 | $ | 9,934 | ||||||
The components of the provision for income taxes are as follows (in thousands):
Years Ended December 31, | |||||||||||||||
2002 | 2001 | 2000 | |||||||||||||
Current:
|
|||||||||||||||
Federal
|
$ | 178 | $ | 140 | $ | 72 | |||||||||
Foreign:
|
|||||||||||||||
Mexico
|
15,177 | 13,303 | 6,086 | ||||||||||||
Europe
|
(297 | ) | 641 | 49 | |||||||||||
Other
|
76 | 190 | 54 | ||||||||||||
14,956 | 14,134 | 6,189 | |||||||||||||
State
|
548 | 544 | 243 | ||||||||||||
Total current
|
15,682 | 14,818 | 6,504 | ||||||||||||
Deferred foreign
|
(646 | ) | 1,506 | 2,539 | |||||||||||
Deferred domestic
|
2,016 | 2,407 | 891 | ||||||||||||
Foreign deferred allocated to other comprehensive
income
|
(783 | ) | (1,311 | ) | | ||||||||||
Total deferred
|
587 | 2,602 | 3,430 | ||||||||||||
Total income taxes on income before income taxes,
extraordinary item and cumulative effect of accounting change
|
16,269 | 17,420 | 9,934 | ||||||||||||
Income tax benefit on early extinguishment of debt
|
| | (195 | ) | |||||||||||
Income tax expense on cumulative effect of
accounting change
|
| 82 | | ||||||||||||
Total income tax expense
|
$ | 16,269 | $ | 17,502 | $ | 9,739 | |||||||||
49
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The components of deferred income tax assets and deferred income tax liabilities at December 31, 2002 and 2001 are as follows (in thousands):
2002 | 2001 | |||||||||
Deferred income tax assets:
|
||||||||||
Accounts receivable
|
$ | 2,454 | $ | 1,733 | ||||||
Net operating loss carryforward
|
15,112 | 13,457 | ||||||||
Disallowed interest expense
|
| 26 | ||||||||
Accrued bonuses
|
33 | 301 | ||||||||
Foreign tax and other credit carryforwards
|
2,193 | 5,333 | ||||||||
Accrued sales promotions
|
1,977 | 2,273 | ||||||||
Other accrued liabilities
|
5,233 | 1,963 | ||||||||
Other
|
1,738 | 4,776 | ||||||||
Total deferred income tax assets
|
28,740 | 29,862 | ||||||||
Less valuation allowance
|
(17,578 | ) | (15,289 | ) | ||||||
Net deferred income tax assets
|
11,162 | 14,573 | ||||||||
Deferred income tax liabilities:
|
||||||||||
Transaction and deferred financing costs
|
(235 | ) | (494 | ) | ||||||
Property and equipment
|
(4,406 | ) | (4,194 | ) | ||||||
Trademark and goodwill
|
(18,129 | ) | (20,272 | ) | ||||||
Inventories
|
(7,914 | ) | (13,399 | ) | ||||||
Other
|
(3,737 | ) | (564 | ) | ||||||
Total deferred income tax liabilities
|
(34,421 | ) | (38,923 | ) | ||||||
Net deferred income tax liabilities
|
$ | (23,259 | ) | $ | (24,350 | ) | ||||
The Company records a valuation allowance on the deferred income tax assets to reduce the total to an amount that management believes is more likely than not to be realized. The valuation allowances at December 31, 2002 and 2001 were based upon the Companys estimates of the future realization of deferred income tax assets. Valuation allowances at December 31, 2002 and 2001 were provided principally to offset operating loss carryforwards and foreign tax credit carryforwards of the Companys U.S., European and South American subsidiaries. Valuation allowances at December 31, 2002 were also provided to offset certain pretax expenses at the companys U.S. subsidiary.
At December 31, 2002, the Companys deferred income tax assets for carryforwards totaled $17,305,000 comprised of foreign asset and other credit carryforwards of $2,193,000 and net operating loss carryforwards of $15,112,000. At December 31, 2001, the Companys deferred income tax assets for carryforwards totaled $18,790,000, comprised of U.S. foreign and foreign asset tax credits of $4,775,000, alternative minimum tax and research and development credits of $558,000 and tax loss carryforwards of certain foreign subsidiaries of $13,457,000. These deferred income tax assets were reduced by a valuation allowance of $17,578,000 and $15,289,000 as December 31, 2002 and 2001, respectively. The tax loss and certain credit carryforwards expire in varying amounts between 2003 and 2012. Realization of the income tax carryforwards is dependent on generating sufficient taxable income prior to expiration of the carryforwards. Although realization is not assured, management believes it is more likely than not that the net carrying value of the income tax carryforwards will be realized.
Income tax expense for the year ended December 31, 2002 was reduced by $1,169,000 as the result of as the result of the enactment of changes in the Mexico corporate statutory tax rate and the related impact on Jafra S.A.s net deferred income tax liabilities. The enactment in Mexico will reduce the Mexico corporate income tax rate annually in one-percent increments from 35% to 32% beginning January 1, 2003 through 2005
50
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(8) Benefit Plans
Certain employees of the Companys German subsidiary participate in a defined benefit pension plan covering key employees (the Germany Plan). Benefits are based on age, years of service and the level of compensation during the final years of employment. The Companys funding policy is to contribute annually to the Germany Plan the amount necessary to meet the minimum funding standards. The Company recognized pension expense of $48,000 and $278,000 for the years ended December 31, 2002 and 2001, respectively, and recognized pension income of $18,000 for the year ended December 31, 2000 due to the departure of certain employees.
Under Mexican labor laws, employees of Jafra S.A. and its subsidiaries are entitled to a payment when they leave the Company if they have fifteen or more years of service. In addition, the Company makes government mandated employee profit sharing distributions equal to ten percent of the taxable income of the subsidiary in which they are employed. Total expense under these programs was $1,222,000, $995,000 and $345,000 for the years ended December 31, 2002, 2001 and 2000, respectively. The total liability was approximately $1,724,000 and $1,010,000 at December 31, 2002 and 2001, respectively, and is classified as a noncurrent liability in the accompanying consolidated balance sheets.
The Companys U.S. subsidiary has an employee savings plan which permits participants to make voluntary contributions by salary deferrals pursuant to section 401(k) of the Internal Revenue Code, which allows employees to defer up to 20% of their total compensation, subject to statutory limitations. Employee contributions of up to 10% of compensation are matched by the Company at the rate of 50 cents per dollar. Employees do not vest in the Company contribution until they have reached two years of service, at which time they become fully vested. The Companys expense under this program was $618,000, $600,000 and $620,000 for the years ended December 31, 2002, 2001 and 2000, respectively.
The Companys U.S. subsidiary also has a supplemental excess benefit savings plan, which permits participants to make unlimited voluntary contributions. Employee contributions are matched on the same basis as under the employee savings plan, and the vesting provisions are the same. The Companys expense under this program was $207,000, $177,000 and $213,000 for the years ended December 31, 2002, 2001 and 2000, respectively. Employee and employer contributions under such plan are placed into a rabbi trust exclusively for the uses and purposes of plan participants and general creditors of the Company. The Company has recorded an asset and the related liability in the accompanying consolidated balance sheets of $2,411,000 and $1,880,000 at December 31, 2002 and 2001, respectively.
(9) Related Party Transactions
Pursuant to a consulting agreement entered into following the Acquisition, until the 10th anniversary of the Acquisition or the date on which CD&R Fund V no longer has an investment in the Company or until the termination by either party with 30 days notice, CD&R will receive an annual fee (and reimbursement of out-of-pocket expenses) for providing advisory, management consulting and monitoring services to the Company. On January 1, 2000, the annual fee was $400,000. As of January 1, 2001, the annual fee was increased to $1,000,000. As required by the terms of the Companys lending arrangements, such fees are determined by arms-length negotiation and are believed by the Company to be reasonable. The amendment, effective January 1, 2001, adds to CD&Rs services under the agreement financial advisory, investment banking and similar services with respect to future proposals for an acquisition, merger, recapitalization, or other similar transaction directly or indirectly involving the Company or any of its subsidiaries. The fee for such additional services in connection with future transactions would be an amount equal to 1% of the transaction value for the transaction to which such fee relates. Such transaction fees may be increased upon approval of a majority of the members of the Companys Board of Directors who are not employees of the Company, CD&R or any affiliate of CD&R. The amendment also provides that if any employee of CD&R is appointed to an executive management position (or a position of comparable responsibility) in the Company or any of its subsidiaries,
51
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
the annual fee will be increased by an amount to be determined by CD&R, the amount of such increase not to exceed 100% of the existing annual fee in effect at that time. The CD&R fees incurred during the years ended December 31, 2002, 2001 and 2000 were $1,000,000, $1,000,000 and $400,000, respectively. In addition, certain officers and directors of CD&R or its affiliates serve as directors of the Company.
Prior to 2000, the Company engaged Guidance Solutions (Guidance), a corporation in which an investment fund managed by CD&R has an investment, to develop its e-commerce systems. Under the agreement entered into by the Company and Guidance, the Company agreed to pay fees of approximately $2.0 million to Guidance in connection with planning, defining, designing and consulting services performed related to the Companys e-commerce initiative. During the year ended December 31, 2000, the Company paid fees to Guidance of $1,798,000. The Company terminated its agreement with Guidance and executed a settlement and mutual release agreement effective September 30, 2000. Upon execution of this agreement in October of 2000, Guidance paid the Company $25,000 and agreed to pay the Company an aggregate additional sum of $475,000, payable in quarterly installments plus interest at 9.5% per annum, beginning in January 2001 through October 2005. At December 31, 2002, the balance was paid in full.
Members of management financed a portion of the cash purchase price of the shares of Company common stock they acquired through loans from the Chase Manhattan Bank on market terms. To help members of management obtain such terms for such financing, the Company fully and unconditionally guaranteed up to 75% of the purchase price for the shares of Company common stock purchased by each such member of management in 1998 and 2000. As of December 31, 2002, the outstanding guarantee was $2,145,000.
(10) Restructuring and Impairment Charges and Related Accruals
Prior Years Restructuring and Impairment Charges. During 2001, the Company wrote-off $0.2 million of intangible assets as the Company determined that the undiscounted cash flows were less than the carrying amount of the assets due to a downturn in the political and economic environment in Argentina. The amount was classified in selling, general and administration in the accompanying consolidated statements of income. In 2000, the Company recorded approximately $1.6 million of restructuring charges and approximately $1.0 million of asset impairment charges. The restructuring charges of approximately $1.6 million related to the Companys repositioning activities in Europe, primarily severance costs, of which $1.4 million was paid in 2000 and 2001 and the remaining $0.2 million was paid in 2002. The asset impairment charges of $1.0 million consisted of approximately $0.3 million related to the Companys repositioning activities in Europe and approximately $0.7 million relating to the write-down of certain capitalized computer software costs in the United States.
The components of the additions and/or adjustments to the aforementioned accruals include severance, lease costs, fixed asset disposals, and other exit costs, and are summarized as follows (in thousands):
Years Ended December 31, | ||||||||||
2001 | 2000 | |||||||||
Additions charges to income:
|
||||||||||
Severance
|
$ | (84 | ) | $ | 1,210 | |||||
Lease costs
|
80 | 295 | ||||||||
Other
|
4 | 102 | ||||||||
Total additions
|
| 1,607 |
52
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
A rollforward of the activity of the restructuring accruals is summarized as follows (in thousands):
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Opening balance
|
$ | 201 | $ | 699 | $ | 1,105 | ||||||
Additions
|
| | 1,607 | |||||||||
Charges against reserves
|
(201 | ) | (498 | ) | (2,013 | ) | ||||||
Ending balance
|
$ | | $ | 201 | $ | 699 | ||||||
The remaining costs at each year-end included in the restructuring accrual are summarized as follows (in thousands):
December 31, | ||||||||
2001 | 2000 | |||||||
Severance
|
$ | | $ | 385 | ||||
Lease costs and other
|
201 | 314 | ||||||
$ | 201 | $ | 699 | |||||
The principal component of the restructuring accruals was severance. A summary of the severance activity is as follows (dollar amounts in thousands):
Years Ended December 31, | ||||||||||||||||
2001 | 2000 | |||||||||||||||
# of | # of | |||||||||||||||
Employees | Amount | Employees | Amount | |||||||||||||
Opening balance
|
16 | $ | 385 | 43 | $ | 1,105 | ||||||||||
Planned terminations
|
| | 35 | 1,210 | ||||||||||||
Adjustment to planned terminations
|
| (84 | ) | | | |||||||||||
Actual terminations
|
(16 | ) | (301 | ) | (62 | ) | (1,930 | ) | ||||||||
Ending balance
|
| $ | | 16 | $ | 385 | ||||||||||
(11) Financial Reporting for Business Segments
Segment information has been prepared in accordance with SFAS No. 131, Disclosure about Segments of an Enterprise and Related Information (SFAS 131). SFAS No. 131 requires disclosure of certain information regarding operating segments, products and services, geographic areas of operations and major customers.
The Companys business is comprised of one industry segment, direct selling, with worldwide operations. The Company is organized into geographical business units that each sell the full line of Jafra cosmetics, skin care, body care, fragrances, and other products. The Company has three reportable business segments: Mexico, the United States, and Europe. Business results for subsidiaries in South America, the Dominican Republic, and Thailand are combined and included in the following table under the caption All Others.
The accounting policies used to prepare the information reviewed by the Companys chief operating decision makers are the same as those described in the summary of significant accounting policies. The Company evaluates performance based on segment operating income, excluding reorganization and restructuring charges, unusual gains and losses, and amortization of goodwill and intangibles. Consistent with the information reviewed by the Companys chief operating decision makers, corporate costs, foreign exchange gains and losses, interest expense, other nonoperating income or expense, and income taxes are not allocated to
53
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
operating segments. The effects of intersegment sales (net sales and related gross profit) are excluded from the computation of segment operating income.
Corporate, | ||||||||||||||||||||||||||||
United | All | Total | Unallocated | Consolidated | ||||||||||||||||||||||||
Mexico | States | Europe | Others | Segments | and Other | Total | ||||||||||||||||||||||
(Dollars in thousands) | ||||||||||||||||||||||||||||
Year ended December 31, 2002
|
||||||||||||||||||||||||||||
Net sales
|
$ | 251,546 | $ | 92,143 | $ | 26,932 | $ | 20,357 | $ | 390,978 | $ | | $ | 390,978 | ||||||||||||||
Operating profit (loss)
|
66,245 | 15,620 | 1,224 | (6,148 | ) | 76,941 | (19,190 | ) | 57,751 | |||||||||||||||||||
Depreciation and amortization
|
2,121 | 2,631 | 411 | 448 | 5,611 | | 5,611 | |||||||||||||||||||||
Capital expenditures
|
4,124 | 6,298 | 174 | 415 | 11,011 | | 11,011 | |||||||||||||||||||||
Segment assets
|
178,629 | 82,532 | 18,673 | 9,890 | 289,724 | (1,434 | ) | 288,290 | ||||||||||||||||||||
Goodwill
|
28,548 | 32,188 | 5,300 | 269 | 66,305 | | 66,305 | |||||||||||||||||||||
Year ended December 31, 2001
|
||||||||||||||||||||||||||||
Net sales
|
247,514 | 79,611 | 26,329 | 22,699 | 376,153 | | 376,153 | |||||||||||||||||||||
Operating profit (loss)
|
71,289 | 11,580 | 1,795 | (5,931 | ) | 78,733 | (22,510 | ) | 56,223 | |||||||||||||||||||
Depreciation and amortization
|
3,908 | 2,709 | 610 | 406 | 7,633 | 116 | 7,749 | |||||||||||||||||||||
Capital expenditures
|
6,024 | 4,529 | 230 | 589 | 11,372 | | 11,372 | |||||||||||||||||||||
Segment assets
|
193,379 | 67,792 | 17,788 | 13,313 | 292,272 | (1,136 | ) | 291,136 | ||||||||||||||||||||
Year ended December 31, 2000
|
||||||||||||||||||||||||||||
Net sales
|
199,777 | 74,137 | 26,882 | 20,432 | 321,228 | | 321,228 | |||||||||||||||||||||
Operating profit (loss)
|
64,364 | 10,709 | 247 | (6,044 | ) | 69,276 | (26,944 | ) | 42,332 | |||||||||||||||||||
Depreciation and amortization
|
4,231 | 2,111 | 905 | 385 | 7,632 | | 7,632 | |||||||||||||||||||||
Capital expenditures
|
2,262 | 3,662 | 109 | 1,072 | 7,105 | | 7,105 | |||||||||||||||||||||
Segment assets
|
$ | 177,086 | $ | 68,843 | $ | 18,254 | $ | 13,165 | $ | 277,348 | $ | (404 | ) | $ | 276,944 |
Additional business segment information regarding product lines is as follows:
2002 | 2001 | 2000 | ||||||||||||||||||||||||
Sales by | Percentage | Sales by | Percentage | Sales by | Percentage | |||||||||||||||||||||
Product Line | of Total | Product Line | of Total | Product Line | of Total | |||||||||||||||||||||
($ in millions) | Sales | ($ in millions) | Sales | ($ in millions) | Sales | |||||||||||||||||||||
Skin care
|
$ | 68.8 | 18.2 | % | $ | 69.4 | 19.0 | % | $ | 65.8 | 21.0 | % | ||||||||||||||
Color cosmetics
|
99.5 | 26.2 | 94.3 | 25.8 | 82.4 | 26.2 | ||||||||||||||||||||
Fragrances
|
126.6 | 33.4 | 125.4 | 34.3 | 103.7 | 33.0 | ||||||||||||||||||||
Body care and personal care
|
42.1 | 11.1 | 37.0 | 10.1 | 29.6 | 9.4 | ||||||||||||||||||||
Other(1)
|
42.0 | 11.1 | 39.3 | 10.8 | 32.6 | 10.4 | ||||||||||||||||||||
Subtotal before shipping and other fees less
commissions
|
379.0 | 100.0 | % | 365.4 | 100.0 | % | 314.1 | 100.0 | % | |||||||||||||||||
Shipping and other fees less commissions
|
12.0 | 10.8 | 7.1 | |||||||||||||||||||||||
Total
|
$ | 391.0 | $ | 376.2 | $ | 321.2 | ||||||||||||||||||||
(1) | Includes sales aids (e.g., party hostess gifts, demonstration products, etc.) and promotional materials, which typically do not qualify for commissions or overrides. |
54
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(12) Commitments and Contingencies
The Company leases office and warehouse facilities as well as manufacturing, transportation and data processing equipment under operating leases which expire at various dates through 2008. The leases contain certain renewal options and require payment of property taxes, utilities, common area maintenance and insurance and contain rent escalation clauses based on consumer price indices. Future minimum lease payments under noncancelable operating leases as of December 31, 2002 are (in thousands):
2003
|
$ | 3,841 | ||
2004
|
3,879 | |||
2005
|
3,784 | |||
2006
|
3,592 | |||
2007
|
3,585 | |||
2008
|
167 | |||
$ | 18,848 | |||
Rental expense was $3,781,000, $3,473,000 and $5,953,000 for the years ended December 31, 2002, 2001 and 2000, respectively.
Other income for 2000 included approximately $1.4 million of income related to a recovery of the effect of inflation from a receivable due from the Mexican government related to taxes.
During 2002, the Company initiated product replacement for a certain product sold in 2001 and 2002. The total cost of the product replacement is approximately $400,000. However, management believes that the majority of the cost will be recovered pursuant to contractual obligations with the third-party manufacturer. (See Note 14).
The Company has implemented a structure in a certain foreign jurisdiction to minimize import taxes. While management believes this structure adequately protects and minimizes the Companys exposure to import taxes, the Company may be adversely impacted if this structure does not withstand challenges by local tax authorities. Management believes that the resolution of a tax authority challenge, if any, will not have a material adverse effect on the Companys business, financial condition or results of operations.
In accordance with FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company recorded impairment losses on long-lived assets used in operations when events and circumstances indicate that long-lived assets might be impaired and undiscounted cash flows estimated to be generated by those assets are less than the carrying amounts of those assets. Subsequent to December 31, 2002, the Company is considering strategic decisions to exit certain non-core markets in South America, Thailand and some or all of Europe through sale or discontinuance of these operations. As of December 31, 2002, no decision had been made on these non-core markets and the undiscounted cash flows indicated that such carrying amounts were expected to be recovered. Given certain strategic decisions made, it is reasonably possible that the estimate of undiscounted cash flows may change in the near term resulting in a need to write down those assets to fair value. In accordance with FASB 142, Goodwill and Other Intangible Assets, the transitional and annual impairment test indicated that fair value of the reporting units associated with the non-core markets exceeded the carrying value, including goodwill, at December 31, 2002.
The Company is involved from time to time in routine legal matters incidental to its business. The Company believes that the resolution of such matters will not have a material adverse effect on the Companys business, financial condition or results of operations.
55
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(13) Management Incentive Arrangements
Company Plan
Effective 1998, the Company adopted a stock incentive plan (the Stock Incentive Plan), which provides for the sale to members of senior management of up to 52,141 shares of common stock of the Parent and the issuance of options to purchase up to 104,282 additional shares of common stock. The Company reserved 156,423 shares for issuance under the Stock Incentive Plan, and as of December 31, 2002, 42,121 shares and 84,242 options were outstanding. A summary of the status and activity of shares purchased under the Stock Incentive Plan is as follows:
Number | Price Per | |||||||
of Shares | Share | |||||||
Shares outstanding at December 31, 1999
|
38,392 | |||||||
Shares issued in 2000
|
4,424 | 206 | ||||||
Options exercised in 2000
|
158 | 100 | ||||||
Shares repurchased in 2000
|
(948 | ) | $ | 210 | ||||
Shares outstanding at December 31, 2000
|
42,026 | |||||||
Shares issued in 2001
|
474 | 210 | ||||||
Options exercised in 2001
|
210 | 150 | ||||||
Shares repurchased in 2001
|
(589 | ) | $ | 250 | ||||
Shares outstanding at December 31, 2001
|
42,121 | |||||||
Shares issued in 2002
|
| | ||||||
Options exercised in 2002
|
| | ||||||
Shares repurchased in 2002
|
| | ||||||
Shares outstanding at December 31, 2002
|
42,121 | |||||||
The purchase price of shares issued in 2000 and 2001 and options exercised in 2000 and 2001 represented the estimated fair value at the respective dates of issuance and exercise, except as discussed below. In 2000, 316 shares were issued at a price below fair value, and the Company recognized compensation expense of approximately $19,000. In 2001, 210 shares were issued at a price below fair value, and the Company recognized compensation expense of approximately $21,000. Under certain circumstances, the management stockholders can require the Company to repurchase their shares, subject to a holding period of at least seven months from the date such shares were acquired, for an amount not to exceed fair value.
In connection with the purchase of common stock of the Parent, certain members of senior management were granted options to purchase two additional shares of common stock for each share purchased at an exercise price equal to the fair value at the date of grant under the Stock Incentive Plan. The options have a life of ten years from the date of grant. Fifty percent of the options granted are expected to vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the continuous employment of the grantee (Option Type 1). The remaining fifty percent of the options become vested as follows, subject to the continuous employment of the grantee: (a) up to one-third of the options become vested as of each of the first three anniversaries of the date of grant if the Company achieves at least 85% of its EBITDA target for the immediately preceding fiscal year, (b) if less than one-third of the total number of options shall have become vested as provided in clause(a) above, the portion that has not become so vested shall become vested as of the first day of the fiscal year following the fiscal year, if any, that the Company achieves its cumulative EBITDA target, and (c) any options that do not become vested as provided above will become vested on the
56
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
ninth anniversary of the date of grant (Option Type 2). A summary of the status and activity of the options under the Stock Incentive Plan is as follows:
2002 | 2001 | 2000 | ||||||||||||||||||||||
Weighted Average | Weighted Average | Weighted Average | ||||||||||||||||||||||
Shares | Exercise Price | Shares | Exercise Price | Shares | Exercise Price | |||||||||||||||||||
Outstanding at beginning of year
|
84,242 | $ | 112.36 | 84,052 | $ | 111.69 | 76,784 | $ | 101.03 | |||||||||||||||
Granted
|
| | 948 | 210.00 | 8,848 | 205.71 | ||||||||||||||||||
Exercised
|
| | (210 | ) | 150.00 | (158 | ) | 100.00 | ||||||||||||||||
Canceled
|
| | (548 | ) | 163.80 | (1,422 | ) | 122.22 | ||||||||||||||||
Outstanding at year-end
|
84,242 | $ | 112.36 | 84,242 | $ | 112.36 | 84,052 | $ | 111.69 | |||||||||||||||
Options exercisable at year-end
|
66,615 | $ | 109.92 | 63,528 | $ | 105.32 | 37,655 | $ | 100.70 | |||||||||||||||
Options available for grant
|
19,093 | | 19,093 | | 19,493 | |
The following table summarizes information about options outstanding as of December 31, 2002:
Outstanding | Exercisable | |||||||||||||||||||
Weighted Average | ||||||||||||||||||||
Exercise | Number | Remaining Contractual | Weighted Average | Number | Weighted Average | |||||||||||||||
Price | of Options | Life (Yrs.) | Exercise Price | of Options | Exercise Price | |||||||||||||||
$100.00
|
74,256 | 5.75 | $ | 100.00 | 60,117 | $ | 100.00 | |||||||||||||
$150.00
|
948 | 6.92 | 150.00 | 902 | 150.00 | |||||||||||||||
$210.00
|
9,038 | 7.63 | 210.00 | 5,596 | 210.00 | |||||||||||||||
84,242 | 5.96 | $ | 112.36 | 66,615 | $ | 109.92 | ||||||||||||||
The Company applies Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, and related Interpretations in accounting for these options. As the options were granted with exercise prices equal to the fair value at the date of grant, no compensation cost was recognized by the Company upon issuance of such options. The fair value of each option granted by the Company was estimated using the minimum value option pricing model. The assumptions used in this pricing model and the weighted average fair value of options granted during 2001 and 2000 are summarized as follows:
2001 | 2000 | |||||||||||||||
Option | Option | Option | Option | |||||||||||||
Type 1 | Type 2 | Type 1 | Type 2 | |||||||||||||
Risk-free interest rate
|
5.80 | % | 5.80 | % | 6.30 | % | 6.30 | % | ||||||||
Expected option life (in years)
|
5.0 | 7.0 | 5.0 | 7.0 | ||||||||||||
Expected volatility
|
0.0 | % | 0.0 | % | 0.0 | % | 0.0 | % | ||||||||
Expected dividend yield
|
0.0 | % | 0.0 | % | 0.0 | % | 0.0 | % | ||||||||
Weighted average fair value per option
|
$ | 52.20 | $ | 69.28 | $ | 56.00 | $ | 73.97 |
57
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Pro Forma Compensation Cost
Had the Company recorded compensation cost based on the fair value of options granted at the grant date, as prescribed by FASB Statement No. 123 Accounting for Stock Based Compensation, pro forma net income would have been as follows (in thousands):
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Net income, as reported
|
$ | 18,772 | $ | 15,840 | $ | 6,335 | ||||||
Pro forma compensation cost
|
92 | 348 | 680 | |||||||||
Pro forma net income
|
$ | 18,680 | $ | 15,492 | $ | 5,655 | ||||||
Employment Agreements
Certain senior executive officers have employment agreements which provide for annual bonuses if the Company achieves the performance goals established under its annual incentive plan for executives.
The Company has a bonus plan for U.S. based employees which provides that 50% of the bonus earned by any Vice President or Director shall be deferred and shall vest in three equal annual installments. As of December 31, 2002 and 2001, $415,000 and $372,000 of bonuses were deferred, respectively. The Company recognizes compensation expense as the vesting requirements are met.
(14) Manufacturing Agreement
The Company and a third-party contractor (the Contractor) entered into a manufacturing agreement, dated as of June 10, 1999, (the Manufacturing Agreement). Subject to the terms and conditions of the Manufacturing Agreement, the Contractor has agreed to manufacture all of the Companys requirements for certain cosmetic and skin care products for an initial term of five years. Following the expiration of the initial five-year term, the Manufacturing Agreement will be automatically extended for additional one-year terms unless terminated by six months prior written notice by either party. The Manufacturing Agreement provides for price renegotiations by the Contractor if the Companys quarterly or annual purchase volume falls below specified minimums. The Manufacturing Agreement requires the Contractor to maintain insurance to cover costs associated with any product liability or product recall caused by the acts or omissions of the Contractor. In addition, the Company is obligated to purchase materials acquired by the Contractor based upon product forecasts provided by the Company if the Contractor is unable to sell such materials to a third-party. There have been no such repurchases to date. The Contractor is solely responsible for obtaining the inventories, manufacturing the inventories at its current location in Chino, California, complying with applicable laws and regulations, and performing quality assurance functions.
During the fourth quarter of 2000, the Contractor obtained $1,000,000 of advances from the Company in exchange for an unsecured promissory note. The note bears interest at an annual rate of 9% and is payable in monthly installments commencing on February 15, 2001. On April 15, 2002, the unsecured promissory note was amended to advance an additional $320,000 to the contractor. At December 31, 2002 and 2001, approximately $101,000 and $349,000, of the note was outstanding and was included in receivables in the accompanying consolidated balance sheets, respectively.
(15) | Foreign Currency Forward and Option Contracts |
The Company is exposed to currency risk relating to its forecasted U.S. dollar-denominated expenditures at Jafra S.A. As part of its overall strategy to reduce the risk of adverse potential exchange rate fluctuations in Mexico, the Company enters into foreign currency exchange contracts. Prior to March 2002, the Company purchased forward exchange contracts (forward contracts or forwards) to hedge its foreign currency
58
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
exposures to the Mexican peso. In March 2002, in accordance with previously approved policies, the Company modified its hedging program to include the use of foreign currency option contracts (option contracts). The Company places forward contracts or option contracts based on its forecasted U.S. dollar cash outflows from Jafra S.A. over a rolling 12 month period and does not hedge transactions that are not included in the 12 month forecast on the date the forward contract is initiated. As a matter of policy, the Company does not hold or issue forward contracts for trading or speculative purposes nor does it enter into contracts or agreements containing embedded derivative features. Prior to entering into forward contracts or option contracts, the Company evaluates the counter parties credit ratings. Credit risk represents the accounting loss that would be recognized at the reporting date if counter parties failed to perform as contracted. The Company does not currently anticipate non-performance by such counter parties.
Effective January 1, 2001, the Company adopted SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. SFAS No. 133, as amended and interpreted, establishes accounting and reporting standards for derivative instruments and hedging activities and requires that all derivative instruments be recorded based on fair value. In connection with the adoption of SFAS No. 133, at January 1, 2001, the Company recorded a net gain of $126,000 (net of a tax effect of $82,000) as a cumulative transition adjustment to earnings. This adjustment relates to derivatives not designated as hedges prior to adoption of SFAS No. 133, and represents the difference between the carrying value and the fair value of such instruments. Under SFAS No. 133, the Companys use of forward contracts or option contracts to hedge certain forecasted transactions does qualify for hedge accounting. Gains and losses from such derivatives are deferred as a separate component of other comprehensive loss, and are recognized in income at the same time that the underlying hedged exposure is recognized in income. This accounting treatment results in the matching of gains and losses from such forward contracts or option contracts with the corresponding gains and losses generated by the underlying hedged transactions. Contracts that do not qualify for hedge accounting under SFAS No. 133 are remeasured based on fair value and the gains and losses are included as a component of net income.
The forward contracts utilized by the Company did not qualify for hedge accounting under the applicable accounting standards prior to adoption of SFAS No. 133 on January 1, 2001, and accordingly such instruments were marked-to-market with gains and losses included as a component of exchange loss in the statements of income for the year ended December 31, 2000.
The Company currently designates certain of its forward contracts and option contacts as cash flow hedges of forecasted U.S. dollar-denominated inventory purchases, forecasted U.S. dollar-denominated intercompany charges from JCI to Jafra S.A., forecasted management fee charges from JCI to Jafra S.A., and U.S. dollar-denominated interest payments. On the date the Company enters into a derivative contract, management designates the derivative as a hedge of the identified exposure. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. In this documentation, the Company specifically identifies the forecasted transaction that has been designated as a hedged item and states how the hedging instrument is expected to hedge the risks related to the hedged item. The Company formally measures effectiveness of its hedging relationships both at the hedge inception and on an ongoing basis in accordance with its risk management policy. For all qualifying and highly effective cash flow hedges, the changes in the fair value of the derivative are deferred as a component of other comprehensive loss. Such amounts will be reclassified from other comprehensive loss into net income when the underlying hedged exposure is recognized in income. For U.S. dollar-denominated inventory purchases, this will occur upon sale to an outside party of the related inventory. For intercompany charges and interest, this will occur at the date such charges are recorded by Jafra S.A.
During the year ended December 31, 2002, the Company recognized losses of approximately $2,605,000 on forward contracts and gains of approximately $886,000 on option contracts (including reclassification of
59
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
other comprehensive loss) as a component of exchange loss in the accompanying consolidated statements of income. During the year ended December 31, 2001, the Company recognized approximately $12,188,000 of losses on forward contracts as a component of exchange loss in the accompanying consolidated statements of income. During the year ended December 31, 2000, the Company recognized approximately $10,050,000 of losses as a component of exchange loss on forward contracts that did not qualify for hedge accounting under accounting standards prior to the adoption of SFAS No. 133.
Additionally, during the year ended December 31, 2001, the Company deferred as a component of other comprehensive loss $5,504,000 of losses on forward contracts qualifying for hedge accounting under SFAS No. 133. Of this amount, approximately $797,000 was reclassified as exchange loss and $961,000 was reclassified as cost of sales upon recognition of the underlying hedged exposure prior to December 31, 2001. As of December 31, 2001, the Company had deferred as a component of other comprehensive income (loss) $3,746,000 of losses on forward contracts.
During the year ended December 31, 2002, the Company deferred approximately an additional $1,782,000 of losses on forward contracts qualifying for hedge accounting under SFAS No. 133. Of the total amount deferred, during the year ended December 31, 2002, approximately $1,650,000 of other comprehensive loss was reclassified into exchange loss and approximately $3,139,000 was reclassified into cost of sales upon the recognition of the underlying hedged exposure. The Company expects that substantially all of the remaining loss of $739,000, deferred as a component of other comprehensive loss, will be recognized into income within the next twelve months.
During the year ended December 31, 2002, the Company deferred as a component of other comprehensive loss $1,336,000 of gains on option contracts qualifying for hedge accounting under SFAS No. 133. Of this amount, approximately $483,000 of other comprehensive loss was reclassified to exchange loss and approximately $378,000 was reclassified as a cost of sales offset upon the recognition of the underlying hedged exposure. The Company expects substantially all of the remaining gain of approximately $475,000, deferred as a component of other comprehensive loss, to be recognized into income within the next twelve months.
The fair value of the forward contacts at December 31, 2001 represented an unrealized loss of $5,540,000 consisting of $2,920,000 of unrealized losses recorded as a component of other comprehensive loss for qualifying hedges and $2,620,000 of unrealized losses recorded as a component of exchange loss for non-qualifying hedges under SFAS No. 133. As of December 31, 2002, the Company had no outstanding forward contracts. The fair value of the option contracts at December 31, 2002 represented an unrealized gain of approximately $402,000, consisting of $382,000 of unrealized gains recorded as a component of other comprehensive loss for qualifying hedges and $21,000 of unrealized gains for non-qualifying hedges under SFAS No. 133.
During the year ended December 31, 2002, the ineffectiveness generated by the Companys forward contracts and option contracts designated as hedges was insignificant. Certain hedged forecasted transactions do not appear probable of occurring due to timing differences between the original and current forecasts, and accordingly $164,000 of gains were reclassified into earnings.
The outstanding option contracts had a notional value denominated in Mexican pesos of $523,000,000 in put and call positions at December 31, 2002 and mature at various dates through December 31, 2003. The outstanding forward contracts had notional values denominated in Mexican pesos of $688,873,000 at December 31, 2001 and matured in 2002. Notional amounts do not quantify market or credit exposure or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts.
60
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The following table provides information about the details of the Companys option contracts as of December 31, 2002 (in thousands):
At December 31, 2002:
Coverage in | Fair Value in | |||||||||||||||
Foreign Currency | Mexican Pesos | Average Strike Price | U.S. Dollars(1) | Maturity Date | ||||||||||||
Purchased Puts (Company may sell Peso/buy USD)
|
||||||||||||||||
Mexican Peso
|
$ | 149,000 | 10.31-10.48 | $ | (113 | ) | Jan.-Mar. 2003 | |||||||||
Mexican Peso
|
100,000 | 11.05-12.19 | 77 | Apr.-June 2003 | ||||||||||||
Mexican Peso
|
150,000 | 11.76-12.79 | 131 | July-Aug 2003 | ||||||||||||
Mexican Peso
|
124,000 | 12.51-12.91 | 21 | Oct.-Dec. 2003 | ||||||||||||
$ | 523,000 | $ | 116 | |||||||||||||
Written Calls (Counterparty may buy Peso/sell USD)
|
||||||||||||||||
Mexican Peso
|
$ | 149,000 | 9.01-9.02 | $ | (207 | ) | Jan.-Mar. 2003 | |||||||||
Mexican Peso
|
100,000 | 9.50-9.84 | (144 | ) | Apr.-June 2003 | |||||||||||
Mexican Peso
|
150,000 | 9.69-10.19 | (112 | ) | July-Aug 2003 | |||||||||||
Mexican Peso
|
124,000 | 10.15-10.19 | (55 | ) | Oct.-Dec. 2003 | |||||||||||
$ | 523,000 | $ | (518 | ) | ||||||||||||
(1) | The fair value of the option contracts presented above, an unrealized gain of $402,000 at December 31, 2002, represents the carrying value and has been recorded in other receivables in the accompanying consolidated balance sheets. |
61
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The tables below describe the forward contracts that were outstanding at December 31, 2001 (in thousands):
December 31, 2001:
Forward Position | ||||||||||||||||
In Mexican | Maturity | Weighted Average | Fair Value in | |||||||||||||
Foreign Currency | Pesos(1) | Date | Contract Rate | U.S. Dollars(1) | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
$ | 108,715 | 1/31/02 | 10.19 | $ | 1,128 | ||||||||||
Sell Mexican Peso/buy US Dollar
|
(20,000 | ) | 1/31/02 | 9.35 | (34 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
71,787 | 2/28/02 | 10.26 | 756 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(20,000 | ) | 2/28/02 | 9.47 | (48 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
94,371 | 3/27/02 | 10.46 | 1,102 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(40,000 | ) | 3/27/02 | 9.48 | (80 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
85,000 | 4/30/02 | 10.23 | 748 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(30,000 | ) | 4/30/02 | 9.62 | (84 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
81,000 | 5/31/02 | 10.11 | 559 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(25,000 | ) | 5/31/02 | 9.71 | (75 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
80,000 | 6/28/02 | 9.95 | 375 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(30,000 | ) | 6/28/02 | 9.78 | (88 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
48,000 | 7/31/02 | 10.07 | 242 | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
100,000 | 8/30/02 | 10.05 | 410 | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
45,000 | 9/30/02 | 10.09 | 169 | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
110,000 | 10/31/02 | 10.09 | 338 | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
30,000 | 11/29/02 | 10.27 | 122 | ||||||||||||
$ | 688,873 | $ | 5,540 | (1) | ||||||||||||
(1) | The Fair Value of the forward positions presented above, an unrealized loss of $5,540,000 at December 31, 2001, represents the carrying value of the forward contracts and has been recorded in accrued liabilities in the accompanying consolidated balance sheets. |
(16) | Fourth Quarter Adjustments |
During the fourth quarter of 2001, the Company recorded a total of approximately $4,288,000 to bad debt expense due to declining consultant liquidity as a result of the general slowdown of the economy in Mexico and Brazil. During the fourth quarter of 2000, the Company recorded certain adjustments related to changes in cost accounting estimates, which resulted in an increase to cost of sales of approximately $3,000,000.
62
INDEPENDENT AUDITORS REPORT
To the Board of Directors and Stockholder of
We have audited the accompanying consolidated balance sheets of Jafra Cosmetics International, Inc. and subsidiaries (the Company), an indirect, wholly owned subsidiary of CDRJ Investments (Lux) S.A., as of December 31, 2001, and the related consolidated statements of income, stockholders equity, and cash flows for each of the two years in the period ended December 31, 2001. These financial statements and financial statement schedule are the responsibility of the Companys management. Our responsibility is to express an opinion on these financial statements and financial statement schedule based on our audits.
We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements referred to above present fairly, in all material respects, the financial position of Jafra Cosmetics International, Inc. and subsidiaries as of December 31, 2001, and the results of their operations and their cash flows for each of the two years in the period ended December 31, 2001, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the financial statement schedule referred to above, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
DELOITTE & TOUCHE, LLP
Los Angeles, California
63
INDEPENDENT AUDITORS REPORT
To the Board of Directors and Stockholder of
We have audited the accompanying consolidated balance sheet of Jafra Cosmetics International, Inc. and subsidiaries (the Company), an indirect, wholly owned subsidiary of CDRJ Investments (Lux) S.A., as of December 31, 2002, and the related consolidated statement of income, stockholders equity, and cash flows for the year then ended. Our audit also included the financial statement schedule for the year ended December 31, 2002 listed at Item 15(a)(2). These financial statements and schedule are the responsibility of the Companys management. Our responsibility is to express an opinion on these financial statements based on our audit.
We conducted our audit in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.
In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Jafra Cosmetics International, Inc. and subsidiaries as of December 31, 2002, and the results of their operations and their cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States. Also, in our opinion, the related financial statement schedule for the year ended December 31, 2002, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
As discussed in Note 2 to the consolidated financial statements, effective January 1, 2002, the Company adopted Statement of Financial Accounting Standards No. 142.
/s/ ERNST & YOUNG, LLP |
Los Angeles, California
64
JAFRA COSMETICS INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31, | ||||||||||
2002 | 2001 | |||||||||
ASSETS | ||||||||||
Current assets:
|
||||||||||
Cash and cash equivalents
|
$ | 13,088 | $ | 4,081 | ||||||
Receivables, less allowances for doubtful
accounts of $613 in 2002 and $523 in 2001.
|
5,713 | 6,447 | ||||||||
Inventories
|
11,974 | 8,677 | ||||||||
Receivables from affiliates
|
25,608 | 23,633 | ||||||||
Prepaids and other current assets
|
2,554 | 1,665 | ||||||||
Deferred income taxes
|
| 55 | ||||||||
Total current assets
|
58,937 | 44,558 | ||||||||
Property and equipment, net
|
26,357 | 22,742 | ||||||||
Other assets:
|
||||||||||
Goodwill
|
37,488 | 38,125 | ||||||||
Notes receivable from affiliates
|
10,694 | 3,902 | ||||||||
Deferred financing fees, net
|
2,375 | 3,004 | ||||||||
Other
|
3,938 | 3,716 | ||||||||
Total
|
$ | 139,789 | $ | 116,047 | ||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
Current liabilities:
|
||||||||||
Current portion of long-term debt
|
$ | 4,000 | $ | 3,000 | ||||||
Accounts payable
|
5,944 | 5,591 | ||||||||
Accrued liabilities
|
12,230 | 12,709 | ||||||||
Income taxes payable
|
815 | 965 | ||||||||
Deferred income taxes
|
643 | | ||||||||
Payables to affiliates
|
20,435 | 2,639 | ||||||||
Total current liabilities
|
44,067 | 24,904 | ||||||||
Long-term debt
|
47,108 | 52,908 | ||||||||
Deferred income taxes
|
4,671 | 3,353 | ||||||||
Other long-term liabilities
|
3,787 | 3,088 | ||||||||
Total liabilities
|
99,633 | 84,253 | ||||||||
Commitments and contingencies
|
| | ||||||||
Stockholders equity:
|
||||||||||
Common stock, par value $.01; authorized, issued
and outstanding, 1,000 shares in 2002 and 2001.
|
| | ||||||||
Additional paid-in capital
|
39,649 | 39,649 | ||||||||
Retained earnings (deficit)
|
3,249 | (5,376 | ) | |||||||
Accumulated other comprehensive loss
|
(2,742 | ) | (2,479 | ) | ||||||
Total stockholders equity
|
40,156 | 31,794 | ||||||||
Total
|
$ | 139,789 | $ | 116,047 | ||||||
See accompanying notes to consolidated financial statements.
65
JAFRA COSMETICS INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
Years Ended December 31, | |||||||||||||
2002 | 2001 | 2000 | |||||||||||
Net sales to third parties
|
$ | 125,199 | $ | 110,227 | $ | 102,267 | |||||||
Sales to affiliates
|
15,817 | 13,442 | 14,297 | ||||||||||
Net sales
|
141,016 | 123,669 | 116,564 | ||||||||||
Cost of sales
|
43,778 | 37,383 | 36,063 | ||||||||||
Gross profit
|
97,238 | 86,286 | 80,501 | ||||||||||
Selling, general and administrative expenses
|
100,316 | 95,022 | 87,496 | ||||||||||
Management fee income from affiliates
|
(7,225 | ) | (8,504 | ) | (8,141 | ) | |||||||
Restructuring and impairment charges
|
| | 2,392 | ||||||||||
Loss on sale of assets
|
1 | 92 | 147 | ||||||||||
Royalty income from affiliates, net
|
(19,775 | ) | (20,098 | ) | (14,620 | ) | |||||||
Market subsidy expense
|
5,121 | | | ||||||||||
Income from operations
|
18,800 | 19,774 | 13,227 | ||||||||||
Other income (expense):
|
|||||||||||||
Exchange gain (loss), net
|
406 | (225 | ) | (178 | ) | ||||||||
Interest expense, net
|
(6,134 | ) | (6,794 | ) | (7,564 | ) | |||||||
Other, net
|
281 | (189 | ) | 9 | |||||||||
Income before income taxes and extraordinary item
|
13,353 | 12,566 | 5,494 | ||||||||||
Income tax expense
|
4,728 | 6,054 | 3,075 | ||||||||||
Income before extraordinary item
|
8,625 | 6,512 | 2,419 | ||||||||||
Extraordinary loss on early extinguishment of
debt, net of income tax benefit of $120.
|
| | 205 | ||||||||||
Net income
|
$ | 8,625 | $ | 6,512 | $ | 2,214 | |||||||
See accompanying notes to consolidated financial statements.
66
JAFRA COSMETICS INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
Years Ended December 31, | ||||||||||||||||||||||||||
2002 | 2001 | 2000 | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | |||||||||||||||||||||
Capital Stock:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
1,000 | $ | | 1,000 | $ | | 1,000 | $ | | |||||||||||||||||
Balance, end of year
|
1,000 | | 1,000 | | 1,000 | | ||||||||||||||||||||
Additional Paid-in Capital:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
39,649 | 39,649 | 38,749 | |||||||||||||||||||||||
Capital contributions by parent
|
| | 900 | |||||||||||||||||||||||
Balance, end of year
|
39,649 | 39,649 | 39,649 | |||||||||||||||||||||||
Retained Earnings (Deficit):
|
||||||||||||||||||||||||||
Balance, beginning of year
|
(5,376 | ) | (11,888 | ) | (14,102 | ) | ||||||||||||||||||||
Net income
|
8,625 | 6,512 | 2,214 | |||||||||||||||||||||||
Balance, end of year
|
3,249 | (5,376 | ) | (11,888 | ) | |||||||||||||||||||||
Accumulated Other Comprehensive
|
||||||||||||||||||||||||||
Loss:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
(2,479 | ) | (2,223 | ) | (2,319 | ) | ||||||||||||||||||||
Currency translation adjustments
|
(263 | ) | (256 | ) | 96 | |||||||||||||||||||||
Balance, end of year
|
(2,742 | ) | (2,479 | ) | (2,223 | ) | ||||||||||||||||||||
Total Stockholders Equity
|
1,000 | $ | 40,156 | 1,000 | $ | 31,794 | 1,000 | $ | 25,538 | |||||||||||||||||
Comprehensive Income:
|
||||||||||||||||||||||||||
Net income
|
$ | 8,625 | $ | 6,512 | $ | 2,214 | ||||||||||||||||||||
Currency translation adjustments
|
(263 | ) | (256 | ) | 96 | |||||||||||||||||||||
Total Comprehensive Income
|
$ | 8,362 | $ | 6,256 | $ | 2,310 | ||||||||||||||||||||
See accompanying notes to consolidated financial statements.
67
JAFRA COSMETICS INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years Ended December 31, | ||||||||||||||||
2002 | 2001 | 2000 | ||||||||||||||
(In thousands) | ||||||||||||||||
Cash flows from operating
activities:
|
||||||||||||||||
Net income
|
$ | 8,625 | $ | 6,512 | $ | 2,214 | ||||||||||
Extraordinary loss on early extinguishment of
debt, net of taxes
|
| | 205 | |||||||||||||
Income before extraordinary item
|
8,625 | 6,512 | 2,419 | |||||||||||||
Adjustments to reconcile income before
extraordinary item to net cash provided by (used in) operating
activities:
|
||||||||||||||||
Loss on sale of property and equipment
|
| 92 | 147 | |||||||||||||
Depreciation and amortization
|
3,231 | 3,484 | 3,014 | |||||||||||||
Provision for uncollectible accounts receivable
|
680 | 559 | 898 | |||||||||||||
Amortization of deferred financing fees
|
629 | 628 | 633 | |||||||||||||
Asset impairment charge
|
| | 1,019 | |||||||||||||
Unrealized foreign exchange (gain) loss
|
(99 | ) | 208 | 249 | ||||||||||||
Deferred income taxes
|
2,016 | 2,407 | 891 | |||||||||||||
Changes in operating assets and liabilities:
|
||||||||||||||||
Receivables
|
54 | (276 | ) | 346 | ||||||||||||
Inventories
|
(3,297 | ) | 778 | (2,287 | ) | |||||||||||
Prepaid expenses and other current assets
|
(889 | ) | 733 | (422 | ) | |||||||||||
Affiliate receivables and payables
|
15,920 | (18,221 | ) | 1,936 | ||||||||||||
Other assets
|
309 | 254 | 841 | |||||||||||||
Accounts payable and accrued liabilities
|
(126 | ) | (240 | ) | (1,999 | ) | ||||||||||
Income taxes payable/prepaid
|
(150 | ) | 572 | 272 | ||||||||||||
Other long-term liabilities
|
699 | 721 | (341 | ) | ||||||||||||
Net cash provided by (used in) operating
activities
|
27,602 | (1,789 | ) | 7,616 | ||||||||||||
Cash flows from investing
activities:
|
||||||||||||||||
Proceeds from sale of property and equipment
|
| | 92 | |||||||||||||
Purchases of property and equipment
|
(6,669 | ) | (5,091 | ) | (4,418 | ) | ||||||||||
Other
|
(531 | ) | (408 | ) | (760 | ) | ||||||||||
Net cash used in investing activities
|
(7,200 | ) | (5,499 | ) | (5,086 | ) | ||||||||||
Cash flows from financing
activities:
|
||||||||||||||||
Repurchase of subordinated notes
|
| | (6,358 | ) | ||||||||||||
Repayments under term loan facility
|
(3,000 | ) | (2,500 | ) | (2,000 | ) | ||||||||||
Net repayments under revolving credit facility
|
(1,800 | ) | (12,700 | ) | (10,000 | ) | ||||||||||
Capital contributions by Parent
|
| | 900 | |||||||||||||
Net transactions with affiliates
|
(6,792 | ) | 23,280 | 14,788 | ||||||||||||
Net cash (used in) provided by financing
activities
|
(11,592 | ) | 8,080 | (2,670 | ) | |||||||||||
Effect of exchange rate changes on cash
|
197 | (93 | ) | 496 | ||||||||||||
Net increase in cash and cash equivalents
|
9,007 | 699 | 356 | |||||||||||||
Cash and cash equivalents at beginning of year
|
4,081 | 3,382 | 3,026 | |||||||||||||
Cash and cash equivalents at end of year
|
$ | 13,088 | $ | 4,081 | $ | 3,382 | ||||||||||
Supplemental disclosure of cash flow
information
|
||||||||||||||||
Cash paid during the year for:
|
||||||||||||||||
Interest
|
$ | 5,847 | $ | 6,748 | $ | 9,669 | ||||||||||
Income Taxes
|
1,051 | 2,586 | 2,154 |
See accompanying notes to consolidated financial statements.
68
JAFRA COSMETICS INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(1) Basis of Presentation and Description of Business
Basis of Presentation
Jafra Cosmetics International, Inc., a Delaware corporation (JCI) is a wholly owned subsidiary of CDRJ North Atlantic (Lux) S.a.r.L., a Luxembourg société à responsabilité limitée, which is a wholly owned subsidiary of CDRJ Investments (Lux) S.A., a Luxembourg société anonyme (the Parent). JCI, its subsidiaries, and certain other subsidiaries of the Parent were organized by Clayton, Dubilier & Rice Fund V Limited Partnership, a Cayman Islands exempted limited partnership managed by Clayton, Dubilier & Rice, Inc. (CD&R) to acquire (the Acquisition) the worldwide Jafra Cosmetics business (the Jafra Business) from The Gillette Company.
The accompanying consolidated financial statements reflect the operations of JCI and its subsidiaries (collectively, JCI). JCI is an operating subsidiary in the United States, and currently has operating subsidiaries in Austria, Germany, Italy, the Netherlands, Switzerland, the Dominican Republic and Thailand. All significant intercompany accounts and transactions have been eliminated in consolidation.
In connection with the Acquisition, JCI and an affiliated company, Jafra Cosmetics International, S.A. de C.V. (Jafra S.A.) (the indirect, wholly owned Mexican subsidiary of the Parent) issued $100 million aggregate principal amount of 11.75% Subordinated Notes due 2008 (the Notes). See Note 6. The Notes represent several obligations of JCI and Jafra S.A., with each participating on a pro rata basis upon redemption. JCI and Jafra S.A. have fully and unconditionally guaranteed the obligations under the Notes of the other on a senior subordinated basis, subject to a 30-day standstill period prior to enforcement of such guarantees. As the cross-guarantee of JCI and Jafra S.A. is subject to a 30-day standstill period, the Parent is filing these separate financial statements of JCI as a schedule to its Annual Report on Form 10-K for the year ended December 31, 2002.
Description of Business
JCI markets its products, which consist of premium skin and body care products, color cosmetics, fragrances, and other personal care products, primarily in the United States, but also through subsidiaries in Austria, Germany, Italy, the Netherlands, Switzerland, the Dominican Republic and Thailand and in a number of additional countries through distributors. JCI utilizes a direct selling, multilevel distribution system comprised of self-employed salespersons (known as consultants).
(2) Summary of Significant Accounting Policies
Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents. Cash and cash equivalents include cash, time deposits and all highly liquid debt instruments purchased with a maturity of three months or less.
Inventories. Inventories, which consist of finished goods, are stated at the lower of cost, as determined by the first-in, first-out basis, or market.
Property and Equipment. Property and equipment are stated at cost. Depreciation of property and equipment is provided for over the estimated useful lives of the respective assets using the straight-line method. Estimated useful lives are 40 years for buildings, the lesser of 40 years or the term of the lease for improvements, 5 to 15 years for machinery and equipment and 5 to 8 years for hardware and software.
69
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Maintenance and repairs, including cost of minor replacements, are charged to operations as incurred. Costs of additions and betterments are added to property and equipment accounts provided that such expenditures increase the useful life or the value of the asset.
Intangible Assets. Intangible assets principally consist of goodwill and trademarks. On January 1, 2002, JCI adopted Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and other Intangible Assets which requires JCI to not amortize goodwill and certain other intangible assets, but to test those intangible assets for impairment at least annually. Prior to adoption of SFAS No. 142, goodwill and other intangible assets were amortized using the straight-line method over a period of 40 years. Goodwill and trademarks resulted from the Parents acquisition of the Jafra Business. The book value of goodwill and trademarks was $37,488,000 and $237,000 at December 31, 2002, respectively. (See New Accounting Standards).
Deferred Financing Costs. In connection with the acquisition of the Jafra Business, JCI incurred approximately $7.2 million of costs related to the 11.75% Senior Subordinated Notes due 2008 (the Notes), the revolving credit facility and the term loan facility (see Note 6). Such costs are being amortized on a basis that approximates the interest method over the expected term of the related debt. Accumulated amortization at December 31, 2002 and 2001 was $3,129,000 and $2,500,000, respectively.
Impairment of Long-Lived Assets and Goodwill. Long-lived assets are reviewed for impairment, based on undiscounted cash flows, whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. If this review indicates that the carrying amount of the long-lived assets is not recoverable, JCI will recognize an impairment loss, measured by the future discounted cash flow method. Goodwill is tested for impairment annually, or whenever events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable based on the provisions of SFAS No. 142. (see New Accounting Standards and Note 10)
Fair Value of Financial Instruments. The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value because of the short-term maturities of these instruments. The fair value of the Notes at December 31, 2002 and 2001 was $46,236,000 and $48,266,000, respectively, based on discussions with one of JCIs largest bondholders and an analysis of current market interest rates and the Parents credit rating. As JCIs revolving credit facility and the term loan are variable rate debt, and the interest rate spread paid by JCI is adjusted for changes in certain financial ratios of the Parent, the fair value of the revolving credit facility and the term loan approximated their carrying amounts at December 31, 2002 and 2001.
Revenue Recognition. JCI recognizes revenue when title passes at shipment in accordance with its shipping terms. Amounts billed to consultants for shipping and handling costs are included in net sales. Sales are reduced by commissions paid to consultants on their personal sales.
Shipping and handling costs. Shipping and handling costs of $12,706,000, $11,265,000 and $12,170,000 for the years ended December 31, 2002, 2001 and 2000, respectively, are included in selling, general and administrative expenses.
Research and Development. Research and development costs are expensed as incurred. Total research and development expense aggregated $1,469,000, $1,842,000 and $1,901,000 for the years ended December 31, 2002, 2001 and 2000, respectively. The portion of the above-identified research and development expenses incurred by the JCI and charged to Jafra S.A. as part of the JCIs management fee income (see Note 9) aggregated $1,081,000, $864,000 and $978,000, for the years ended December 31, 2002, 2001 and 2000, respectively.
Income Taxes. JCI accounts for income taxes under the balance sheet approach that requires the recognition of deferred income tax assets and liabilities for the expected future consequences of events that
70
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
have been recognized in JCIs financial statements or income tax returns. Management provides a valuation allowance for deferred income tax assets when it is more likely than not that a portion of such deferred income tax assets will not be realized. Income tax expense of JCI is computed on a separate-company basis.
Foreign Currency Translation. The functional currency for foreign subsidiaries is generally the local currency. Assets and liabilities of such foreign subsidiaries are translated into U.S. dollars at current exchange rates, and related revenues and expenses are translated at average exchange rates in effect during the period. Resulting translation adjustments are recorded as a component of other comprehensive loss.
New Accounting Standards. In June 2001, the Financial Accounting Standards Board (FASB) approved two new statements: SFAS No. 141, Business Combinations and SFAS No. 142, Goodwill and Other Intangible Assets. SFAS No. 141 requires business combinations entered into after June 30, 2001 to be accounted for using the purchase method of accounting. SFAS No. 142 requires that goodwill not be amortized, but be tested for impairment at least annually. SFAS No. 142 was effective for fiscal years beginning after December 15, 2001 to all goodwill and other intangible assets recognized in an entitys statement of financial position at that date, regardless of when those assets were initially recognized. JCI adopted SFAS No. 142 on January 1, 2002. In accordance with such adoption, JCI identified all reporting units in conjunction with the provisions of SFAS No. 142 and allocated all goodwill accordingly. Prior to June 30, 2002, JCI completed the transitional goodwill impairment test required by SFAS No. 142. Based on the transitional and annual impairment test, JCI determined that there was no impairment to goodwill. During the year ended December 31, 2002, no impairment was identified. The changes in the carrying amount of goodwill for the year ended December 31, 2002 are as follows:
United | Consolidated | |||||||||||
Goodwill | States | Europe | Total | |||||||||
Balance as of December 31, 2001
|
$ | 32,188 | $ | 5,937 | $ | 38,125 | ||||||
Translation effect
|
| (637 | ) | (637 | ) | |||||||
Balance as of December 31, 2002
|
$ | 32,188 | $ | 5,300 | $ | 37,488 | ||||||
JCIs other intangible assets consist of trademarks. During the year ended December 31, 2002, JCI determined trademarks to have an indefinite life and performed the transitional impairment test as required under SFAS No. 142. Based upon the transitional and annual test, JCI determined that there was no impairment of trademarks. The carrying value of trademarks was $237,000 at December 31, 2002 and is included in other assets in the accompanying consolidated balance sheets.
In accordance with SFAS No. 142, JCI discontinued amortization of goodwill and other intangible assets with an indefinite life. A reconciliation of previously reported net income to amounts adjusted for the exclusion of goodwill and trademark amortization, net of the related income tax effects, where applicable, is as follows (in thousands):
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Net income
|
$ | 8,625 | $ | 6,512 | $ | 2,214 | ||||||
Goodwill amortization, net of tax
|
| 725 | 863 | |||||||||
Trademark amortization, net of tax
|
| 26 | 54 | |||||||||
Adjusted net income
|
$ | 8,625 | $ | 7,263 | $ | 3,131 | ||||||
In November 2001, the Emerging Issues Task Force (EITF) issued EITF Issue No. 01-9, Accounting for Consideration Given by a Vendor to a Customer or a Reseller of the Vendors Products. This new guidance provides that consideration from a vendor to a reseller is generally presumed to be a reduction of the selling prices of the vendors products, and, therefore, should be characterized as a reduction of revenue when
71
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
recognized in the vendors income statement. On January 1, 2002, JCI adopted EITF Issue No. 01-9 and reclassified commissions paid to consultants of $1,417,000 and $1,254,000 on their personal sales, previously reported as a component of selling, general and administrative expenses, as a reduction in net sales and selling, general and administrative expenses for the years ended December 31, 2001 and 2000, respectively.
On January 1, 2002, JCI adopted SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets. SFAS No. 144 supersedes SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed of. SFAS No. 144 retains substantially all of the requirements of SFAS No. 121, while resolving certain implementation issues and addressing the accounting for a component of a business accounted for as a discontinued operation. SFAS No. 144 was adopted with no significant impact on the financial position or results of operations of JCI.
In April 2002, the FASB issued SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections. This Statement rescinds or modifies existing authoritative pronouncements including SFAS No. 4 Reporting Gains and Losses from Extinguishment of Debt. As a result of the issuance of SFAS No. 145, gains and losses from extinguishment of debt should be classified as extraordinary items only if they meet the criteria in Accounting Principles Board (APB) Opinion 30, Reporting the Results of Operations-Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions. Applying the provisions of APB Opinion 30 will distinguish transactions that are part of an entitys recurring operations from those that are unusual or infrequent or that meet the criteria for classification as an extraordinary item. The provisions of this Statement related to the rescission of SFAS No. 4 shall be applied in fiscal years beginning after May 15, 2002. Any gain or loss on extinguishment of debt that was classified as an extraordinary item in prior periods presented that does not meet the criteria in APB Opinion 30 for classification as an extraordinary item shall be reclassified. JCI is currently evaluating the impact that this statement may have on any potential future extinguishments of debt. Upon adoption of SFAS No. 145, JCI will reclassify items previously reported as extraordinary items as a component of operating income on the accompanying statements of income.
In June 2002, the FASB approved SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities. This statement addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. The provisions of this statement are effective for exit or disposal activities that are initiated after December 31, 2002, with early application encouraged. JCI is currently evaluating the impact that this statement may have on any potential future exit or disposal activities.
During 2002, the FASB issued SFAS No. 148, Accounting for Stock Based Compensation Transaction and Disclosure, an amendment to FASB Statement No. 123. This Statement requires more extensive interim disclosure related to stock based compensation for all companies and permits additional transition methods for companies that elect to use the fair value method for employee stock compensation. This statement is effective for fiscal years ending after December 15, 2002, with early adoption regarding annual disclosure encouraged. JCI adopted the disclosure requirements of SFAS No. 148. (See note 13).
Reclassifications. Certain reclassifications were made to the prior year financial statements to conform to current year presentation.
72
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(3) Inventories
Inventories consist of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Raw materials and supplies
|
$ | 243 | $ | | ||||
Finished goods
|
11,731 | 8,677 | ||||||
Total inventories
|
$ | 11,974 | $ | 8,677 | ||||
(4) Property and Equipment
Property and equipment consist of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Land
|
$ | 6,188 | $ | 6,188 | ||||
Buildings and improvements
|
7,099 | 6,763 | ||||||
Machinery, equipment and other
|
22,460 | 15,971 | ||||||
35,747 | 28,922 | |||||||
Less accumulated depreciation
|
9,390 | 6,180 | ||||||
Property and equipment, net
|
$ | 26,357 | $ | 22,742 | ||||
(5) Accrued Liabilities
Accrued liabilities consist of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Sales promotions, commissions and overrides
|
$ | 2,965 | $ | 3,182 | ||||
Accrued restructuring charges (Note 10)
|
| 128 | ||||||
Accrued interest
|
880 | 931 | ||||||
Compensation and other benefit accruals
|
4,832 | 4,291 | ||||||
State and local sales taxes and other taxes
|
1,180 | 1,282 | ||||||
Other
|
2,373 | 2,895 | ||||||
Total accrued liabilities
|
$ | 12,230 | $ | 12,709 | ||||
(6) Debt
Debt consists of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Subordinated Notes, unsecured, interest payable
semi-annually at 11.75% due in 2008.
|
$ | 45,108 | $ | 45,108 | ||||
Term loan, secured, principal and interest due in
quarterly installments through April 30, 2004, interest
rates at 3.1% and 4.3% at December 31, 2002 and 2001,
respectively
|
6,000 | 9,000 | ||||||
Revolving loan, secured, due April 30, 2004,
weighted average interest rates of 5.4% at December 31, 2001
|
| 1,800 | ||||||
Total debt
|
51,108 | 55,908 | ||||||
Less current maturities
|
4,000 | 3,000 | ||||||
Long-term debt
|
$ | 47,108 | $ | 52,908 | ||||
73
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
JCIs long-term debt matures as follows (in thousands): $4,000 in 2003, $2,000 in 2004, $0 in 2005, 2006 and 2007 and $45,108 thereafter.
On April 30, 1998, JCI and Jafra S.A. borrowed $125 million by issuing $100 million aggregate principal amount of 11.75% Subordinated Notes due 2008 (the Notes) pursuant to an Indenture dated April 30, 1998 (the Indenture) and $25 million under a senior credit agreement.
At the date of issuance, the Notes represented several obligations of JCI and Jafra S.A. in the amount of $60 million and $40 million, respectively, with each participating on a pro rata basis upon redemption. The Notes mature in 2008 and bear a fixed interest rate of 11.75% payable semi-annually.
JCI and Jafra S.A. are indirect, wholly owned subsidiaries of the Parent and have fully and unconditionally guaranteed the obligations under the Notes of the other on a senior subordinated basis, subject to a 30-day standstill period prior to enforcement of such guarantees. In addition, the Parent has fully and unconditionally guaranteed the Notes on a senior subordinated basis. JCI has no U.S. subsidiaries. Each acquired or organized U.S. subsidiary of JCI will also be required to fully and unconditionally guarantee the Notes jointly and severally, on a senior subordinated basis. Each existing subsidiary of Jafra S.A. fully and unconditionally guarantees the Notes jointly and severally, on a senior subordinated basis, and each subsequently acquired or organized subsidiary of Jafra S.A. will fully and unconditionally guarantee the Notes jointly and severally, on a senior subordinated basis. The nonguarantor entities are JCIs indirect subsidiaries in Austria, Germany, Italy, the Netherlands, Switzerland, the Dominican Republic and Thailand, and the Parents indirect subsidiaries in Poland, Argentina, Brazil, Chile, Colombia, Peru, and Venezuela. All guarantor and nonguarantor entities are either direct or indirect wholly owned subsidiaries of the Parent. The Notes were registered in a registered exchange offer, effective as of January 25, 1999, under the Securities Act of 1933, as amended.
The Notes are unsecured and are generally non-callable for five years. Thereafter, the Notes will be callable at premiums declining to par in the eighth year.
Consents and waivers, dated June 30, 2001 and November 19, 1999, to the senior credit agreement, as described below, allow JCI and Jafra S.A. to repurchase the Notes in the open market from time to time, with the aggregate purchase price for all such Notes repurchased not to exceed $50 million. Aggregate repurchases as of December 31, 2002 were $24.8 million. During 2000, JCI retired notes, prior to maturity, with a face value of $6.5 million. The debt repurchases in 2000 resulted in an extraordinary loss of $205,000, net of an income tax benefit of $120,000. In connection with the early retirement of the Notes as described above, a portion of the unamortized deferred financing costs was written off and included in the determination of the extraordinary loss on early extinguishment of debt. In 2000, $459,000 of the unamortized deferred financing fees were written off.
In addition, JCI and Jafra S.A. entered into a senior credit agreement that provides for senior secured credit facilities in an aggregate principal amount of $90 million, consisting of a multicurrency revolving credit facility of $65 million and a term loan facility of $25 million. Borrowings under the term loan facility are payable in quarterly installments of principal and interest over six years through April 30, 2004. Borrowings under the revolving credit facility mature on April 30, 2004. Borrowings under the senior credit agreement currently bear interest at an annual rate of LIBOR plus a margin of 1.625% or an alternate base rate (the higher of the prime rate or federal funds rate plus 0.5%, plus an applicable margin of 0.625%). The interest rate in effect at December 31, 2002 was approximately 3.1% for the LIBOR-based borrowings. Borrowings under the senior credit agreement are secured by substantially all of the assets of JCI and Jafra S.A. No amounts were outstanding under the revolving credit facility at December 31, 2002.
Both the Indenture and the Senior Credit Agreement contain certain covenants that limit JCIs ability to incur additional indebtedness, pay cash dividends and make certain other payments. These debt agreements also require the Parent to maintain certain financial ratios including a minimum EBITDA to cash interest expense coverage ratio and a maximum debt to EBITDA ratio.
74
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(7) Income Taxes
JCIs income before income taxes consists of the following (amounts in thousands):
Years Ended December 31, | |||||||||||||
2002 | 2001 | 2000 | |||||||||||
Income before income taxes and extraordinary item:
|
|||||||||||||
United States
|
$ | 12,859 | $ | 13,530 | $ | 9,741 | |||||||
Foreign
|
494 | (964 | ) | (4,247 | ) | ||||||||
$ | 13,353 | $ | 12,566 | $ | 5,494 | ||||||||
Actual income tax expense differs from the expected tax expense (computed by applying the U.S. federal corporate rate of 35% to income before income taxes) as a result of the following:
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Provision for income taxes at federal statutory
rate
|
$ | 4,674 | $ | 4,398 | $ | 1,922 | ||||||
Foreign income subject to tax other than at
federal statutory rate, principally withholding taxes
|
1,886 | 2,532 | 1,298 | |||||||||
Foreign tax and other credits
|
(2,312 | ) | (3,230 | ) | (1,724 | ) | ||||||
State income taxes
|
548 | 544 | 243 | |||||||||
Valuation allowance domestic
|
19 | 944 | (616 | ) | ||||||||
Valuation allowance foreign
|
23 | 674 | 1,911 | |||||||||
Other
|
(110 | ) | 192 | 41 | ||||||||
Income tax expense
|
$ | 4,728 | $ | 6,054 | $ | 3,075 | ||||||
The components of the provision for income taxes are as follows (in thousands):
Years Ended December 31, | |||||||||||||||
2002 | 2001 | 2000 | |||||||||||||
Current:
|
|||||||||||||||
Federal
|
$ | 178 | $ | 140 | $ | 72 | |||||||||
Foreign:
|
|||||||||||||||
Foreign withholding taxes
|
2,250 | 2,296 | 1,820 | ||||||||||||
Europe
|
(297 | ) | 641 | 49 | |||||||||||
Other
|
33 | 26 | | ||||||||||||
1,986 | 2,963 | 1,869 | |||||||||||||
State
|
548 | 544 | 243 | ||||||||||||
Total current
|
2,712 | 3,647 | 2,184 | ||||||||||||
Deferred foreign
|
| | | ||||||||||||
Deferred domestic
|
2,016 | 2,407 | 891 | ||||||||||||
Total deferred
|
2,016 | 2,407 | 891 | ||||||||||||
Total income taxes on income before income taxes
and extraordinary item
|
4,728 | 6,054 | 3,075 | ||||||||||||
Income tax benefit on early extinguishment of debt
|
| | (120 | ) | |||||||||||
Total income tax expense
|
$ | 4,728 | $ | 6,054 | $ | 2,955 | |||||||||
75
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The components of deferred income tax assets and deferred income tax liabilities at December 31, 2002 and 2001 are as follows (in thousands):
2002 | 2001 | |||||||||
Deferred income tax assets:
|
||||||||||
Net operating loss carryforward
|
$ | 6,857 | $ | 6,834 | ||||||
Disallowed interest expense
|
| 26 | ||||||||
Foreign tax and other credit carryforward
|
2,071 | 2,646 | ||||||||
Other accrued liabilities
|
180 | 331 | ||||||||
Other
|
1,409 | 1,927 | ||||||||
Total deferred income tax assets
|
10,517 | 11,764 | ||||||||
Less valuation allowance
|
(9,522 | ) | (9,480 | ) | ||||||
Net deferred income tax assets
|
995 | 2,284 | ||||||||
Deferred income tax liabilities:
|
||||||||||
Property and equipment
|
(2,007 | ) | (1,602 | ) | ||||||
Trademark and goodwill
|
(3,474 | ) | (2,631 | ) | ||||||
Inventories
|
(261 | ) | (930 | ) | ||||||
Other
|
(567 | ) | (419 | ) | ||||||
Total deferred income tax liabilities
|
(6,309 | ) | (5,582 | ) | ||||||
Net deferred income tax liabilities
|
$ | (5,314 | ) | $ | (3,298 | ) | ||||
JCI records a valuation allowance on the deferred income tax assets to reduce the total to an amount that management believes is more likely than not to be realized. The valuation allowances at December 31, 2002 and 2001 were based upon JCIs estimates of the future realization of deferred income tax assets. Valuation allowances at December 31, 2002 were provided to offset foreign operating loss carryforwards of $6,857,000 and foreign tax, other credit carryforwards of $2,071,000 and certain other pretax expenses. These amounts were reduced by a valuation allowance of $10,517,000. Valuation allowances at December 31, 2001 were provided to offset foreign operating loss carryforwards of $6,834,000 and foreign tax and other credit carryforwards of $2,646,000 resulting from JCIs U.S. and European subsidiaries. These deferred income tax assets were reduced by a valuation allowance of $9,522,000 and $9,480,000 as December 31, 2002 and 2001, respectively. The tax loss carryforwards expire in varying amounts between 2003 and 2012. Realization of the income tax carryforwards is dependent on generating sufficient taxable income prior to expiration of the carryforwards.
(8) Benefit Plans
Certain employees of the JCIs German subsidiary participate in a defined benefit pension plan covering key employees (the Germany Plan). Benefits are based on age, years of service and the level of compensation during the final years of employment. JCIs funding policy is to contribute annually to the Germany Plan the amount necessary to meet the minimum funding standards. JCI recognized pension expense of $48,000 and $278,000 for the years ended December 31, 2002 and 2001, respectively and recognized pension income of $18,000 for the year ended December 31, 2000 due to the departure of certain employees.
JCI has an employee savings plan which permits participants to make voluntary contributions by salary deferrals pursuant to section 401(k) of the Internal Revenue Code, which allows employees to defer up to 20% of their total compensation, subject to statutory limitations. Employee contributions of up to 10% of compensation are matched by JCI at the rate of 50 cents per dollar. Employees do not vest in JCIs contribution until they have reached two years of service, at which time they become fully vested. The JCIs
76
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
expense under this program was $618,000, $600,000 and $620,000 for the years ended December 31, 2002, 2001 and 2000, respectively.
JCI also has a supplemental excess benefit savings plan, which permits participants to make unlimited voluntary contributions. Employee contributions are matched on the same basis as under the employee savings plan, and the vesting provisions are the same. JCIs expense under this program was $207,000, $177,000 and $213,000 for the years ended December 31, 2002, 2001 and 2000, respectively. Employee and employer contributions under such plan are placed into a rabbi trust exclusively for the uses and purposes of plan participants and general creditors of JCI. The JCI has recorded an asset and the related liability in the accompanying consolidated balance sheets of $2,411,000 and $1,880,000 at December 31, 2002 and 2001, respectively.
(9) Related Party Transactions
JCI distributes skin and body products to other subsidiaries of the Parent (affiliates). Sales to affiliates, primarily in Mexico and South America, were $15,817,000, $13,442,000 and $14,297,000 for the years ended December 31, 2002, 2001 and 2000, respectively. These sales were made at cost plus a markup ranging from 0 to 11%. JCI also purchases color and fragrance products from the Parents Mexico affiliate (Jafra S.A.) totaling $13,592,000, $9,849,000 and $8,856,000 for the years ended December 31, 2002, 2001 and 2000, respectively.
In addition, JCI provides certain management services, such as legal, accounting and treasury, management oversight, and other administrative functions to affiliates. The cost of these services is included in selling, general and administrative expenses in the accompanying consolidated statements of income. JCI charges out a portion of these management expenses to its affiliates based upon charges identified to specific affiliates and upon a formula using the percentage of revenues of each affiliate to the total consolidated revenues of the Parent. JCI believes the amounts and methods of allocations are reasonable and approximate the cost of the actual services provided. The management fee income, which consists of amounts billed to affiliates in Mexico and South America, was $7,225,000, $8,504,000 and $8,141,000 for the years ended December 31, 2002, 2001 and 2000, respectively.
During 1999, JCI sold U.S. trademarks and German trademarks to Jafra S.A. As a result of these sales, Jafra S.A. charges JCI a fee for the right to use the Jafra trademark in the United States and Europe. The total royalty expense charged by Jafra S.A. to JCI was $2,443,000, $1,639,000 and $1,126,000 for the years ended December 31, 2002, 2001 and 2000, respectively, and is offset against royalty income from affiliates in the accompanying consolidated statements of income.
JCI owns the worldwide rights to its multi-level sales know-how (referred to as the Jafra Way). The Jafra Way was initially developed in the United States for lineage, training, and compensation of consultants. JCI charges Jafra S.A. a royalty for the use of the Jafra Way. The royalty fees charged by JCI were $22,218,000, $21,737,000 and $15,746,000 for the years ended December 31, 2002, 2001 and 2000, respectively, and were based upon a percentage of Jafra S.A.s sales.
JCI has granted loans to certain affiliates at annual interest rates ranging from 6% to 9%. Such loans are due to be repaid five years from the date of grant, with no prepayment penalty. Notes receivable from affiliates at December 31, 2002 and 2001 consists primarily of loans JCI has made to subsidiaries of the Parent to fund certain of their operations in South America. Net interest income from affiliates, was $351,000, $703,000 and $2,126,000 the years ended December 31, 2002, 2001 and 2000, respectively.
JCI reimburses certain foreign affiliates for the expenses that they incur in establishing a direct selling, multilevel distribution system and customer base in new markets. Such subsidies amounted to $5,121,000 in 2002 and $0 in 2001 and 2000.
77
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Pursuant to a consulting agreement entered into following the Acquisition, until the 10th anniversary of the Acquisition or the date on which CD&R Fund V no longer has an investment in the Parent or until the termination by either party with 30 days notice, CD&R will receive an annual fee (and reimbursement of out-of-pocket expenses) for providing advisory, management consulting and monitoring services to the Parent. On January 1, 2000, the annual fee was $400,000. As of January 1, 2001, the annual fee was increased to $1,000,000. As required by the terms of the Parents lending arrangements, such fees are determined by arms-length negotiation and are believed by the Parent to be reasonable. The amendment, effective January 1, 2001, adds to CD&Rs services under the agreement financial advisory, investment banking and similar services with respect to future proposals for an acquisition, merger, recapitalization, or other similar transaction directly or indirectly involving the Parent or any of its subsidiaries. The fee for such additional services in connection with future transactions would be an amount equal to 1% of the transaction value for the transaction to which such fee relates. Such transaction fees may be increased upon approval of a majority of the members of the Parents Board of Directors who are not employees of the Parent, CD&R or any affiliate of CD&R. The amendment also provides that if any employee of CD&R is appointed to an executive management position (or a position of comparable responsibility) in the Parent or any of its subsidiaries, the annual fee will be increased by an amount to be determined by CD&R, the amount of such increase not to exceed 100% of the existing annual fee in effect at that time. The CD&R fees incurred during the years ended December 31, 2002, 2001 and 2000 were $1,000,000, $1,000,000 and $400,000, respectively. These fees were recorded as selling, general, and administrative expenses in the accompanying consolidated statements of income, and a portion of the fees was allocated to affiliates as part of JCIs management fee income from affiliates. Certain officers and directors of CD&R or its affiliates serve as directors of the Parent.
Prior to 2000, JCI engaged Guidance Solutions (Guidance), a corporation in which an investment fund managed by CD&R has an investment, to develop its e-commerce systems. Under the agreement entered into by both parties, JCI agreed to pay fees of approximately $2.0 million to Guidance in connection with planning, defining, designing and consulting services performed related to its e-commerce initiative. During the years ended December 31, 2000, JCI paid fees to Guidance of $1,798,000. A portion of these amounts was allocated to JCIs affiliates. JCI terminated its agreement with Guidance and executed a settlement and mutual release agreement effective September 30, 2000. Upon execution of this agreement in October of 2000, Guidance paid JCI $25,000 and agreed to pay the JCI an aggregate additional sum of $475,000, payable in quarterly installments plus interest at 9.5% per annum, beginning in January 2001 through October 2005. As of December 31, 2002, the balance was paid in full.
(10) Restructuring and Impairment Charges and Related Accruals
Prior Years Restructuring and Impairment Charges. In 2000, JCI recorded approximately $1.4 million of restructuring charges and approximately $1.0 million of asset impairment charges. The restructuring charges of approximately $1.4 million related to the JCIs repositioning activities in Europe, primarily severance, of which $1.3 million was paid in 2000 and 2001 and the remaining $0.1 million was paid in 2002. The asset impairment charges of $1.0 million consisted of approximately $0.3 million related to JCIs repositioning activities in Europe and approximately $0.7 million related to the write-down of certain capitalized computer software costs in the United States.
78
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The components of the additions and/or adjustments to the aforementioned accruals include severance, lease costs, fixed asset disposals, and other exit costs, and are summarized as follows (in thousands):
Years Ended | ||||||||||
December 31, | ||||||||||
2001 | 2000 | |||||||||
Additions charges to income:
|
||||||||||
Severance
|
$ | (84 | ) | $ | 1,170 | |||||
Lease costs
|
80 | 170 | ||||||||
Other
|
4 | 84 | ||||||||
Total additions
|
$ | | $ | 1,424 | ||||||
A rollforward of the activity of the restructuring accruals is summarized as follows (in thousands):
Years Ended December 31, | |||||||||||||
2002 | 2001 | 2000 | |||||||||||
Opening balance
|
$ | 128 | $ | 516 | $ | 1,105 | |||||||
Additions
|
| | 1,424 | ||||||||||
Charges against reserves
|
(128 | ) | (388 | ) | (2,013 | ) | |||||||
Ending balance
|
$ | | $ | 128 | $ | 516 | |||||||
The remaining costs at each year-end included in the restructuring accrual are summarized as follows (in thousands):
December 31, | ||||||||
2001 | 2000 | |||||||
Severance
|
$ | | $ | 346 | ||||
Lease costs and other
|
128 | 170 | ||||||
$ | 128 | $ | 516 | |||||
The principal component of the restructuring accruals was severance. A summary of the severance activity is as follows (dollar amounts in thousands):
Years Ended December 31, | |||||||||||||||||
2001 | 2000 | ||||||||||||||||
Number of | Number of | ||||||||||||||||
Employees | Amount | Employees | Amount | ||||||||||||||
Opening balance
|
10 | $ | 346 | 43 | $ | 1,105 | |||||||||||
Planned terminations
|
| | 29 | 1,170 | |||||||||||||
Adjustment to planned terminations
|
| (84 | ) | | | ||||||||||||
Actual terminations
|
(10 | ) | (262 | ) | (62 | ) | (1,929 | ) | |||||||||
Ending balance
|
| $ | | 10 | $ | 346 | |||||||||||
(11) Financial Reporting for Business Segments
Segment information has been prepared in accordance with SFAS No. 131, Disclosure about Segments of an Enterprise and Related Information. SFAS No. 131 requires disclosure of certain information regarding operating segments, products and services, geographic areas of operations and major customers.
JCIs business is comprised of one industry segment, direct selling, with worldwide operations, principally in the United States and Europe. JCI is organized into geographical business units that each sell the full line
79
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
of Jafra cosmetics, skin care, body care, fragrances, and other products. JCI has two reportable business segments: the United States and Europe. Business results for subsidiaries in the Dominican Republic and Thailand are combined and included in the following table under the caption All Others.
The accounting policies used to prepare the information reviewed by the JCIs chief operating decision makers are the same as those described in the summary of significant accounting policies. JCI evaluates performance based on segment operating income, excluding reorganization and restructuring charges, unusual gains and losses, and amortization of goodwill and intangibles. Consistent with the information reviewed by the JCIs chief operating decision makers, corporate costs, foreign exchange gains and losses, interest expense, other nonoperating income or expense, and income taxes are not allocated to operating segments. The effects of intersegment sales (net sales and related gross profit) are excluded from the computation of segment operating income. Gross profit from affiliates and notes and accounts receivable from affiliates (primarily in Mexico and South America) are included in the following table under the caption Corporate, Unallocated and Other.
Corporate, | ||||||||||||||||||||||||
United | All | Total | Unallocated | Consolidated | ||||||||||||||||||||
Dollars in thousands | States | Europe(1) | Others | Segments | and Other | Total | ||||||||||||||||||
Year ended December 31, 2002
|
||||||||||||||||||||||||
Net sales
|
$ | 92,143 | $ | 26,932 | $ | 6,124 | $ | 125,199 | $ | 15,817 | $ | 141,016 | ||||||||||||
Operating profit (loss)
|
15,620 | 1,224 | (89 | ) | 16,755 | 2,045 | 18,800 | |||||||||||||||||
Depreciation and amortization
|
2,631 | 382 | 218 | 3,231 | | 3,231 | ||||||||||||||||||
Capital expenditures
|
6,298 | 174 | 197 | 6,669 | | 6,669 | ||||||||||||||||||
Segment assets
|
82,532 | 18,414 | 2,541 | 103,487 | 36,302 | 139,789 | ||||||||||||||||||
Goodwill
|
32,188 | 5,300 | | 37,488 | | 37,488 | ||||||||||||||||||
Year ended December 31, 2001
|
||||||||||||||||||||||||
Net sales
|
79,611 | 26,295 | 4,321 | 110,227 | 13,442 | 123,669 | ||||||||||||||||||
Operating profit (loss)
|
11,580 | 2,143 | (768 | ) | 12,955 | 6,819 | 19,774 | |||||||||||||||||
Depreciation and amortization
|
2,709 | 601 | 174 | 3,484 | | 3,484 | ||||||||||||||||||
Capital expenditures
|
4,529 | 230 | 332 | 5,091 | | 5,091 | ||||||||||||||||||
Segment assets
|
67,792 | 17,522 | 3,198 | 88,512 | 27,535 | 116,047 | ||||||||||||||||||
Year ended December 31, 2000
|
||||||||||||||||||||||||
Net sales
|
74,137 | 26,680 | 1,450 | 102,267 | 14,297 | 116,564 | ||||||||||||||||||
Operating profit (loss)
|
10,709 | 876 | (790 | ) | 10,795 | 2,432 | 13,227 | |||||||||||||||||
Depreciation and amortization
|
2,111 | 883 | 20 | 3,014 | | 3,014 | ||||||||||||||||||
Capital expenditures
|
3,662 | 90 | 666 | 4,418 | | 4,418 | ||||||||||||||||||
Segment assets
|
$ | 68,843 | $ | 17,650 | $ | 2,102 | $ | 88,595 | $ | 32,547 | $ | 121,142 |
(1) | excludes Poland, an indirect wholly-owned subsidiary of the Parent, an affiliate of JCI. |
80
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Additional business segment information regarding product lines is as follows:
2002 | 2001 | 2000 | ||||||||||||||||||||||||
Sales by | Percentage | Sales by | Percentage | Sales by | Percentage | |||||||||||||||||||||
Product | of Total | Product | of Total | Product | of Total | |||||||||||||||||||||
Line | Sales | Line | Sales | Line | Sales | |||||||||||||||||||||
(in millions) | (in millions) | (in millions) | ||||||||||||||||||||||||
Skin care
|
$ | 35.2 | 29.4 | % | $ | 36.2 | 34.3 | % | $ | 34.3 | 34.9 | % | ||||||||||||||
Color cosmetics
|
21.6 | 18.0 | 18.7 | 17.7 | 17.9 | 18.2 | ||||||||||||||||||||
Fragrances
|
26.2 | 21.9 | 22.1 | 21.0 | 20.5 | 20.9 | ||||||||||||||||||||
Body care and personal care
|
18.0 | 15.0 | 12.5 | 11.9 | 12.0 | 12.2 | ||||||||||||||||||||
Other(1)
|
18.8 | 15.7 | 15.9 | 15.1 | 13.6 | 13.8 | ||||||||||||||||||||
Subtotal before shipping, other fees and sales to
affiliates, less commissions
|
119.8 | 100.0 | % | 105.4 | 100.0 | % | 98.3 | 100.0 | % | |||||||||||||||||
Shipping and other fees, less commissions
|
5.4 | 4.8 | 4.0 | |||||||||||||||||||||||
Sales to affiliates
|
15.8 | 13.5 | 14.3 | |||||||||||||||||||||||
Total
|
$ | 141.0 | $ | 123.7 | $ | 116.6 | ||||||||||||||||||||
(1) | Includes sales aids (e.g.; party hostess gifts, demonstration products, etc.) and promotional materials, which typically do not qualify for commissions or overrides. |
(12) Commitments and Contingencies
The Company leases office and warehouse facilities as well as manufacturing, transportation and data processing equipment under operating leases which expire at various dates through 2007. The leases contain certain renewal options and require payment of property taxes, utilities, common area maintenance and insurance and rent escalation clauses based upon consumer price indices. Future minimum lease payments under noncancelable operating leases as of December 31, 2002 are (in thousands):
2003
|
$ | 1,186 | ||
2004
|
1,127 | |||
2005
|
967 | |||
2006
|
712 | |||
2007
|
601 | |||
$ | 4,593 | |||
Rental expense was $1,058,000, $1,453,000 and $1,617,000 for the years ended December 31, 2002, 2001 and 2000, respectively.
In connection with the issuance of the Parents Common Stock, the Parent has guaranteed loans for some members of JCIs management. As of December 31, 2002, approximately $2,145,000 of loans were outstanding and guaranteed by the Parent.
During 2002, JCI initiated product replacement for a certain product sold in 2001 and 2002. The total cost of the product replacement is approximately $400,000. However, management believes that the majority the cost will be recovered pursuant to contractual obligations with the third-party manufacturer. (See Note 14).
81
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
In accordance with FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, JCI recorded impairment losses on long-lived assets used in operations when events and circumstances indicate that long-lived assets might be impaired and undiscounted cash flows estimated to be generated by those assets are less than the carrying amounts of those assets. Subsequent to December 31, 2002, JCI is considering strategic decisions to exit certain non-core markets in Thailand and some or all of Europe through sale or discontinuance of these operations. As of December 31, 2002, no decision had been made on these non-core markets and the undiscounted cash flows indicated that such carrying amounts were expected to be recovered. It is reasonably possible that the estimate of undiscounted cash flows may change in the near term resulting in a need to write down those assets to fair value. In accordance with FASB 142, Goodwill and Other Intangible Assets, the transitional and annual impairment test indicated that fair value of the reporting units associated with the non-core markets exceeded the carrying value, including goodwill, at December 31, 2002.
JCI is involved from time to time in routine legal matters incidental to its business. JCI believes that the resolution of such matters will not have a material adverse effect on JCIs business, financial condition or results of operations.
(13) Management Incentive Arrangements
Company Plan
Effective 1998, the Parent adopted a stock incentive plan (the Stock Incentive Plan), which provides for the sale to members of senior management of up to 52,141 shares of common stock of the Parent and the issuance of options to purchase up to 104,282 additional shares of common stock. The Parent reserved 156,423 shares for issuance under the Stock Incentive Plan, and as of December 31, 2002, 42,121 shares and 84,242 options were outstanding. A summary of the status and activity of shares purchased under the Stock Incentive Plan is as follows:
Number of | Price Per | |||||||
Shares | Share | |||||||
Shares outstanding at December 31, 1999
|
38,392 | |||||||
Shares issued in 2000
|
4,424 | 206 | ||||||
Options exercised in 2000
|
158 | 100 | ||||||
Shares repurchased in 2000
|
(948 | ) | $ | 210 | ||||
Shares outstanding at December 31, 2000
|
42,026 | |||||||
Shares issued in 2001
|
474 | 210 | ||||||
Options exercised in 2001
|
210 | 150 | ||||||
Shares repurchased in 2001
|
(589 | ) | $ | 250 | ||||
Shares outstanding at December 31, 2001
|
42,121 | |||||||
Shares issued in 2002
|
| | ||||||
Options exercised in 2002
|
| | ||||||
Shares repurchased in 2002
|
| | ||||||
Shares outstanding at December 31, 2002
|
42,121 | |||||||
The purchase price of shares issued in 2000 and 2001 and options exercised in 2000 and 2001 represented the estimated fair value at the respective dates of issuance and exercise, except as discussed below. In 2000, 316 shares were issued at a price below fair value, and the Parent recognized compensation expense of approximately $19,000. In 2001, 210 shares were issued at a price below fair value, and the Company recognized compensation expense of approximately $21,000. Under certain circumstances, the management
82
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
stockholders can require the Parent to repurchase their shares, subject to a holding period of at least seven months from the date such shares were acquired, for an amount not to exceed fair value.
In connection with the purchase of common stock of the Parent, certain members of senior management were granted options to purchase two additional shares of common stock for each share purchased at an exercise price equal to the fair value at the date of grant under the Stock Incentive Plan. The options have a life of ten years from the date of grant. Fifty percent of the options granted are expected to vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the continuous employment of the grantee (Option Type 1). The remaining fifty percent of the options become vested as follows, subject to the continuous employment of the grantee: (a) up to one-third of the options become vested as of each of the first three anniversaries of the date of grant if the Parent achieves at least 85% of its EBITDA target for the immediately preceding fiscal year, (b) if less than one-third of the total number of options shall have become vested as provided in clause (a) above, the portion that has not become so vested shall become vested as of the first day of the fiscal year following the fiscal year, if any, that the Parent achieves its cumulative EBITDA target, and (c) any options that do not become vested as provided above will become vested on the ninth anniversary of the date of grant (Option Type 2). A summary of the status and activity of the options under the Stock Incentive Plan is as follows:
2002 | 2001 | 2000 | ||||||||||||||||||||||
Weighted | Weighted | Weighted | ||||||||||||||||||||||
Average | Average | Average | ||||||||||||||||||||||
Exercise | Exercise | Exercise | ||||||||||||||||||||||
Shares | Price | Shares | Price | Shares | Price | |||||||||||||||||||
Outstanding at beginning of year
|
84,242 | $ | 112.36 | 84,052 | $ | 111.69 | 76,784 | $ | 101.03 | |||||||||||||||
Granted
|
| | 948 | 210.00 | 8,848 | 205.71 | ||||||||||||||||||
Exercised
|
| | (210 | ) | 150.00 | (158 | ) | 100.00 | ||||||||||||||||
Canceled
|
| | (548 | ) | 163.80 | (1,422 | ) | 122.22 | ||||||||||||||||
Outstanding at year-end
|
84,242 | $ | 112.36 | 84,242 | $ | 112.36 | 84,052 | $ | 111.69 | |||||||||||||||
Options exercisable at year-end
|
66,615 | $ | 109.92 | 63,528 | $ | 105.32 | 37,655 | $ | 100.70 | |||||||||||||||
Options available for grant
|
19,093 | | 19,093 | | 19,493 | |
The following table summarizes information about options outstanding as of December 31, 2002:
Outstanding | Exercisable | |||||||||||||||||||||
Weighted | ||||||||||||||||||||||
Average | Weighted | Weighted | ||||||||||||||||||||
Remaining | Average | Average | ||||||||||||||||||||
Exercise | Number | Contractual | Exercise | Number | Exercise | |||||||||||||||||
Price | of Options | Life (Yrs.) | Price | of Options | Price | |||||||||||||||||
$ | 100.00 | 74,256 | 5.75 | $ | 100.00 | 60,117 | $ | 100.00 | ||||||||||||||
$ | 150.00 | 948 | 6.92 | 150.00 | 902 | 150.00 | ||||||||||||||||
$ | 210.00 | 9,038 | 7.63 | 210.00 | 5,596 | 210.00 | ||||||||||||||||
84,242 | 5.96 | $ | 112.36 | 66,615 | $ | 109.92 | ||||||||||||||||
JCI applies Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, and related Interpretations in accounting for these options. As the options were granted with exercise prices equal to the fair value at the date of grant, no compensation cost was recognized by JCI upon issuance of such options. The fair value of each option granted by JCI was estimated using the minimum value option pricing
83
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
model. The assumptions used in this pricing model and the weighted average fair value of options granted during 2001 and 2000 are summarized as follows:
2001 | 2000 | |||||||||||||||
Option | Option | Option | Option | |||||||||||||
Type 1 | Type 2 | Type 1 | Type 2 | |||||||||||||
Risk-free interest rate
|
5.80 | % | 5.80 | % | 6.30 | % | 6.30 | % | ||||||||
Expected option life (in years)
|
5.0 | 7.0 | 5.0 | 7.0 | ||||||||||||
Expected volatility
|
0.0 | % | 0.0 | % | 0.0 | % | 0.0 | % | ||||||||
Expected dividend yield
|
0.0 | % | 0.0 | % | 0.0 | % | 0.0 | % | ||||||||
Weighted average fair value per option
|
$ | 52.20 | $ | 69.28 | $ | 56.00 | $ | 73.97 |
Pro Forma Compensation Cost
Had JCI recorded compensation cost based on the fair value of options granted at the grant date, as prescribed by FASB Statement No. 123, Accounting for Stock Based Compensation, pro forma net income would have been as follows (in thousands):
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Net income, as reported
|
$ | 8,625 | $ | 6,512 | $ | 2,214 | ||||||
Pro forma compensation cost
|
83 | 319 | 609 | |||||||||
Pro forma net income
|
$ | 8,542 | $ | 6,193 | $ | 1,605 | ||||||
Employment Agreements
Certain senior executive officers have employment agreements which provide for annual bonuses if the Parent achieves the performance goals established under its annual incentive plan for executives.
JCI has a bonus plan for U.S. based employees which provides that 50% of the bonus earned by any Vice President or Director shall be deferred and shall vest in three equal annual installments. As of December 31, 2002 and 2001, $415,000 and $372,000 of bonuses were deferred, respectively. JCI recognizes compensation expense as the vesting requirements are met.
(14) Manufacturing Agreement
JCI and a third-party contractor (the Contractor) entered into a manufacturing agreement, dated June 10, 1999, (the Manufacturing Agreement). Subject to the terms and conditions of the Manufacturing Agreement, the Contractor has agreed to manufacture all of the JCIs requirements for certain cosmetic and skin care products for an initial term of five years. Following the expiration of the initial five-year term, the Manufacturing Agreement will be automatically extended for additional one-year terms unless terminated by six months prior written notice by either party. The Manufacturing Agreement provides for price renegotiations by the Contractor if JCIs quarterly or annual purchase volume falls below specified minimums. The Manufacturing Agreement requires the Contractor to maintain insurance to cover costs associated with any product liability or product recall caused by the acts or omissions of the Contractor. In addition, JCI is obligated to purchase materials acquired by the Contractor based upon product forecasts provided by JCI if the Contractor is unable to sell such materials to a third-party. There have been no such repurchases to date. The Contractor is solely responsible for obtaining the inventories, manufacturing the inventories at its current location in Chino, California, complying with applicable laws and regulations, and performing quality assurance functions.
84
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
During the fourth quarter of 2000, the Contractor obtained $1,000,000 of advances from JCI in exchange for an unsecured promissory note. The note bears interest at an annual rate of 9% and is payable in monthly installments commencing on February 15, 2001. On April 15, 2002, the unsecured promissory note was amended to advance an additional $320,000 to the contractor. At December 31, 2002 and 2001, approximately $101,000 and $349,000, of the note was outstanding and was included in receivables in the accompanying consolidated balance sheets, respectively.
85
INDEPENDENT AUDITORS REPORT
To the Board of Directors and Stockholders of
We have audited the accompanying consolidated balance sheets of Jafra Cosmetics International, S.A. de C.V. and subsidiaries (the Company), an indirect, wholly owned subsidiary of CDRJ Investments (Lux) S.A., as of December 31, 2001, and the related consolidated statements of income, stockholders equity, and cash flows for each of the two years in the period ended December 31, 2001. These financial statements and the financial statement schedule are the responsibility of the Companys management. Our responsibility is to express an opinion on these financial statements and the financial statement schedule based on our audits.
We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements referred to above present fairly, in all material respects, the financial position of Jafra Cosmetics International, S.A. de C.V. and subsidiaries as of December 31, 2001, and the results of their operations and their cash flows for each of the two years in the period ended December 31, 2001, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the financial statement schedule referred to above, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
DELOITTE & TOUCHE, LLP
Mexico City, Mexico
86
INDEPENDENT AUDITORS REPORT
To the Board of Directors and Stockholders of
We have audited the accompanying consolidated balance sheets of Jafra Cosmetics International, S.A. de C.V. and subsidiaries (the Company), an indirect, wholly owned subsidiary of CDRJ Investments (Lux) S.A., as of December 31, 2002, and the related consolidated statement of income, stockholders equity, and cash flows for the year then ended. Our audit also included the financial statement schedule for the year ended December 31, 2002 listed at Item 15(a)(2). These financial statements and schedule are the responsibility of the Companys management. Our responsibility is to express an opinion on these financial statements and schedule based on our audit.
We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.
In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Jafra Cosmetics International, S.A. de C.V. and subsidiaries as of December 31, 2002, and the results of their operations and their cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States. Also, in our opinion, the related financial statement schedule for the year ended December 31, 2002, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
As discussed in Note 2 to the consolidated financial statements, effective January 1, 2002, the Company adopted Statement of Financial Accounting Standards No. 142.
/S/ ERNST & YOUNG, LLP |
Mexico City, Mexico
87
JAFRA COSMETICS INTERNATIONAL, S.A. DE C.V. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
ASSETS
December 31, | ||||||||||
2002 | 2001 | |||||||||
Current assets:
|
||||||||||
Cash and cash equivalents
|
$ | 13,394 | $ | 920 | ||||||
Receivables, less allowances for doubtful
accounts of $7,161 in 2002 and
$4,952 in 2001. |
33,518 | 34,430 | ||||||||
Inventories
|
21,200 | 29,622 | ||||||||
Receivables from affiliates
|
17,675 | 5,938 | ||||||||
Prepaid expenses and other current assets
|
2,130 | 5,514 | ||||||||
Total current assets
|
87,917 | 76,424 | ||||||||
Property and equipment, net
|
33,809 | 36,121 | ||||||||
Other assets:
|
||||||||||
Goodwill
|
28,548 | 32,401 | ||||||||
Trademarks
|
44,408 | 50,402 | ||||||||
Deferred financing fees, net
|
395 | 1,270 | ||||||||
Other
|
1,227 | 2,699 | ||||||||
Total
|
$ | 196,304 | $ | 199,317 | ||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
Current liabilities:
|
||||||||||
Current portion of long-term debt
|
$ | 2,489 | $ | 3,188 | ||||||
Accounts payable
|
11,966 | 20,205 | ||||||||
Accrued liabilities
|
31,469 | 27,299 | ||||||||
Income taxes payable
|
4,097 | 6,122 | ||||||||
Payables to affiliates
|
21,894 | 21,373 | ||||||||
Deferred income taxes
|
1,430 | 4,094 | ||||||||
Total current liabilities
|
73,345 | 82,281 | ||||||||
Long-term debt
|
30,786 | 33,993 | ||||||||
Deferred income taxes
|
16,515 | 16,958 | ||||||||
Total liabilities
|
120,646 | 133,232 | ||||||||
Commitments and contingencies
|
| | ||||||||
Stockholders equity:
|
||||||||||
Series B common stock, no par value;
authorized, issued and outstanding, 151 shares in 2002 and
2001.
|
| | ||||||||
Additional paid-in capital
|
34,184 | 34,184 | ||||||||
Retained earnings
|
49,046 | 32,194 | ||||||||
Accumulated other comprehensive loss
|
(7,572 | ) | (293 | ) | ||||||
Total stockholders equity
|
75,658 | 66,085 | ||||||||
Total
|
$ | 196,304 | $ | 199,317 | ||||||
See accompanying notes to consolidated financial statements.
88
JAFRA COSMETICS INTERNATIONAL, S.A. DE C.V. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
Years Ended December 31, | |||||||||||||
2002 | 2001 | 2000 | |||||||||||
Net sales to third parties
|
$ | 251,545 | $ | 247,514 | $ | 199,777 | |||||||
Sales to affiliates
|
14,994 | 11,583 | 10,538 | ||||||||||
Net sales
|
266,539 | 259,097 | 210,315 | ||||||||||
Cost of sales
|
74,542 | 68,654 | 61,208 | ||||||||||
Gross profit
|
191,997 | 190,443 | 149,107 | ||||||||||
Selling, general and administrative expenses
|
124,535 | 119,490 | 90,951 | ||||||||||
Management fee expense to affiliate
|
7,224 | 8,498 | 8,164 | ||||||||||
Gain on sale of assets
|
(77 | ) | | | |||||||||
Royalty expense to affiliates, net
|
19,775 | 20,098 | 14,811 | ||||||||||
Income from operations
|
40,540 | 42,357 | 35,181 | ||||||||||
Other income (expense):
|
|||||||||||||
Exchange loss, net
|
(7,184 | ) | (9,183 | ) | (11,295 | ) | |||||||
Interest expense, net
|
(4,883 | ) | (6,111 | ) | (7,789 | ) | |||||||
Other, net
|
(123 | ) | (23 | ) | 1,586 | ||||||||
Income before income taxes, extraordinary item
and cumulative effect of accounting change
|
28,350 | 27,040 | 17,683 | ||||||||||
Income tax expense
|
11,498 | 11,202 | 6,805 | ||||||||||
Income before extraordinary item and cumulative
effect of accounting change
|
16,852 | 15,838 | 10,878 | ||||||||||
Extraordinary loss on early extinguishment of
debt, net of income tax benefit of $75.
|
| | 110 | ||||||||||
Income before cumulative effect of accounting
change
|
16,852 | 15,838 | 10,768 | ||||||||||
Cumulative effect of accounting change, net of
income tax expense of $82.
|
| 126 | | ||||||||||
Net income
|
$ | 16,852 | $ | 15,964 | $ | 10,768 | |||||||
See accompanying notes to consolidated financial statements.
89
JAFRA COSMETICS S.A. DE C.V. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
Years Ended December 31, | ||||||||||||||||||||||||||
2002 | 2001 | 2000 | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | |||||||||||||||||||||
Capital Stock:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
151 | | 151 | | 151 | | ||||||||||||||||||||
Balance, end of year
|
151 | | 151 | | 151 | | ||||||||||||||||||||
Additional Paid-in Capital:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
$ | 34,184 | $ | 34,184 | $ | 34,184 | ||||||||||||||||||||
Balance, end of year
|
34,184 | 34,184 | 34,184 | |||||||||||||||||||||||
Retained Earnings:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
32,194 | 27,030 | 16,262 | |||||||||||||||||||||||
Net income
|
16,852 | 15,964 | 10,768 | |||||||||||||||||||||||
Dividends paid to parent
|
| (10,800 | ) | | ||||||||||||||||||||||
Balance, end of year
|
49,046 | 32,194 | 27,030 | |||||||||||||||||||||||
Accumulated Other Comprehensive
Loss:
|
||||||||||||||||||||||||||
Balance, beginning of year
|
(293 | ) | (1,458 | ) | (309 | ) | ||||||||||||||||||||
Net unrealized and deferred realized losses on
derivatives
|
(264 | ) | (3,746 | ) | | |||||||||||||||||||||
Tax benefit on unrealized and deferred realized
losses on derivatives
|
92 | 1,311 | | |||||||||||||||||||||||
Currency translation adjustments
|
(7,107 | ) | 3,600 | (1,149 | ) | |||||||||||||||||||||
Balance, end of year
|
(7,572 | ) | (293 | ) | (1,458 | ) | ||||||||||||||||||||
Total Stockholders Equity
|
151 | $ | 75,658 | 151 | $ | 66,085 | 151 | $ | 59,756 | |||||||||||||||||
Comprehensive Income:
|
||||||||||||||||||||||||||
Net income
|
$ | 16,852 | $ | 15,964 | $ | 10,768 | ||||||||||||||||||||
Unrealized and deferred realized losses on
derivatives
|
(4,192 | ) | (5,504 | ) | | |||||||||||||||||||||
Reclassified to exchange loss
|
1,167 | 797 | | |||||||||||||||||||||||
Reclassified to cost of sales
|
2,761 | 961 | | |||||||||||||||||||||||
Tax benefit on unrealized and deferred realized
losses on derivatives
|
92 | 1,311 | | |||||||||||||||||||||||
Currency translation adjustments
|
(7,107 | ) | 3,600 | (1,149 | ) | |||||||||||||||||||||
Total Comprehensive Income
|
$ | 9,573 | $ | 17,129 | $ | 9,619 | ||||||||||||||||||||
See accompanying notes to consolidated financial statements.
90
JAFRA COSMETICS INTERNATIONAL, S.A. DE C.V. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years Ended December 31, | ||||||||||||||||
2002 | 2001 | 2000 | ||||||||||||||
Cash flows from operating
activities:
|
||||||||||||||||
Net income
|
$ | 16,852 | $ | 15,964 | $ | 10,768 | ||||||||||
Extraordinary loss on early extinguishment of
debt, net of taxes
|
| | 110 | |||||||||||||
Cumulative effect of accounting change, net of
taxes
|
| (126 | ) | | ||||||||||||
Income before extraordinary item and cumulative
effect of accounting change
|
16,852 | 15,838 | 10,878 | |||||||||||||
Adjustments to reconcile income before
extraordinary item and cumulative effect of accounting change to
net cash provided by operating activities:
|
||||||||||||||||
Gain on sale of property and equipment
|
(77 | ) | (24 | ) | | |||||||||||
Depreciation and amortization
|
2,121 | 3,908 | 4,231 | |||||||||||||
Amortization of deferred financing fees
|
776 | 805 | 797 | |||||||||||||
Provision for uncollectible accounts receivable
|
11,033 | 7,681 | 4,956 | |||||||||||||
Unrealized foreign exchange and derivative losses
|
4,667 | (994 | ) | 2,669 | ||||||||||||
Deferred realized derivative losses
|
181 | (827 | ) | | ||||||||||||
Deferred income taxes
|
(1,429 | ) | 1,506 | 2,539 | ||||||||||||
Changes in operating assets and liabilities:
|
||||||||||||||||
Receivables
|
(14,010 | ) | (13,795 | ) | (10,655 | ) | ||||||||||
Inventories
|
5,249 | (3,021 | ) | (6,047 | ) | |||||||||||
Prepaid expenses and other current assets
|
744 | (1,126 | ) | (1,108 | ) | |||||||||||
Value-added tax receivables and payables
|
5,890 | 3,057 | 103 | |||||||||||||
Intercompany receivables and payables
|
(11,628 | ) | 17,980 | 15 | ||||||||||||
Other assets
|
1,232 | 154 | (1,728 | ) | ||||||||||||
Accounts payable and accrued liabilities
|
1,107 | 330 | 13,581 | |||||||||||||
Income taxes payable/prepaid
|
(960 | ) | 6,688 | 11,667 | ||||||||||||
Net cash provided by operating activities
|
21,748 | 38,160 | 31,898 | |||||||||||||
Cash flows from investing
activities:
|
||||||||||||||||
Proceeds from sale of property and equipment
|
225 | 93 | | |||||||||||||
Purchases of property and equipment
|
(4,124 | ) | (6,024 | ) | (2,262 | ) | ||||||||||
Net cash used in investing activities
|
(3,899 | ) | (5,931 | ) | (2,262 | ) | ||||||||||
Cash flows from financing
activities:
|
||||||||||||||||
Repurchase of subordinated debt
|
| | (4,239 | ) | ||||||||||||
Repayments under term loan facility
|
(3,125 | ) | (2,000 | ) | (1,500 | ) | ||||||||||
Net borrowings under revolving credit facility
|
| | (500 | ) | ||||||||||||
Net (repayments) borrowings under bank debt
|
(781 | ) | 1,263 | 346 | ||||||||||||
Payment of note payable to affiliate
|
| (20,756 | ) | (22,946 | ) | |||||||||||
Payment of dividends
|
| (10,800 | ) | | ||||||||||||
Net cash used in financing activities
|
(3,906 | ) | (32,293 | ) | (28,839 | ) | ||||||||||
Effect of exchange rate changes on cash
|
(1,469 | ) | 423 | (239 | ) | |||||||||||
Net increase in cash and cash equivalents
|
12,474 | 359 | 558 | |||||||||||||
Cash and cash equivalents at beginning of year
|
920 | 561 | 3 | |||||||||||||
Cash and cash equivalents at end of year
|
$ | 13,394 | $ | 920 | $ | 561 | ||||||||||
Supplemental disclosure of cash flow
information
|
||||||||||||||||
Cash paid (received) during the year for:
|
||||||||||||||||
Interest
|
$ | 4,305 | $ | 4,786 | $ | 5,652 | ||||||||||
Income Taxes
|
7,213 | 2,734 | (7,401 | ) |
At December 31, 2002, Jafra S.A. had deferred net gains of $0.4 million on foreign currency option contracts recorded as other comprehensive loss and other receivables. At December 31, 2001, Jafra S.A. had deferred losses of $2.9 million on foreign currency forward contracts recorded in accrued liabilities and other comprehensive income. Additionally, the related deferred income tax benefit of $1.3 million related to the deferred losses was recorded as a component of net deferred tax liability and other comprehensive income.
See accompanying notes to consolidated financial statements.
91
JAFRA COSMETICS INTERNATIONAL, S.A. DE C.V. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(1) Basis of Presentation and Description of Business
Basis of Presentation
Jafra Cosmetics International, S.A. de C.V., a sociedad anónima de capital variable, organized under the laws of the United Mexican States (Jafra S.A.) is owned by five indirect wholly owned subsidiaries of CDRJ Investments (Lux) S.A., a Luxembourg société anonyme (the Parent). Jafra S.A., its subsidiaries, and certain other subsidiaries of the Parent were organized by Clayton, Dubilier & Rice Fund V Limited Partnership, a Cayman Islands exempted limited partnership managed by Clayton, Dubilier & Rice, Inc. (CD&R) to acquire (the Acquisition) the worldwide Jafra Cosmetics business (the Jafra Business) from The Gillette Company (Gillette).
The accompanying consolidated financial statements for the years ended December 31, 2002, 2001 and 2000 reflect the operations of Jafra S.A. and its subsidiaries (collectively, Jafra S.A.). All significant intercompany accounts and transactions between entities have been eliminated in consolidation.
In connection with the Acquisition, Jafra S.A. and an affiliated company, Jafra Cosmetics International, Inc. (JCI) (the indirect, wholly owned United States subsidiary of the Parent) issued $100 million aggregate principal amount of 11.75% Subordinated Notes due 2008 (the Notes). See Note 6. The Notes represent several obligations of Jafra S.A. and JCI, with each participating on a pro rata basis upon redemption. Jafra S.A. and JCI have fully and unconditionally guaranteed the obligations under the Notes of the other on a senior subordinated basis, subject to a 30-day standstill period prior to enforcement of such guarantees. As the cross-guarantee of Jafra S.A. and JCI is subject to a 30-day standstill period, the Parent is filing these separate financial statements of Jafra S.A. as a schedule to its Annual Report on Form 10-K for the year ended December 31, 2002.
Description of Business
Jafra S.A. is a marketer of premium skin and body care products, color cosmetics, fragrances, and other personal care products in Mexico through a direct selling, multilevel distribution system comprised of self-employed salespersons (known as consultants). In addition, Jafra S.A. manufactures color cosmetics and fragrance products for its own use as well as for distribution to the international subsidiaries of the Parent (referred to herein as the affiliates).
(2) Summary of Significant Accounting Policies
Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents. Cash and cash equivalents include cash, time deposits and all highly liquid debt instruments purchased with a maturity of three months or less.
Inventories. Inventories are stated at the lower of cost, as determined by the first-in, first-out basis, or market.
Property and Equipment. Property and equipment are stated at cost. Depreciation of property and equipment is provided for over the estimated useful lives of the respective assets using the straight-line method. Estimated useful lives are 20 years for buildings, the lesser of 20 years or the term of the lease for improvements, 5 to 10 years for machinery and equipment and 3 years for hardware and software. Maintenance and repairs, including cost of minor replacements, are charged to operations as incurred. Costs of
92
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
additions and betterments are added to property and equipment accounts provided that such expenditures increase the useful life or the value of the asset.
Intangible Assets. Intangible assets principally consist of goodwill and trademarks. On January 1, 2002, Jafra S.A. adopted Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and other Intangible Assets which requires the Company to not amortize goodwill and other intangible assets, but to test those intangible assets for impairment at least annually. Prior to adoption of SFAS No. 142, goodwill and other intangible assets were amortized using the straight-line method over a period of 40 years. The book value of goodwill and trademarks was $28,548,000 and $44,408,000 at December 31, 2002, respectively. (See New Accounting Standards).
Deferred Financing Costs. In connection with the acquisition of the Jafra Business, Jafra S.A. incurred approximately $4.8 million of costs related to the 11.75% Senior Subordinated Notes due 2008 (the Notes), the revolving credit facility and the term loan facility (see Note 6). Such costs are being amortized on a basis that approximates the interest method over the expected term of the related debt. Accumulated amortization at December 31, 2002 and 2001 was $3,425,000 and $3,066,000, respectively.
Impairment of Long-Lived Assets and Goodwill. Long-lived assets are reviewed for impairment based on undiscounted cash flows, whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. If this review indicates that the carrying amount of the long-live assets is not recoverable, Jafra S.A. will recognize an impairment loss, measured by the future discounted cash flow method. Goodwill is tested for impairment annually, or whenever events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable based on the provisions of SFAS No. 142 (see new Accounting Standards).
Foreign Currency Forward and Option Contracts. During 2002 and 2001, Jafra S.A. entered into foreign currency forward contracts, In 2002, Jafra S.A. entered into forward currency option contracts. Jafra S.A. enters into these contracts to reduce the effect of potentially adverse exchange rate fluctuations in the exchange rate of the Mexican peso to the U.S. dollar. Effective January 1, 2001, Jafra S.A. adopted SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. SFAS No. 133, as amended and interpreted, establishes accounting and reporting standards for derivative instruments and hedging activities and requires that all derivative instruments be recorded based on fair value. In connection with the adoption of SFAS No. 133, at January 1, 2001, Jafra S.A. recorded a net gain of $126,000 (net of a tax effect of $82,000) as a cumulative transition adjustment to earnings. This adjustment relates to derivatives not designated as hedges prior to adoption of SFAS No. 133, and represents the difference between the carrying value and the fair value of such instruments.
As a matter of policy, Jafra S.A. does not hold or issue foreign currency forward contracts or foreign currency option contracts for trading or speculative purposes. The forward contracts utilized by Jafra S.A. did not qualify for hedge accounting under the applicable accounting standards prior to adoption of SFAS No. 133 on January 1, 2001, and accordingly such instruments were marked-to-market each month based upon the change in the spot rate from the date of contract inception to the balance sheet date. The premium on such contracts was amortized to expense over the life of the contracts. However, under SFAS No. 133, Jafra S.A.s use of forward contracts and option contracts to hedge certain forecasted transactions qualifies for hedge accounting. Gains and losses from qualifying hedged derivative instruments are deferred as a separate component of other comprehensive loss, and are recognized in income at the same time that the underlying hedged exposure is recognized in income. This accounting treatment results in the matching of gains and losses from such forward contracts and option contracts with the corresponding gains and losses generated by the underlying hedged transactions. Under SFAS No. 133, certain of Jafra S.A.s foreign currency forward and option contracts do not qualify for hedge accounting and therefore, are remeasured based on fair value, with gains and losses included as a component of net income. At December 31, 2001, the carrying value of the forward contracts was $5,540,000 and was included in accrued liabilities in the accompanying consolidated
93
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
balance sheets, At December 31, 2002, the carrying value of the option contracts was $402,000 and was included in other receivables in the accompanying consolidated balance sheets.
Fair Value of Financial Instruments. The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value because of the short-term maturities of these instruments. The fair value of the Notes and other fixed rate long-term debt at December 31, 2002 and 2001 was $31,652,000 and $33,786,000, respectively, based upon discussions with one of Jafra S.A.s largest bondholders and an analysis of current market interest rates and the Companys credit rating. As Jafra S.A.s Revolving Credit Facility and the Term Loan are variable rate debt, and the interest rate spread paid by Jafra S.A. is adjusted for changes in certain financial ratios of the Parent, the fair value of the Revolving Credit Facility and the Term Loan approximated their carrying amounts at December 31, 2002 and 2001.
Revenue Recognition. Jafra S.A. recognizes revenue when title passes at shipment in accordance with its shipping terms. Amounts billed to consultants for shipping and handling costs are included in net sales. Sales are reduced by commissions paid to consultants on their personal sales.
Shipping and Handling Costs. Shipping and handling costs of $17,442,000, $15,182,000 and $10,651,000 for the years ended December 31, 2002, 2001 and 2000, respectively, are included in selling, general and administrative expenses.
Income Taxes. Jafra S.A. accounts for income taxes under the balance sheet approach that requires the recognition of deferred income tax assets and liabilities for the expected future consequences of events that have been recognized in the financial statements or income tax returns. Management provides a valuation allowance for deferred income tax assets when it is more likely than not that a portion of such deferred income tax assets will not be realized.
Foreign Currency Translation. The functional currency for Jafra S.A. is the Mexican peso. For presentation purposes, assets and liabilities are translated into U.S. dollars at current exchange rates, and related revenues and expenses are translated at average exchange rates in effect during the period. Resulting translation adjustments are recorded as a component of other comprehensive loss.
Mexico has historically experienced periods of hyperinflation, and the value of the peso has been subject to significant fluctuations with respect to the U.S. dollar. Jafra S.A. had outstanding U.S. dollar-denominated debt of $32,447,000 and $35,572,000 at December 31, 2002 and 2001, respectively. This debt is remeasured at each reporting date, subjecting Jafra S.A. to additional foreign exchange risk.
New Accounting Standards. Effective January 1, 2001, Jafra S.A. adopted SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. SFAS No. 133, as amended and interpreted, established accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. All derivatives, whether designated in hedging relationships or not, are required to be recorded on the balance sheet at fair value. If the derivative is designated in a fair-value hedge, the changes in the fair value of the derivative and the underlying hedged item are recognized concurrently in earnings. If the derivative is designated in a cash-flow hedge, changes in the fair value of the derivative are recorded in other comprehensive income (loss) (OCI) and are recognized in the statement of income when the hedged item affects earnings. SFAS No. 133 defined new requirements for designation and documentation of hedging relationships as well as ongoing effectiveness assessments in order to use hedge accounting. For a derivative that does not qualify as a hedge, changes in fair value are recognized concurrently in earnings. As of January 1, 2001, Jafra S.A. recorded a net gain of $126,000 (net of a tax effect of $82,000) as a cumulative transition adjustment to earnings. This adjustment relates to derivatives not designated as hedges prior to adoption of SFAS No. 133, and represents the difference between the carrying value as measured by the difference in the spot rate to the forward rate and the fair value as determined by forward rates of such instruments at January 1, 2001.
94
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
In June 2001, the Financial Accounting Standards Board (FASB) approved two new statements: SFAS No. 141, Business Combinations and SFAS No. 142, Goodwill and Other Intangible Assets. SFAS No. 141 requires business combinations entered into after June 30, 2001 to be accounted for using the purchase method of accounting. SFAS No. 142 requires that goodwill not be amortized, but be tested for impairment at least annually. SFAS No. 142 was effective for fiscal years beginning after December 15, 2001 to all goodwill and other intangible assets recognized in an entitys statement of financial position at that date, regardless of when those assets were initially recognized. Jafra S.A. adopted SFAS No. 142 on January 1, 2002. In accordance with such adoption, the Company identified all reporting units in conjunction with the provisions of SFAS No. 142 and allocated all goodwill accordingly. During the year ended December 31, 2002, Jafra S.A. completed the transitional goodwill impairment test required by SFAS No. 142. Based on the transitional and annual impairment test, Jafra S.A. determined that there was no impairment to goodwill. There were no changes, except for translation effects, to the carrying amount of goodwill for the year ended December 31, 2002.
Jafra S.A.s other intangible assets consist of trademarks. During the year ended December 31, 2002, Jafra S.A. determined trademarks to have an indefinite life and performed the transitional impairment test as required under SFAS No. 142. Based upon the transitional and annual test, Jafra S.A. determined that there was no impairment of trademarks. The carrying value of trademarks was $44,408,000 at December 31, 2002 on the accompanying consolidated balance sheets.
In accordance with SFAS No. 142, Jafra S.A. discontinued amortization of goodwill and other intangible assets with an indefinite life. A reconciliation of previously reported net income to amounts adjusted for the exclusion of goodwill and trademark amortization, net of the related income tax effects, where applicable, is as follows (in thousands):
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Net income
|
$ | 16,852 | $ | 15,964 | $ | 10,768 | ||||||
Goodwill amortization
|
| 870 | 859 | |||||||||
Trademark amortization, net of tax
|
| 796 | 825 | |||||||||
Adjusted net income
|
$ | 16,852 | $ | 17,630 | $ | 12,452 | ||||||
In November 2001, the Emerging Issues Task Force (EITF) issued EITF Issue No. 01-9, Accounting for Consideration Given by a Vendor to a Customer or a Reseller of the Vendors Products. This new guidance provides that consideration from a vendor to a reseller is generally presumed to be a reduction of the selling prices of the vendors products, and, therefore, should be characterized as a reduction of revenue when recognized in the vendors income statement. On January 1, 2002, Jafra S.A. adopted EITF Issue No. 01-9 and reclassified commissions paid to consultants of $2,260,000 and $1,948,000 on their personal sales, previously as a component of selling, general and administrative expenses, as a reduction in net sales and selling, general and administrative expenses for the years ended December 31, 2001 and 2000, respectively.
On January 1, 2002, the Jafra S.A. adopted SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets. SFAS No. 144 supersedes SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed of. SFAS No. 144 retains substantially all of the requirements of SFAS No. 121, while resolving certain implementation issues and addressing the accounting for a component of a business accounted for as a discontinued operation. SFAS No. 144 was adopted with no significant impact on the financial position or results of operations of Jafra S.A.
In April 2002, the FASB issued SFAS No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections. This Statement rescinds or modifies existing authoritative pronouncements including SFAS No. 4 Reporting Gains and Losses from Extinguish-
95
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
ment of Debt. As a result of the issuance of SFAS No. 145, gains and losses from extinguishment of debt should be classified as extraordinary items only if they meet the criteria in Accounting Principles Board (APB) Opinion 30. Reporting the Results of Operations-Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions.Applying the provisions of APB Opinion 30 will distinguish transactions that are part of an entitys recurring operations from those that are unusual or infrequent or that meet the criteria for classification as an extraordinary item. The provisions of this Statement related to the rescission of SFAS No. 4 shall be applied in fiscal years beginning after May 15, 2002. Any gain or loss on extinguishment of debt that was classified as an extraordinary item in prior periods presented that does not meet the criteria in APB Opinion 30 for classification as an extraordinary item shall be reclassified. Jafra S.A. is currently evaluating the impact that this statement may have on any potential future extinguishments of debt. Upon adoption of SFAS No. 145, Jafra S.A. will reclassify items previously reported as extraordinary items as a component of operating income on the accompanying statements of income.
In June 2002, the FASB approved SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities. This statement addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. The provisions of this statement are effective for exit or disposal activities that are initiated after December 31, 2002, with early application encouraged. Jafra S.A. is currently evaluating the impact that this statement may have on any potential future exit or disposal activities.
Reclassifications. Certain reclassifications were made to the prior year financial statements to conform to current year presentation.
(3) Inventories
Inventories consist of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Raw materials and supplies
|
$ | 4,858 | $ | 5,717 | ||||
Finished goods
|
16,342 | 23,905 | ||||||
Total inventories
|
$ | 21,200 | $ | 29,622 | ||||
(4) Property and Equipment
Property and equipment consist of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Land
|
$ | 10,260 | $ | 11,645 | ||||
Buildings and improvements
|
10,311 | 11,703 | ||||||
Machinery, equipment and other
|
18,726 | 17,532 | ||||||
39,297 | 40,880 | |||||||
Less accumulated depreciation
|
5,488 | 4,759 | ||||||
Property and equipment, net
|
$ | 33,809 | $ | 36,121 | ||||
96
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(5) Accrued Liabilities
Accrued liabilities consist of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Sales promotions, commissions and overrides
|
$ | 12,048 | $ | 10,936 | ||||
Accrued interest
|
618 | 618 | ||||||
Compensation and other benefit accruals
|
3,503 | 3,755 | ||||||
State and local sales taxes and other taxes
|
11,407 | 3,399 | ||||||
Unrealized losses on forward contracts
|
| 5,540 | ||||||
Other
|
3,893 | 3,051 | ||||||
Total accrued liabilities
|
$ | 31,469 | $ | 27,299 | ||||
(6) Debt
Debt consists of the following at December 31, 2002 and 2001 (in thousands):
2002 | 2001 | |||||||
Subordinated Notes, U.S. dollar-denominated,
unsecured, interest payable semi-annually at 11.75% due in 2008
|
$ | 30,072 | $ | 30,072 | ||||
Term loan, secured, U.S. dollar-denominated,
principal and interest due in quarterly installments through
April 30, 2004, interest rates at 3.1% and 4.3% at
December 31, 2002 and 2001, respectively
|
2,375 | 5,500 | ||||||
Unsecured bank loan agreement, principal and
interest due in monthly installments through January 25,
2005, weighted average interest rates of 18.5% and 18.7% at
December 31, 2002 and 2001, respectively
|
828 | 1,609 | ||||||
Total debt
|
33,275 | 37,181 | ||||||
Less current maturities
|
2,489 | 3,188 | ||||||
Long-term debt
|
$ | 30,786 | $ | 33,993 | ||||
Jafra S.A.s long-term debt matures as follows (in thousands): $2,489 in 2003, $714 in 2004, $0 in 2005, 2006 and 2007, and $30,072 thereafter.
On April 30, 1998, Jafra S.A. and JCI borrowed $125 million by issuing $100 million aggregate principal amount of 11.75% Subordinated Notes due 2008 (the Notes) pursuant to an Indenture dated April 30, 1998 (the Indenture) and $25 million under a senior credit agreement.
At the date of issuance, the Notes represented several obligations of Jafra S.A. and JCI in the amount of $40 million and $60 million, respectively, participating on a pro rata basis upon redemption. The Notes mature in 2008 and bear a fixed interest rate of 11.75% payable semi-annually.
Jafra S.A. and JCI are indirect, wholly owned subsidiaries of the Parent and have fully and unconditionally guaranteed the obligations under the Notes of the other on a senior subordinated basis, subject to a 30-day standstill period prior to enforcement of such guarantees. In addition, the Parent has fully and unconditionally guaranteed the Notes on a senior subordinated basis. Each existing subsidiary of Jafra S.A. fully and unconditionally guarantees the Notes jointly and severally, on a senior subordinated basis, and each subsequently acquired or organized subsidiary of Jafra S.A. will fully and unconditionally guarantee the Notes jointly and severally, on a senior subordinated basis. JCI currently has no U.S. subsidiaries. Each acquired or organized U.S. subsidiary of JCI will also be required to fully and unconditionally guarantee the Notes jointly and severally, on a senior subordinated basis. The nonguarantor entities are the Parents indirect European subsidiaries in Austria, Germany, Italy, the Netherlands, Poland, and Switzerland; its indirect South
97
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
American subsidiaries in Argentina, Brazil, Chile, Colombia, Peru, and Venezuela; and its indirect subsidiaries in the Dominican Republic and Thailand. All guarantor and nonguarantor entities are either direct or indirect wholly owned subsidiaries of the Parent. The Notes were registered in a registered exchange offer, effective as of January 25, 1999, under the Securities Act of 1933, as amended.
The Notes are unsecured and are generally non-callable for five years. Thereafter, the Notes will be callable at premiums declining to par in the eighth year.
Consents and waivers, dated June 30, 2001 and November 19, 1999, to the senior credit agreement, as described below, allow Jafra S.A. and JCI to repurchase the Notes in the open market from time to time, with the aggregate purchase price for all such Notes repurchased not to exceed $50 million. Aggregate repurchases as of December 31, 2002 were $24.8 million. During 2000, Jafra S.A. retired notes, prior to maturity, with a face value of $4.3 million. The debt repurchases in 2000 resulted in an extraordinary loss of $110,000, net of an income tax benefit of $75,000. In connection with the early retirement of the Notes as described above, a portion of the unamortized deferred financing costs was written off and included in the determination of the extraordinary loss on early extinguishment of debt. In 2000, $274,000 of the unamortized deferred financing fees were written off.
In addition, Jafra S.A. and JCI entered into a senior credit agreement that provides for senior secured credit facilities in an aggregate principal amount of $90 million, consisting of a multicurrency revolving credit facility of $65 million and a term loan facility of $25 million. Borrowings under the term loan facility are payable in quarterly installments of principal and interest over 6 years through April 30, 2004. Borrowings under the revolving credit facility mature on April 30, 2004. Borrowings under the senior credit agreement currently bear interest at an annual rate of LIBOR plus a margin of 1.625% or an alternate base rate (the higher of the prime rate or federal funds rate plus 0.5%, plus an applicable margin of 0.625%). The interest rate in effect at December 31, 2002 was approximately 3.1% for the LIBOR-based borrowings. Borrowings under the senior credit agreement are secured by substantially all of the assets of Jafra S.A. and JCI. No amounts were outstanding under the revolving credit facility at December 31, 2002.
Both the Indenture and the senior credit agreement contain certain covenants that limit the Jafra S.A.s ability to incur additional indebtedness, pay cash dividends and make certain other payments. These debt agreements also require the Parent to maintain certain financial ratios including a minimum EBITDA to cash interest expense coverage ratio and a maximum debt to EBITDA ratio.
During the year ended December 31, 2001, Jafra S.A. repaid the balance remaining under a one-year term loan originally due on August 16, 2001, and entered into an unsecured bank loan agreement. Under this agreement, Jafra S.A. had the peso equivalent of $828,000 outstanding at December 31, 2002 at a weighted average fixed interest rate of 18.5%. Principal and interest payments are due monthly through January 25, 2005.
As of December 31, 2002, Jafra S.A. has irrevocable standby letters of credit outstanding, totaling $2.8 million. These letters of credit, expiring on February 17, 2003 collateralize the Companys obligation to a third-party in connection with certain lease agreements.
98
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(7) Income Taxes
Actual income tax expense differs from the expected tax expense (computed by applying the Mexican federal corporate rate of 35% to income before income taxes) as a result of the following (in thousands):
Years Ended December 31, | ||||||||||||
2002 | 2001 | 2000 | ||||||||||
Provision for income taxes at statutory rate
|
$ | 9,923 | $ | 9,464 | $ | 6,189 | ||||||
Permanent differences, principally effect of
inflation upon taxable income
|
829 | 1,116 | 616 | |||||||||
Change in net deferred income tax liabilities due
to enactment of changes of Mexicos future statutory rate
|
(1,169 | ) | | | ||||||||
Other
|
1,915 | 622 | | |||||||||
Income tax expense
|
$ | 11,498 | $ | 11,202 | $ | 6,805 | ||||||
The components of the provision for income taxes are as follows (in thousands):
Years Ended December 31, | ||||||||||||||
2002 | 2001 | 2000 | ||||||||||||
Current
|
$ | 14,605 | $ | 11,007 | $ | 4,266 | ||||||||
Deferred
|
(4,326 | ) | 1,506 | 2,539 | ||||||||||
Deferred allocated to other comprehensive income
|
1,219 | (1,311 | ) | | ||||||||||
Total deferred
|
(3,107 | ) | 195 | 2,539 | ||||||||||
Total income taxes on income before income taxes,
extraordinary item and cumulative effect
|
11,498 | 11,202 | 6,805 | |||||||||||
Income tax benefit on early extinguishment of debt
|
| | (75 | ) | ||||||||||
Income tax expense on cumulative effect of
accounting change
|
| 82 | | |||||||||||
Total income tax expense
|
$ | 11,498 | $ | 11,284 | $ | 6,730 | ||||||||
The components of deferred income tax assets and deferred income tax liabilities at December 31, 2002 and 2001 are as follows (in thousands):
2002 | 2001 | |||||||||
Deferred income tax assets:
|
||||||||||
Accounts receivable
|
$ | 2,435 | $ | 1,733 | ||||||
Net operating loss carryforward of subsidiaries
|
199 | 814 | ||||||||
Asset tax credit carryforward
|
122 | 2,687 | ||||||||
Accrued bonuses
|
33 | 301 | ||||||||
Accrued sales promotions
|
1,977 | 2,273 | ||||||||
Other accrued liabilities
|
5,053 | 1,632 | ||||||||
Other
|
348 | 2,849 | ||||||||
Total deferred income tax assets
|
10,167 | 12,289 |
99
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2002 | 2001 | |||||||||
Deferred income tax liabilities:
|
||||||||||
Transaction and deferred financing costs
|
(130 | ) | (445 | ) | ||||||
Property and equipment
|
(2,399 | ) | (2,592 | ) | ||||||
Trademark and goodwill
|
(14,655 | ) | (17,641 | ) | ||||||
Inventories
|
(7,653 | ) | (12,469 | ) | ||||||
Prepaid purchases and expenses
|
(3,163 | ) | | |||||||
Other
|
(112 | ) | (194 | ) | ||||||
Total deferred income tax liabilities
|
(28,112 | ) | (33,341 | ) | ||||||
Net deferred income tax liabilities
|
$ | (17,945 | ) | $ | (21,052 | ) | ||||
At December 31, 2002 and 2001, Jafra S.A.s deferred income tax assets included $199,000 and $814,000, respectively, for operating loss carryforwards. The tax loss and asset credit carryforwards expire in varying amounts through 2012. Although realization is not assured, management believes it is more likely than not that the net carrying value of the income tax loss and credit carryforwards will be realized.
Income tax expense for the year ended December 31, 2002 was reduced by $1,169,000 as the result of the enactment of changes in the Mexico corporate statutory tax rate and the related impact on Jafra S.A.s net deferred income tax liabilities. The enactment in Mexico will reduce the Mexico corporate income tax rate annually in one-percent increments from 35% to 32% beginning January 1, 2003 through 2005
(8) Benefit Plans
Under Mexican labor laws, employees of Jafra S.A. and its subsidiaries are entitled to a payment when they leave Jafra S.A. if they have fifteen or more years of service. In addition, Jafra S.A. makes government mandated employee profit sharing distributions equal to ten percent of the taxable income of the subsidiary in which they are employed. Total expense under these programs was $1,222,000, $995,000 and $345,000 for the years ended December 31, 2002, 2001 and 2000, respectively. The total liability was approximately $1,724,000 and $1,010,000 at December 31, 2002 and 20001 respectively, and is classified as a noncurrent liability in the accompanying consolidated balance sheets.
(9) Related Party Transactions
Jafra S.A. manufactures and distributes color cosmetics and fragrance products to other subsidiaries of the Parent (affiliates). Sales to affiliates, primarily in the United States and Germany, were $14,994,000, $11,538,000 and $10,538,000 for the years ended December 31, 2002, 2001 and 2000, respectively. These sales were made at cost plus a markup ranging from 0 to 11%. Jafra S.A. also purchases skin and body products from the Parents United States affiliate. Purchases were $14,483,000, $12,044,000 and $12,331,000 for the years ended December 31, 2002, 2001 and 2000, respectively.
In addition, Jafra S.A. is provided with certain management services, such as legal, accounting and treasury, management oversight, and other administrative functions from an affiliate. The cost of these services is included in management fee expense to affiliate in the accompanying consolidated statements of income. JCI charges out a portion of these management expenses to its affiliates based principally upon a formula using the percentage of revenues of each affiliate to the total consolidated revenues of the Parent. Jafra S.A. believes the amounts and methods of allocations are reasonable and approximate the cost of the actual services received. The management fee expense charged by JCI to Jafra S.A. was $7,224,000, $8,498,000 and $8,164,000, for the years ended December 31, 2002, 2001 and 2000 respectively.
During 1999, Jafra S.A. purchased U.S. and German trademarks from JCI. Jafra S.A. charges JCI a royalty for the right to use the Jafra trademark in the United States and Europe. The total royalty income
100
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
charged by Jafra S.A. to JCI was $2,443,000, $1,639,000 and $1,126,000 for the years ended December 31, 2002, 2001 and 2000, respectively, and is offset against royalty expense to affiliates in the accompanying consolidated statements of income.
JCI owns the worldwide rights to its multi-level sales know-how (referred to as the Jafra Way). The Jafra Way was initially developed in the United States for lineage, training, and compensation of consultants. JCI charges Jafra S.A. a royalty for the use of the Jafra Way. The royalty fees charged by JCI were $22,218,000, $21,737,000, and $15,746,000 for the years ended December 31, 2002, 2001 and 2000, and were based on a percentage of Jafra S.A.s sales.
In prior years, Jafra S.A. obtained loans from certain affiliates at annual interest rates ranging from 6% to 9%. Such loans are due to be repaid five years from the date of grant, with no prepayment penalty. At December 31, 2002 and 2001, Jafra S.A. did not have any notes payable to affiliates outstanding. Additionally, in 2002, Jafra S.A. began charging interest to affiliates on aging payables. Net interest income from affiliates was $9,000 for the year ended December 31, 2002 and net interest expense to affiliates, primarily JCI, was $257,000 and $1,780,000 for the years ended December 31, 2001 and 2000, respectively. Interest income and expense relating to affiliates is included in interest expense, net, in the accompanying consolidated statements of income.
(10) Financial Reporting for Business Segments
Segment information has been prepared in accordance with SFAS No. 131, Disclosure about Segments of an Enterprise and Related Information. SFAS No. 131 requires disclosure of certain information regarding operating segments, products and services, geographic areas of operations and major customers. The Parents business is comprised of one industry segment, direct selling, with worldwide operations. The Parent is organized into geographical business units that each sell the full line of Jafra cosmetics, skin care, body care, fragrances, and other products. Jafra S.A. is one of the Parents reportable business segments, and as such, the only additional business segment information presented is the following breakdown of sales by product lines:
2002 | 2001 | 2000 | ||||||||||||||||||||||||
Sales by | Percentage | Sales by | Percentage | Sales by | Percentage | |||||||||||||||||||||
Product | of Total | Product | of Total | Product | of Total | |||||||||||||||||||||
Line | Sales | Line | Sales | Line | Sales | |||||||||||||||||||||
(in millions) | (in millions) | (in millions) | ||||||||||||||||||||||||
Skin care
|
$ | 29.5 | 12.0 | % | $ | 27.7 | 11.5 | % | $ | 25.7 | 13.0 | % | ||||||||||||||
Color cosmetics
|
75.3 | 30.8 | 72.1 | 29.8 | 60.8 | 30.9 | ||||||||||||||||||||
Fragrances
|
96.4 | 39.4 | 99.3 | 41.1 | 79.6 | 40.4 | ||||||||||||||||||||
Body care and personal care
|
21.8 | 8.9 | 21.4 | 8.9 | 14.7 | 7.5 | ||||||||||||||||||||
Other(1)
|
21.8 | 8.9 | 21.0 | 8.7 | 16.1 | 8.2 | ||||||||||||||||||||
Subtotal before shipping fees, and sales to
affiliates less commissions
|
244.8 | 100.0 | % | 241.5 | 100.0 | % | 196.9 | 100.0 | % | |||||||||||||||||
Shipping fees less commissions
|
6.7 | 6.0 | 2.9 | |||||||||||||||||||||||
Sales to affiliates
|
15.0 | 11.6 | 10.5 | |||||||||||||||||||||||
Total
|
$ | 266.5 | $ | 259.1 | $ | 210.3 | ||||||||||||||||||||
(1) | Includes sales aids (e.g., party hostess gifts, demonstration products, etc.) and promotional materials, which typically do not qualify for commissions or overrides. |
101
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(11) Commitments and Contingencies
Jafra S.A. leases office and warehouse facilities as well as manufacturing, transportation and data processing equipment under operating leases which expire at various dates through 2008. The leases contain certain renewal options and require payment of property taxes, utilities, common area maintenance and insurance and contain rent escalation clauses based upon consumer price indices. Future minimum lease payments under noncancelable operating leases as of December 31, 2002 are (in thousands):
2003
|
$ | 2,037 | ||
2004
|
2,108 | |||
2005
|
2,176 | |||
2006
|
2,243 | |||
2007
|
2,310 | |||
2008
|
167 | |||
$ | 11,041 | |||
Rental expense was $1,939,000, $1,507,000 and $3,624,000 for the years ended December 31, 2002, 2001 and 2000, respectively.
Other income for 2000 included approximately $1.4 million of income related to a recovery of the effect of inflation from a receivable due from the Mexican government related to taxes.
Jafra S.A. is involved from time to time in routine legal matters incidental to its business. Jafra S.A. believes that the resolution of such matters will not have a material adverse effect on Jafra S.A.s business, financial condition or results of operations.
(12) Management Incentive Arrangements
Effective as of the closing of the Acquisition, the Parent adopted a stock incentive plan (the Stock Incentive Plan), which provides for the sale of up to 52,141 shares of common stock of the Parent and the issuance of options to purchase up to 104,282 additional shares of common stock to members of senior management of certain of the Parents subsidiaries. Four employees of Jafra S.A. participate in the Stock Incentive Plan. These employees currently hold 3,761 shares of the Parents stock, and hold options to purchase an additional 7,522 shares. The activity related to these employees holdings under the Stock Incentive Plan is not significant to Jafra S.A. Jafra S.A. applies Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees and related interpretations in accounting for these options. As the options were granted with exercise prices equal to the fair value at the date of grant, no compensation expense was recognized by Jafra S.A. upon issuance of such options.
Certain senior executive officers have employment agreements which provide for annual bonuses if Jafra S.A. and the Parent achieve the performance goals established under its annual incentive plan for executives.
(13) Foreign Currency Forward and Option Contracts
Jafra S.A. is exposed to currency risk relating to its forecasted U.S. dollar-denominated expenditures. As part of its overall strategy to reduce the risk of adverse potential exchange rate fluctuations, Jafra S.A. enters into foreign currency exchange contracts. Prior to March 2002, Jafra S.A. purchased forward exchange contracts (forward contracts or forwards) to hedge its foreign currency exposures to the Mexican peso. In March 2002, in accordance with previously approved policies, Jafra S.A. modified its hedging program to include the use of foreign currency option contracts (option contracts). Jafra S.A. places forward contracts or option contracts based on its forecasted U.S. dollar cash outflows over a rolling 12 month period and does
102
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
not hedge transactions that are not included in the 12 month forecast on the date the forward contract is initiated. As a matter of policy, Jafra S.A. does not hold or issue forward contracts for trading or speculative purposes nor does it enter into contracts or agreements containing embedded derivative features. Prior to entering into forward contracts or option contracts, Jafra S.A. evaluates the counter parties credit ratings. Credit risk represents the accounting loss that would be recognized at the reporting date if counter parties failed to perform as contracted. Jafra S.A. does not currently anticipate non-performance by such counter parties.
Effective January 1, 2001, Jafra S.A. adopted SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. SFAS No. 133, as amended and interpreted, establishes accounting and reporting standards for derivative instruments and hedging activities and requires that all derivative instruments be recorded based on fair value. In connection with the adoption of SFAS No. 133, at January 1, 2001, the Company recorded a net gain of $126,000 (net of a tax effect of $82,000) as a cumulative transition adjustment to earnings. This adjustment relates to derivatives not designated as hedges prior to adoption of SFAS No. 133, and represents the difference between the carrying value and the fair value of such instruments. Under SFAS No. 133, Jafra S.A.s use of forward contracts or option contracts to hedge certain forecasted transactions does qualify for hedge accounting. Gains and losses from such derivatives are deferred as a separate component of other comprehensive loss, and are recognized in income at the same time that the underlying hedged exposure is recognized in income. This accounting treatment results in the matching of gains and losses from such forward contracts or option contracts with the corresponding gains and losses generated by the underlying hedged transactions. Contracts that do not qualify for hedge accounting under SFAS No. 133 are remeasured based on fair value and the gains and losses are included as a component of net income.
The forward contracts utilized by Jafra S.A. did not qualify for hedge accounting under the applicable accounting standards prior to adoption of SFAS No. 133 on January 1, 2001, and accordingly such instruments were marked-to-market with gains and losses included as a component of exchange loss in the accompanying consolidated statements of income for the year ended December 31, 2000.
Jafra S.A. currently designates certain of its forward contracts and option contacts as cash flow hedges of forecasted U.S. dollar-denominated inventory purchases, forecasted U.S. dollar-denominated intercompany charges from JCI, forecasted management fee charges from JCI, and U.S. dollar-denominated interest payments. On the date Jafra S.A. enters into a derivative contract, management designates the derivative as a hedge of the identified exposure. Jafra S.A. formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. In this documentation, Jafra S.A. specifically identifies the forecasted transaction that has been designated as a hedged item and states how the hedging instrument is expected to hedge the risks related to the hedged item. Jafra S.A. formally measures effectiveness of its hedging relationships both at the hedge inception and on an ongoing basis in accordance with its risk management policy. For all qualifying and highly effective cash flow hedges, the changes in the fair value of the derivative are deferred as a component of other comprehensive loss. Such amounts will be reclassified from other comprehensive loss into net income when the underlying hedged exposure is recognized in income. For U.S. dollar-denominated inventory purchases, this will occur upon sale to an outside party of the related inventory. For intercompany charges and interest, this will occur at the date such charges are recorded by Jafra S.A.
During the year ended December 31, 2002, Jafra S.A. recognized losses of approximately $2,605,000 on forward contracts and gains of approximately $886,000 on option contracts (including reclassification of other comprehensive loss) as a component of exchange loss in the accompanying consolidated statements of income. During the year ended December 31, 2001, Jafra S.A. recognized approximately $12,188,000 of losses on forward contracts as a component of exchange loss in the accompanying consolidated statements of income. During the year ended December 31, 2000, the Company recognized approximately $10,050,000 of
103
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
losses as a component of exchange loss on forward contracts that did not qualify for hedge accounting under accounting standards prior to the adoption of SFAS No. 133.
Additionally, during the year ended December 31, 2001, Jafra S.A. deferred as a component of other comprehensive loss $5,504,000 of losses on forward contracts qualifying for hedge accounting under SFAS No. 133. Of this amount, approximately $797,000 was reclassified as exchange loss and $961,000 was reclassified as cost of sales upon recognition of the underlying hedged exposure prior to December 31, 2001. As of December 31, 2001, Jafra S.A. had deferred as a component of other comprehensive loss $3,746,000 of losses on forward contracts.
During the year ended December 31, 2002, Jafra S.A. deferred approximately an additional $1,782,000 of losses on forward contracts qualifying for hedge accounting under SFAS No. 133, Of the total amount deferred, during the year ended December 31, 2002, approximately $1,650,000 of other comprehensive loss was reclassified into exchange loss and approximately $3,139,000 was reclassified into cost of sales upon the recognition of the underlying hedged exposure. Jafra S.A. expects that substantially all of the remaining loss of $739,000, deferred as a component of other comprehensive loss, will be recognized into income within the next twelve months.
During the year ended December 31, 2002, Jafra S.A. deferred as a component of other comprehensive loss $1,336,000 of gains on option contracts qualifying for hedge accounting under SFAS No. 133. Of this amount, approximately $483,000 was reclassified to exchange loss and approximately $378,000 was reclassified as an offset to cost of sales upon the recognition of the underlying hedged exposure. Jafra S.A. expects substantially all of the remaining gain of approximately $475,000, deferred as a component of other comprehensive loss, to be recognized into income within the next twelve months.
The fair value of the forward contacts at December 31, 2001 represented an unrealized loss of $5,540,000 consisting of $2,920,000 of unrealized losses recorded as a component of other comprehensive loss for qualifying hedges and $2,620,000 of unrealized losses recorded as a component of exchange loss for non-qualifying hedges under SFAS No. 133. As of December 31, 2002, Jafra S.A. had no outstanding forward contracts. The fair value of the option contracts at December 31, 2002 represented an unrealized gain of approximately $402,000, consisting of $382,000 of unrealized gains of recorded as a component of other comprehensive loss for qualifying hedges and $21,000 of unrealized gains for non-qualifying hedges under SFAS No. 133.
During the year ended December 31, 2002, the ineffectiveness generated by the Jafra S.A.s forward contracts and option contracts designated as hedges was insignificant. Certain hedged forecasted transactions do not appear probable of occurring due to timing differences between the original and current forecasts, and accordingly $164,000 of gains were reclassified into earnings.
The outstanding option contracts had a notional value denominated in Mexican pesos of $523,000,000 in put and call positions at December 31, 2002 and mature at various dates through December 31, 2003. The outstanding forward contracts had notional values denominated in Mexican pesos of $688,873,000 at December 31, 2001 and matured in 2002. Notional amounts do not quantify market or credit exposure or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts.
104
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The following table provides information about the details of Jafra S.A.s option contracts as of December 31, 2002 (in thousands):
At December 31, 2002:
Coverage in | ||||||||||||||||
Mexican | Average | Fair Value in | ||||||||||||||
Foreign Currency | Pesos | Strike Price | U.S. Dollars(1) | Maturity Date | ||||||||||||
Purchased Puts (Company may sell Peso/buy USD)
Mexican Peso
|
$ | 149,000 | 10.31-10.48 | $ | (113 | ) | Jan.-Mar. 2003 | |||||||||
Mexican Peso
|
100,000 | 11.05-12.19 | 77 | Apr.-June 2003 | ||||||||||||
Mexican Peso
|
150,000 | 11.76-12.79 | 131 | July-Aug 2003 | ||||||||||||
Mexican Peso
|
124,000 | 12.51-12.91 | 21 | Oct.-Dec. 2003 | ||||||||||||
$ | 523,000 | $ | 116 | |||||||||||||
Written Calls (Counterparty may buy Peso/sell
USD) Mexican Peso
|
$ | 149,000 | 9.01-9.02 | $ | (207 | ) | Jan.-Mar. 2003 | |||||||||
Mexican Peso
|
100,000 | 9.50-9.84 | (144 | ) | Apr.-June 2003 | |||||||||||
Mexican Peso
|
150,000 | 9.69-10.19 | (112 | ) | July-Aug 2003 | |||||||||||
Mexican Peso
|
124,000 | 10.15-10.19 | (55 | ) | Oct.-Dec. 2003 | |||||||||||
$ | 523,000 | $ | (518 | ) | ||||||||||||
(1) | The fair value of the option contracts presented above, an unrealized gain of $402,000 at December 31, 2002, represents the carrying value and has been recorded in other receivables in the accompanying consolidated balance sheets. |
105
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The tables below describe the forward contracts that were outstanding at December 31, 2001 (in thousands):
December 31, 2001:
Weighted | ||||||||||||||||
Forward | Average | Fair | ||||||||||||||
Position In | Maturity | Contract | Value in | |||||||||||||
Foreign Currency | Mexican Pesos(1) | Date | Rate | U.S. Dollars(1) | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
$ | 108,715 | 1/31/02 | 10.19 | $ | 1,128 | ||||||||||
Sell Mexican Peso/buy US Dollar
|
(20,000 | ) | 1/31/02 | 9.35 | (34 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
71,787 | 2/28/02 | 10.26 | 756 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(20,000 | ) | 2/28/02 | 9.47 | (48 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
94,371 | 3/27/02 | 10.46 | 1,102 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(40,000 | ) | 3/27/02 | 9.48 | (80 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
85,000 | 4/30/02 | 10.23 | 748 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(30,000 | ) | 4/30/02 | 9.62 | (84 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
81,000 | 5/31/02 | 10.11 | 559 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(25,000 | ) | 5/31/02 | 9.71 | (75 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
80,000 | 6/28/02 | 9.95 | 375 | ||||||||||||
Sell Mexican Peso/buy US Dollar
|
(30,000 | ) | 6/28/02 | 9.78 | (88 | ) | ||||||||||
Buy US Dollar/sell Mexican Peso
|
48,000 | 7/31/02 | 10.07 | 242 | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
100,000 | 8/30/02 | 10.05 | 410 | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
45,000 | 9/30/02 | 10.09 | 169 | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
110,000 | 10/31/02 | 10.09 | 338 | ||||||||||||
Buy US Dollar/sell Mexican Peso
|
30,000 | 11/29/02 | 10.27 | 122 | ||||||||||||
$ | 688,873 | $ | 5,540 | (1) | ||||||||||||
(1) | The Fair Value of the forward positions presented above, an unrealized loss of $5,540,000 at December 31, 2001 represents the carrying value of the forward contracts and has been recorded in accrued liabilities in the accompanying consolidated balance sheets. |
(14) Fourth Quarter Adjustments
During the fourth quarter of 2001, Jafra S.A. recorded a total of approximately $3,809,000 to bad debt expense due to declining consultant liquidity as a result of the general slowdown of the economy in Mexico. During the fourth quarter of 2000, Jafra S.A. recorded certain adjustments related to changes in cost accounting estimates, which resulted in an increase to cost of sales of approximately $3,000,000.
106
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS
CDRJ Investments (Lux) S.A. and Subsidiaries:
Charged | |||||||||||||||||
Balance | to | Balance | |||||||||||||||
at beginning | costs and | Deductions- | at end | ||||||||||||||
Descriptions | of period | expenses | recoveries | of period | |||||||||||||
Accounts Receivable:
|
|||||||||||||||||
2002
|
$ | 7,267 | $ | 12,376 | $ | 11,247 | $ | 8,396 | |||||||||
2001
|
3,553 | 9,464 | 5,750 | 7,267 | |||||||||||||
2000
|
3,087 | 5,958 | 5,492 | 3,553 | |||||||||||||
Inventories:
|
|||||||||||||||||
2002
|
2,821 | 2,635 | 2,807 | 2,649 | |||||||||||||
2001
|
2,462 | 1,879 | 1,520 | 2,821 | |||||||||||||
2000
|
$ | 2,442 | $ | 1,973 | $ | 1,953 | $ | 2,462 |
Jafra Cosmetics International, Inc. and Subsidiaries:
Charged | |||||||||||||||||
Balance | to | Balance | |||||||||||||||
at beginning | costs and | Deductions- | at end | ||||||||||||||
Descriptions | of period | expenses | Recoveries | of period | |||||||||||||
Accounts Receivable:
|
|||||||||||||||||
2002
|
$ | 523 | $ | 680 | $ | 590 | $ | 613 | |||||||||
2001
|
536 | 559 | 572 | 523 | |||||||||||||
2000
|
800 | 898 | 1,162 | 536 | |||||||||||||
Inventories:
|
|||||||||||||||||
2002
|
1,479 | 1,108 | 887 | 1,700 | |||||||||||||
2001
|
1,404 | 692 | 617 | 1,479 | |||||||||||||
2000
|
$ | 2,084 | $ | 532 | $ | 1,212 | $ | 1,404 |
Jafra Cosmetics International, S.A. de C.V. and Subsidiaries:
Charged | |||||||||||||||||
Balance | to | Balance | |||||||||||||||
at beginning | costs and | Deductions- | at end | ||||||||||||||
Descriptions | of period | expenses | Recoveries | of period | |||||||||||||
Accounts Receivable:
|
|||||||||||||||||
2002
|
$ | 4,952 | $ | 11,033 | $ | 8,824 | $ | 7,161 | |||||||||
2001
|
2,117 | 7,681 | 4,846 | 4,952 | |||||||||||||
2000
|
1,956 | 4,956 | 4,795 | 2,117 | |||||||||||||
Inventories:
|
|||||||||||||||||
2002
|
1,057 | 1,502 | 1,705 | 854 | |||||||||||||
2001
|
894 | 1,035 | 872 | 1,057 | |||||||||||||
2000
|
$ | 269 | $ | 1,337 | $ | 712 | $ | 894 |
107
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
On June 25, 2002, Deloitte & Touche LLP (Deloitte) advised the Company that, because of an independence issue between Deloitte and Riverwood Holding, Inc., an entity in which the Companys majority shareholder holds an approximately 29.7% common stock interest, Deloitte no longer considered itself independent with respect to the Company. In light of this determination by Deloitte, at a meeting held on July 10, 2002, upon the recommendation of the Audit Committee, the Board of Directors of the Company determined to dismiss Deloitte as the Companys auditors, subject to the approval of the Companys shareholders. On July 15, 2002, the Audit Committee, pursuant to the authorization of the Board of Directors, recommended that the Company appoint Ernst & Young LLP (Ernst & Young) as the Companys independent auditor for the fiscal year ending December 31, 2002 and for each fiscal year thereafter through the fiscal year ending December 31, 2007. On July 30, 2002, a majority of the Companys shareholders approved the dismissal of Deloitte and the selection of Ernst & Young, as the Companys independent auditor.
Deloittes determination with respect to its independence does not affect its reports on the Companys consolidated financial statements for any past fiscal year or its reviews of the Companys interim condensed consolidated financial statements for any previous quarterly period. Deloittes report on the Companys consolidated financial statements for each of the past two fiscal years did not contain an adverse opinion or disclaimer of opinion, and was not qualified or modified as to uncertainty, audit scope or accounting principles.
During each of the Companys two most recent fiscal years and the subsequent interim period through July 10, 2002, (i) there was no disagreement with Deloitte on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement, if not resolved to the satisfaction of Deloitte, would have caused Deloitte to make reference to the subject matter of the disagreement in connection with its reports on the Companys consolidated financial statements for such years; (ii) the Company did not consult Ernst & Young regarding the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Companys consolidated financial statements, or any other matter or reportable event as set forth in Items 304(a)(2)(i) and (ii) of Regulation S-K; and (iii) no reportable event as defined in Item 304(a)(1)(v) of Regulation S-K.
108
PART III
Item 10. Directors, Executive Officers and Significant Employees of the Company
The names, ages and positions of the executive officers, significant employees and directors of the Company as of March 15, 2003 are set forth below.
Name | Age | Position | ||||
Ronald B. Clark
|
67 | Chairman and Chief Executive Officer; Director | ||||
Gonzalo R. Rubio
|
59 | President and Chief Operating Officer; Director | ||||
Ralph S. Mason, III
|
51 | Vice Chairman, Executive Vice President and General Counsel | ||||
Michael A. DiGregorio
|
48 | Senior Vice President and Chief Financial Officer | ||||
Alan Fearnley
|
52 | Senior Vice President of Strategic Planning and Business Development | ||||
Jaime Lopez Guirao
|
55 | President of Global Operations | ||||
Eugenio Lopez Barrios
|
61 | President of Mexican Operations | ||||
Jose Luis Peco
|
57 | President of European Operations | ||||
Ademar Serodio
|
58 | President of South American Operations | ||||
Beatriz Gutai
|
42 | General Manager of U.S. Operations Hispanic Division | ||||
Dyan Lucero
|
53 | General Manager of U.S. Operations General Division | ||||
Donald J. Gogel
|
54 | Director | ||||
Steven D. Goldstein
|
51 | Director | ||||
Thomas E. Ireland
|
53 | Director | ||||
Siri Marshall
|
54 | Director | ||||
David A. Novak
|
34 | Director | ||||
Ann Reese
|
49 | Director | ||||
Edward H. Rensi
|
58 | Director | ||||
Kenneth D. Taylor
|
68 | Director |
None of the Companys officers has any family relationship with any director or other officer. Family relationship for this purpose means any relationship by blood, marriage or adoption, not more remote than first cousin. The business experience during the past five years of each of the directors and executive officers listed above is as follows:
Ronald B. Clark has served as a director and the Chairman and Chief Executive Officer since joining the Company in May 1998. From 1997 to 1998, Mr. Clark served as President, Richmont Europe (Mary Kay Holding Company). Prior to 1997, he was President of Mary Kay Europe, Executive Vice President of Primerica Corp., President of Jafra Cosmetics International, Inc., and Vice President of Avon Products, Inc. Mr. Clarks employment agreement provides that he shall be a director of CDRJ Investments (Lux) S.A. during the term of his employment.
Gonzalo R. Rubio has served as a director and the President and Chief Operating Officer since joining the Company in May 1998. Mr. Rubio served from prior through 1997 as Area Vice President and later President of the European operations of Mary Kay Inc. Prior to that, Mr. Rubio was employed by Avon Products Inc., serving alternately as Area Director for Europe, International Operations Director and Area Director for Latin America. Mr. Rubios employment agreement provides that he shall be a director of CDRJ Investments (Lux) S.A. during the term of his employment.
Ralph S. Mason, III has served as the Companys Vice Chairman, Executive Vice President and General Counsel since joining the Company in May 1998. For more than the prior five years, Mr. Mason was the senior and founding partner at Mason, Taylor & Colicchio, a law firm in Princeton, New Jersey.
Michael A. DiGregorio has served as Senior Vice President and Chief Financial Officer of the Company since June of 1999. In his eight years with the Company, his previous responsibilities included Financial
109
Alan Fearnley has served as Senior Vice President of Strategic Planning and Business Development of the Company since July of 2001. From 1998 to 2001, Mr. Fearnley served as Senior Vice President of Global Marketing of the Company. From 1997 to 1998, Mr. Fearnley served as Vice President of Marketing for Dermatologica. Prior to that, Mr. Fearnley took a years sabbatical to attend the Sloan Fellowship Masters Program at the London Business School. During this sabbatical, Mr. Fearnley also served as consultant to various companies.
Jaime Lopez Guirao has served as President, Global Operations since joining the Company in June 1998. For more than the prior five years, Mr. Guirao was employed by Avon Products, Inc., holding several operational, management and Country President positions in Europe and the Americas.
Eugenio Lopez Barrios has served as President of Mexican Operations since joining the Company in June 1998. From prior to 1998, Mr. Barrios was President of Mary Kay Mexico.
Jose Luis Peco has served as President of European Operations of the Company since joining the Company in June 1998. From prior to 1998, Mr. Peco served as Vice President of European Operations for Mary Kay Cosmetics and President of Mary Kay Cosmetics Iberia.
Ademar Serodio joined the Company in January 2000 and currently serves as President of South America Operations. For more than the prior five years, Mr. Serodio was employed by Avon Products, Inc., holding several Country President roles in Avons South American markets.
Beatriz Gutai has served as General Manager of the Hispanic Division of United States Operations since September of 2000. Prior to that time, Ms. Gutai served as Vice President of Sales for the Hispanic Division and in various positions in sales management, programs, and events since joining the Company in 1982.
Dyan Lucero has served as General Manager of the General Division of United States Operations since September of 2000. Prior to that time, Ms. Lucero served as Vice President of Sales for the General Division and in various positions in sales management and business development since joining the Company in 1972.
Donald J. Gogel has been a director of the Company since January 1998. Since 1998, Mr. Gogel has served as Chief Executive Officer of CD&R; since prior to 1997 he has served as President and a director of CD&R and since 1989 he has been a principal of CD&R. Mr. Gogel is also a limited partner of CD&R Associates V Limited Partnership (Associates V), the general partner of CD&R Fund V, and President and Chief Executive Officer and a shareholder and director of CD&R Investment Associates II, Inc. (Investment Associates II), a Cayman Islands exempted company that is the managing general partner of Associates V. Mr. Gogel is a director of Kinkos, Inc., a corporation in which Fund V has an investment, and a director of Global Decisions Group, LLC, a limited liability company in which an investment fund managed by CD&R has an investment, and Turbochef, Inc. Mr. Gogel serves as a member of the compensation committee of the board of directors of Turbochef, Inc.
Steven D. Goldstein has been a director of the Company since July 1998. Since February of 1998, Mr. Goldstein has served as President and Chief Executive Officer of Chaycon Inc. From November of 2000 to July of 2001, Mr. Goldstein served as Chairman and Chief Executive Officer of More Benefits, Corp. From December 1997 to November of 2000, Mr. Goldstein served as Chairman and Chief Executive Officer of Invenet, LLC. Prior to joining Invenet, LLC, Mr. Goldstein was employed as President, Credit of Sears, Roebuck & Co. Prior to 1997, Mr. Goldstein was employed by American Express Co., serving most recently as the Chairman and Chief Executive Officer of American Express Bank.
Thomas E. Ireland has been a director of the Company since March 1998 and is a principal of CD&R, a limited partner of Associates V and a shareholder and a director of Investment Associates II. From prior to 1997 until joining CD&R in 1997, Mr. Ireland served as a senior managing director of Alvarez & Marsal, Inc. Mr. Ireland also serves on the board of directors of the Maine Coast Heritage Trust. Mr. Ireland is a director
110
Siri Marshall has been a director of the Company since July 1999. Ms. Marshall has been employed by General Mills since prior to 1997 and currently serves as its Senior Vice President, Corporate Affairs and General Counsel and Secretary. She is also a director of Snack Ventures Europe, a joint venture between General Mills and PepsiCo.
David A. Novak has been a director of the Company since January 1998. Mr. Novak is a principal of CD&R, a limited partner of Associates V, and a shareholder of Investment Associates II. Prior to joining CD&R in 1997, Mr. Novak worked in the Private Equity and Investment Banking Divisions of Morgan Stanley & Co. Incorporated and for the Central European Development Corporation. Mr. Novak also serves on the board of directors of Italtel Holdings.
Ann Reese has been a director of the Company since July 1998. Ms. Reese has been the Executive Director of Center for Adoption Policy Studies since October 2000. From 1999 to December 2000, Ms. Reese was a professional employee of CD&R. From prior to 1997 to March 1998, Ms. Reese was Chief Financial Officer of ITT Corp., a company in the hotel and gaming businesses and previously in insurance and manufacturing.
Edward H. Rensi has been a director of the Company since July 1998. For more than the prior five years, Mr. Rensi has been employed by McDonalds Corp. USA, serving most recently as President and Chief Executive Officer. Mr. Rensi also serves as a director of Snap-On Inc. and I.S.C. Corporation, and serves as a member of the compensation committee of the board of directors of Snap-On Inc. and I.S.C. Corporation.
Kenneth D. Taylor has been a director of the Company since July 1998 and has been the Chairman of Global Public Affairs, Inc. since prior to 1997.
At present, all directors will hold office until their successors are elected and qualified, or until their earlier removal or resignation.
111
Item 11. Executive Compensation
Compensation Of Executive Officers
The following table sets forth the compensation earned by Companys Chief Executive Officer and the four additional most highly compensated executive officers of the Company for each (each, a named executive officer) of the last three fiscal years.
Summary Compensation Table
Long-Term | |||||||||||||||||||||
Compensation | |||||||||||||||||||||
Securities | All Other | ||||||||||||||||||||
Underlying | Compensation | ||||||||||||||||||||
Name and Principal Position | Year | Salary($) | Bonus($) | Options(#) | ($)(1) | ||||||||||||||||
Ronald B. Clark
|
2002 | $ | 674,848 | $ | 370,319 | $ | 53,184 | ||||||||||||||
Chairman and Chief
|
2001 | 648,729 | 391,872 | 43,691 | |||||||||||||||||
Executive Officer
|
2000 | 626,218 | 227,610 | 56,811 | |||||||||||||||||
Gonzalo R. Rubio
|
2002 | 562,358 | 308,591 | 44,446 | |||||||||||||||||
President and Chief
|
2001 | 540,555 | 326,550 | 36,408 | |||||||||||||||||
Operating Officer
|
2000 | 521,832 | 189,666 | 47,341 | |||||||||||||||||
Ralph S. Mason, III
|
2002 | 506,148 | 277,746 | 6,616 | |||||||||||||||||
Vice Chairman, Executive
|
2001 | 486,557 | 293,910 | 6,554 | |||||||||||||||||
Vice President and General Counsel
|
2000 | 469,672 | 170,712 | 8,517 | |||||||||||||||||
Jaime Lopez Guirao
|
2002 | 505,135 | 277,190 | 64,757 | |||||||||||||||||
President of Global Operations
|
2001 | 484,202 | 293,322 | 56,434 | |||||||||||||||||
2000 | 467,518 | 170,360 | 42,476 | ||||||||||||||||||
Michael A. DiGregorio
|
2002 | 337,465 | 185,182 | 35,714 | |||||||||||||||||
Senior Vice President and Chief
|
2001 | 323,877 | 163,300 | 27,432 | |||||||||||||||||
Financial Officer
|
2000 | 312,664 | 94,845 | 1,264 | 18,048 |
(1) | Amounts shown in this column constitute the Companys contributions under its 401(k) and Supplemental Savings Plan and automobile expense for Mr. Lopez Guirao and Mr. DiGregorio. |
FISCAL YEAR-END OPTION VALUE TABLE
The following table sets forth information for each Named Executive Officer with regard to the aggregate value of options held at December 31, 2002. No options were exercised by such executive officers during the year ended December 31, 2002.
Number of | ||||||||||||||||
Securities Underlying | Value of Unexercised | |||||||||||||||
Unexercised Options | In-the-Money Options | |||||||||||||||
at December 31, 2002(#) | at December 31, 2002($)(1) | |||||||||||||||
Name | Exercisable | Unexercisable | Exercisable | Unexercisable | ||||||||||||
Ronald B. Clark
|
14,839 | 3,489 | $ | 3,412,970 | $ | 802,470 | ||||||||||
Gonzalo R. Rubio
|
14,839 | 3,489 | 3,412,970 | 802,470 | ||||||||||||
Ralph S. Mason, III
|
11,769 | 2,767 | 2,706,870 | 636,410 | ||||||||||||
Jaime Lopez Guirao
|
4,857 | 1,143 | 1,117,110 | 262,890 | ||||||||||||
Michael A. DiGregorio
|
3,596 | 1,144 | 741,060 | 210,100 |
(1) | Calculated based on a per share price of Parent Common Stock of $330, the estimated fair market value, less the per share exercise price. |
Compensation Of Directors
During 2002, each outside director of the Company received a retainer of $40,000 for serving on the Board of Directors of the Company and was reimbursed for his or her out-of-pocket expenses incurred in connection with attending board meetings. The Company pays no additional remuneration to officers of the Company or the principals or employees of CD&R for serving as directors.
112
Employment Agreements
The Company has employment agreements with each of the Named Executive Officers. The employment agreements of Messrs. Clark, Rubio and Mason have an initial term of three years that becomes a continuous rolling two year term as of the first anniversary of the closing of the Acquisition (the Closing). The employment agreements of Messrs. Guirao and DiGregorio have a continuous rolling term of two years, commencing as of June 1, 1998. Pursuant to their respective agreements, as of their 2002 anniversary dates, Messrs. Clark, Rubio, Mason, Guirao and DiGregorio receive annual base salaries of $686,000, $571,000, $514,000, $513,000 and $343,000, respectively. In addition, each of Messrs. Clark, Rubio, Mason and Guirao are eligible for a target annual bonus equal to 60%, and Mr. DiGregorio is eligible for a target annual bonus equal to 50%, of such Named Executive Officers annual base salary if the Company achieves the performance goals established under its annual incentive plan for executives and may receive a larger bonus if such goals are exceeded. The employment agreements further provide that, in the event of a termination of any such Named Executive Officers employment by the Company without cause (as defined in the employment agreement) or by such executive for good reason (as so defined), such Named Executive Officer will be entitled to continued payments of his base salary for the remaining term of his employment agreement and to payment of a pro rata annual bonus for the year of termination provided that the Company achieves the performance objectives applicable for such year and each year thereafter. Each of the employment agreements also contains covenants regarding nondisclosure of confidential information, noncompetition and nonsolicitation.
Compensation Committee Interlocks And Insider Participation
The Board of Directors of the Company established a Compensation Committee to review all compensation arrangements for executive officers of the Company. During 2002, the individuals serving on the Compensation Committee were Mr. Taylor, Mr. Ireland and Ms. Marshall.
Pursuant to a consulting agreement entered into following the Acquisition, CD&R receives a fee for advisory, management consulting and monitoring services to the Company. The annual fee received by CD&R was $400,000 for the year ended December 31, 2000. As of January 1, 2001, the annual fee was increased to $1,000,000 based on an amendment to the consulting agreement. The annual fee received by CD&R was $1,000,000 for the years ended December 31, 2001 and 2002. The amendment provides for an annual fee for ongoing services provided to the Company. As required by the terms of the Companys lending arrangements, such fees were determined by arms-length negotiation and are believed by the Company to be reasonable. In addition, the amendment adds to CD&Rs services under the agreement financial advisory, investment banking and similar services with respect to future proposals for an acquisition, merger, recapitalization, or other similar transaction directly or indirectly involving the Company or any of its subsidiaries. The fee for such additional services in connection with future transactions would be an amount equal to 1% of the transaction value for the transaction to which such fee relates. Such transaction fees may be increased upon approval of a majority of the members of the Companys Board of Directors who are not employees of the Company, CD&R or any affiliate of CD&R. The amendment also provides that if any employee of CD&R is appointed to an executive management position (or a position of comparable responsibility) in the Company or any of its subsidiaries, the annual fee will be increased by an amount to be determined by CD&R, the amount of such increase not to exceed 100% of the existing annual fee in effect at that time. Parent has also agreed to indemnify the members of the Board employed by CD&R and CD&R against liabilities incurred under securities laws, liabilities to third parties, and liabilities relating to the provision by CD&R of advisory management, consulting and monitoring services.
The Company also engaged an entity, in which CD&R has an investment, to develop its e-commerce business. During 2000, the Company paid such entity fees of $1,798,000. The Company terminated this agreement and entered into a settlement and release agreement with such entity in 2000, pursuant to which such entity agreed to pay the Company $500,000 in quarterly installments, together with interest at 9.5% per annum through October 2005. At December 31, 2002, the balance was paid in full. See Certain Relationships and Related Transactions.
113
Item 12. | Security Ownership of Certain Beneficial Owners and Management |
Parent owns, indirectly, all of the outstanding capital stock of JCI and Jafra S.A. The table below sets forth, as of February 14, 2002, the owners of 5% or more of the Parent Common Stock and the ownership of Parent Common Stock by the directors and each Named Executive Officer, as well as by all directors and Named Executive Officers of the Company as a group.
Number | Percent | |||||||
Name | of Shares(1) | of Class(2) | ||||||
Clayton, Dubilier & Rice Fund V
Limited Partnership(3)
|
769,600 | 92.51 | ||||||
Donald J. Gogel(4)
|
| | ||||||
Steven D. Goldstein
|
2,000 | * | ||||||
Thomas E. Ireland(4)
|
| | ||||||
Siri Marshall
|
1,667 | * | ||||||
David A. Novak(4)
|
| | ||||||
Ann Reese
|
2,500 | * | ||||||
Edward H. Rensi
|
2,500 | * | ||||||
Kenneth D. Taylor
|
500 | * | ||||||
Ronald B. Clark(5)
|
24,003 | 2.83 | ||||||
Gonzalo R. Rubio(6)
|
24,003 | 2.83 | ||||||
Ralph S. Mason, III(7)
|
19,037 | 2.26 | ||||||
Jaime Lopez Guirao(8)
|
7,857 | * | ||||||
Michael A. DiGregorio(9)
|
5,526 | * | ||||||
All directors and Executive Officers as a group
(14 persons)(10)
|
115,715 | 12.85 |
(1) | Represents shares of common stock beneficially owned on December 31, 2002. Unless otherwise noted, each person has sole voting and investment power with respect to such shares. |
(2) | Based upon 831,888 shares of common stock outstanding as of December 31, 2002. |
(3) | Associates V is the general partner of CD&R Fund V and has the power to direct CD&R Fund V as to the voting and disposition of shares held by CD&R Fund V. Investment Associates II is the managing general partner of Associates V and has the power to direct Associates V as to its direction of CD&R Fund Vs voting and disposition of the shares held by CD&R Fund V. No person controls the voting and dispositive power of Investment Associates II with respect to the shares owned by CD&R Fund V. Each of Associates V and Investment Associates II expressly disclaims beneficial ownership of the shares owned by CD&R Fund V. The business address for each of CD&R Fund V, Associates V and Investment Associates II is c/o Investment Associates II, 1403 Foulk Road, Suite 106, Wilmington, Delaware 19803. |
(4) | Does not include shares owned by CD&R Fund V. |
(5) | Includes 14,839 shares as to which Mr. Clark has a right to acquire through the exercise of stock options. |
(6) | Includes 14,839 shares as to which Mr. Rubio has a right to acquire through the exercise of stock options. |
(7) | Includes 11,769 shares as to which Mr. Mason has a right to acquire through the exercise of stock options. |
(8) | Includes 4,857 shares as to which Mr. Guirao has a right to acquire through the exercise of stock options. |
(9) | Includes 3,596 shares as to which Mr. DiGregorio has a right to acquire through the exercise of stock options, and excludes 440 shares held by the trustee of subtrusts established for the benefit of Mr. DiGregorios children. |
(10) | Includes 65,594 shares which the executive officers as a group have a right to acquire through the exercise of stock options and excludes 440 shares held by trustee of subtrusts established for the benefit of Mr. DiGregorios children. On July 11, 2000, a member of management purchased 316 shares of |
114
Common Stock; on July 27, 2000, a former member of management exercised 158 options to purchase Common Stock, and then sold a total of 632 shares of Common Stock back to the Company; on August 9, 2000, certain members of management purchased an aggregate of 4,108 shares of Common Stock, and on November 6, 2000, a former member of management sold 316 shares of the Common Stock back to the Company; on February 10, 2001, certain members of management purchased an aggregate of 474 shares of Common Stock; on June 14, 2001, a former member of management and a former director, sold an aggregate total of 2,563 shares of Common Stock back to the Company; on September 19, 2001, a former member of management exercised options to purchase 210 shares of Common Stock, and then sold a total of 526 shares of Common Stock back to the Company in transactions exempt from the registration requirements of the Securities Act. Shares owned by CD&R Fund V are not included herein. Mr. Gogel is an officer, director and shareholder of Investment Associates II, Mr. Ireland is a director and shareholder of Investment Associates II, and Mr. Novak is a shareholder of Investment Associates II. |
115
Item 13. | Certain Relationships and Related Transactions |
CD&R Fund V, which is Parents largest stockholder, is a private investment fund managed by CD&R. Amounts contributed to CD&R Fund V by its limited partners are invested at the discretion of the general partner in equity or equity-related securities of entities formed to effect leveraged buy-out transactions and in the equity of corporations where the infusion of capital, coupled with the provision of managerial assistance by CD&R, can be expected to generate returns on investments comparable to returns historically achieved in leveraged buyout transactions. The general partner of CD&R Fund V is Associates V, and the general partners of Associates V are Investment Associates II, CD&R Investment Associates, Inc. and CD&R Cayman Investment Associates, Inc., a Cayman Islands exempted company. Each of Mr. Gogel, who is President, Chief Executive Officer and a director of CD&R; President, Chief Executive Officer, and a shareholder and a director of Investment Associates II; and a limited partner of Associates V, Mr. Ireland, who is a principal of CD&R, a limited partner of Associates V and a shareholder and a director of Investment Associates II, and Mr. Novak, who is a principal of CD&R, a limited partner of Associates V, and a shareholder of Investment Associates II, is a director of Parent. See Directors and Executive Officers of the Company.
CD&R is a private investment firm that is organized as a Delaware corporation. CD&R is the manager of a series of investment funds, including CD&R Fund V. CD&R generally assists in structuring, arranging financing for and negotiating the transactions in which the funds it manages invest. After the consummation of such transactions, CD&R generally provides advisory, management consulting and monitoring services to the companies in which its investment funds have invested during the period of such funds investment.
Pursuant to a consulting agreement entered into at the closing of the Acquisition, until the tenth anniversary of the Acquisition or the date on which CD&R Fund V no longer has an investment in the Company or until the termination by either party with 30 days notice, CD&R will receive an annual fee (and reimbursement of out-of-pocket expenses) for providing advisory, management consulting and monitoring services to the Company. Effective January 1, 2000, the annual fee was $400,000. Such services include, among others, helping the Company to establish effective banking, legal and other business relationships and assisting management in developing and implementing strategies for improving the operational, marketing and financial performance of the Company. Based on an amendment to the consulting agreement, effective January 1, 2001, the annual fee was increased to $1,000,000, for ongoing services provided to the Company. As required by the terms of the Companys lending arrangements, such fees were determined by arms-length negotiation and are believed by the Company to be reasonable.
In addition, the amendment adds to CD&Rs services under the agreement financial advisory, investment banking and similar services with respect to future proposals for an acquisition, merger, recapitalization, or other similar transaction directly or indirectly involving the Company or any of its subsidiaries. The fee for such additional services in connection with future transactions would be an amount equal to 1% of the transaction value for the transaction to which such fee relates. Such transaction fees may be increased upon approval of a majority of the members of the Companys Board of Directors who are not employees of the Company, CD&R or any affiliate of CD&R.
The amendment also provides that if any employee of CD&R is appointed to an executive management position (or a position of comparable responsibility) in the Company or any of its subsidiaries, the annual fee will be increased by an amount to be determined by CD&R, the amount of such increase not to exceed 100% of the existing annual fee in effect at that time.
CD&R, CD&R Fund V and Parent entered into an indemnification agreement, pursuant to which Parent has agreed to indemnify the members of its board of directors, as well as CD&R, CD&R Fund V, Associates V, Investment Associates II and certain of their members, partners, associates and affiliates (the Indemnitees) to the fullest extent allowable under applicable law and to indemnify the Indemnitees against any suits, claims, damages or expenses which may be made against or incurred by them under applicable securities laws in connection with offerings of securities of the Company, liabilities to third parties arising out of any action or failure to act by the Company, and, except in cases of gross negligence or intentional misconduct, the provision by CD&R of advisory, management consulting and monitoring services.
116
During 1999, the Company engaged Guidance Solutions Inc. (Guidance), a corporation in which an investment fund managed by CD&R has an investment, to develop its e-commerce business. Under the agreement entered into by both parties, the Company agreed to pay fees of approximately $2.0 million to Guidance in connection with the planning, defining, designing and consulting services performed related to the Companys e-commerce initiative. During 2000, the Company paid fees to Guidance of $1,798,000. The Company terminated its agreement with Guidance and executed a settlement and mutual release agreement effective September 30, 2000. Upon execution of this settlement and mutual release agreement in October of 2000, Guidance paid the Company $25,000 and agreed to pay the Company an aggregate additional sum of $475,000, payable in quarterly installments, plus interest at 9.5% per annum, beginning in January 2001 through October 2005. At December 31, 2002, the balance was paid in full.
The Company has entered into employment agreements with various members of management, including each of the Named Executive Officers. See Executive Compensation Employment Agreements. The employment agreements of Messrs. Clark and Rubio provide that each will be a director of Parent during the term of his employment.
Under certain circumstances, stockholders can require the Company to purchase their shares of Common Stock. Management stockholders are subject to a holding period of at least seven months from the date such shares were acquired. In June 2001, a former member of management and a director both requested that the Company purchase their entire balance of Common Stock, consisting of an aggregate of 2,563 shares. In September 2001, a former member of management exercised options to purchase 210 shares of Common Stock, and then requested that the Company purchase his entire balance of Common Stock, consisting of 526 shares. In July 2000, a former member of management exercised options to purchase 158 shares of Common Stock, and then requested that the Company purchase his entire balance of Common Stock, consisting of 632 shares. The Company repurchased the shares in 2001 at a total cost of $772,000, or $250 per share, which represented the respective estimated fair values at the time of the purchases.
Certain members of management, including Named Executive Officers, financed a portion of the cash purchase price of the shares of Common Stock they acquired through loans from the Chase Manhattan Bank on market terms. In February 2001, certain members of management purchased an aggregate of 474 shares of the Common Stock at a purchase price of $210 per share, which represented the estimated fair value at the time of the purchase. In September 2001, a former member of management purchased 210 shares of Common Stock at a purchase price of $150 per share, which was below the estimated fair value at the time of the purchase of $250 per share. The Company recognized compensation expense of approximately $21,000 at the time of the purchase. During 2001, certain members of management were also granted options to purchase an aggregate of 948 shares of Common Stock. To help members of management obtain such terms for such financing, the Company fully and unconditionally guaranteed up to 75% of the purchase price for the shares of Common Stock purchased by each such member of management. The Company guaranteed loans for $687,300, $687,300, $545,100, $225,000 and $230,000 extended to Messrs. Clark, Rubio, Mason, Guirao, and DiGregorio, respectively, portions of which remain outstanding.
Item 14. | Controls and Procedures |
The Companys principal executive officer and principal financial officer have evaluated the effectiveness of the Companys disclosure controls and procedures, as such term is defined in Rule 13a-14(c) of the Securities Exchange Act of 1934, as amended, within 90 days of the filing date of this Annual Report on Form 10-K. Based upon their evaluation, the principal executive officer and principal financial officer concluded that the Companys disclosure controls and procedures are effective.
There have been no significant changes in the Companys internal controls or in other factors that could significantly affect these controls subsequent to the date the Company performed the evaluation.
117
PART IV
Item 15. | Exhibits, Financial Statement Schedules and Reports on Form 8-K |
(a)(1) Financial Statements. Reference is made to the Index to Financial Statements and Schedules of the Company on page 28 of this Annual Report on Form 10-K.
(a)(2) Financial Statement Schedules. Reference is made to the Index to Financial Statements and Financial Statement Schedules of the Company on page 28 of this Annual Report on Form 10-K. See also the following financial statement schedules which should be read in conjunction with the financial statements included in Item 8 of this Annual Report on Form 10-K.
Pages in this | |||||
Annual Report | |||||
On Form 10-K | |||||
Jafra Cosmetics International, Inc.:
|
|||||
Independent Auditors Reports
|
58 | ||||
Consolidated Balance Sheets as of
December 31, 2002 and 2001
|
59 | ||||
Consolidated Statements of Operations for the
years ended December 31, 2002, 2001 and 2000
|
60 | ||||
Consolidated Statements of Stockholders
Equity for the years ended December 31, 2002, 2001 and 2000
|
61 | ||||
Consolidated Statements of Cash Flows for the
years ended December 31, 2002, 2001 and 2000
|
62 | ||||
Notes to Consolidated Financial Statements
|
63 | ||||
Jafra Cosmetics International, S.A. de
C.V.:
|
|||||
Independent Auditors Reports
|
80 | ||||
Consolidated Balance Sheets as of
December 31, 2002 and 2001
|
81 | ||||
Consolidated Statements of Operations for the
years ended December 31, 2002, 2001 and 2000
|
82 | ||||
Consolidated Statements of Stockholders
Equity for the years ended December 31, 2002, 2001 and 2000
|
83 | ||||
Consolidated Statements of Cash Flows for the
years ended December 31, 2002, 2001 and 2000
|
84 | ||||
Notes to Consolidated Financial Statements
|
85 | ||||
Schedule II Valuation and Qualifying
Accounts
|
99 |
(a)(3) Exhibits. The following documents are exhibits to this Annual Report on Form 10-K.
Exhibit | ||||
Number | Description of Document | |||
3 | .1 | Articles of Association (Statuts Coordonnes) of CDRJ Investments (Lux) S.A., as restated on September 30, 1998; previously filed as Exhibit 3.1 to Amendment 2 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed December 23, 1998, and incorporated herein by reference. | ||
3 | .2 | Certificate of Incorporation of CDRJ Acquisition Corporation, dated March 31, 1998; previously filed as Exhibit 3.2 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
3 | .3 | Certificate of Merger of Jafra Cosmetics International, Inc. into CDRJ Acquisition Corporation, dated April 30, 1998; previously filed as Exhibit 3.3 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. |
118
Exhibit | ||||
Number | Description of Document | |||
3 | .4 | Amended and Restated By-laws of Jafra Cosmetics International, Inc. (formerly CDRJ Acquisition Corporation), as adopted on July 21, 1998; previously filed as Exhibit 3.4 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
3 | .5 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Jafra Cosmetics International, S.A. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.5 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
3 | .6 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Dirsamex, S.A. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.7 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | ||
3 | .7 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Jafra Cosmetics S.A. de C.V., formerly known as Jafra Cosmetics S. de R.L. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.9 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | ||
3 | .8 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Qualifax, S.A. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.10 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | ||
3 | .9 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Reday, S.A. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.11 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | ||
3 | .10 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Cosmeticos Y Fragrancias, S.A. de C.V., together with an unofficial summary thereof in English; previously filed as exhibit 3.10 to the Companys Annual Report on Form 10-K for the fiscal year ended 2000, filed on April 2, 2001, and incorporated herein by reference. | ||
3 | .11 | Notarial Deed and Resolutions, together with an unofficial summary thereof in English, for the transformation of Jafra Cosmetics S. de R.L. de C.V. into Jafra Cosmetics S.A. de C.V.; previously filed as Exhibit 3.12 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | ||
3 | .12 | Approval, dated as of April 17, 2000, by the Public Registry of Commerce of the United Mexican States of the merger of Consultoria Jafra S.A. de C.V. and Distribuidora Venus, S.A. de C.V. with and into Reday, S.A. de C.V., together with supporting shareholders resolutions and the unofficial English translation thereof; previously filed as Exhibit 3.1 to the Companys Quarterly Report on Form 10-Q for the second quarter ended June 30, 2000, filed on August 14, 2000, and incorporated herein by reference. | ||
3 | .13 | Notarial Deed and Resolutions, together with an unofficial summary thereof in English, for the changing of the corporate name from Reday, S.A. de C.V. to Distribuidora Venus, S.A. de C.V. as a consequence of the merger of Distribuidora Venus, S.A. de C.V. into Reday, S.A. de C.V.; previously filed as Exhibit 3.11 to the Companys Annual Report on Form 10-K for the fiscal year ended 2000, filed on April 2, 2001, and incorporated herein by reference. |
119
Exhibit | ||||
Number | Description of Document | |||
3 | .14 | Notarial Deed and Resolutions, together with an unofficial summary thereof in English, for the renaming of Qualifax, S.A. de C.V. as Serviday S.A. de C.V.; previously filed as Exhibit 3.1 to the Companys Quarterly Report on Form 10-Q for the second quarter ended June 30, 2001, filed on August 14, 2001, and incorporated herein by reference. | ||
4 | .1 | Indenture, dated April 30, 1998, among CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V., CDRJ Investments (Lux) S.A., and State Street Bank and Trust Company; previously filed as Exhibit 4.1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .2 | First Supplemental Indenture, dated April 30, 1998, among Consultoria Jafra, S.A. de C.V., Distribuidora Venus, S.A. de C.V., Dirsamex, S.A. de C.V., Reday, S.A. de C.V., Qualifax S.A. de C.V., and Jafra Cosmetics S.R.L., CDRJ Acquisition Corporation and Jafra Cosmetics International, S.A. de C.V. and State Street Bank and Trust Company; previously filed as Exhibit 4.2 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .3 | Purchase Agreement, dated April 28, 1998, between Credit Suisse First Boston Corporation, Chase Securities Inc., CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V., and CDRJ Investments (Lux) S.A.; previously filed as Exhibit 4.3 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .4 | Purchase Agreement Amendment, dated April 30, 1998, executed on behalf of each of Reday, S.A. de C.V., Distribuidora Venus, S.A. de C.V., Dirsamex, S.A. de C.V., Qualifax, S.A. de C.V., Jafra Cosmetics, S.R.L., Consultoria Jafra, S.A. de C.V., Credit Suisse First Boston Corporation, and Chase Securities Inc.; previously filed as Exhibit 4.4 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .5 | Registration Rights Agreement, dated April 30, 1998, among CDRJ Acquisition Corporation, Jafra Cosmetics International, Inc., Jafra Cosmetics International, S.A. de C.V., CDRJ Investments (Lux) S.A., Reday, S.A. de C.V., Distribuidora, S.A. de C.V., Dirsamex, S.A. de C.V., Qualifax, S.A. de C.V., Jafra Cosmetics, S.A. de C.V., Consultoria Jafra, S.A. de C.V., and Credit Suisse First Boston Corporation; previously filed as Exhibit 4.5 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .6 | Credit Agreement, dated April 30, 1998, among CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V., CDRJ Investments (Lux) S.A., as Guarantor and Parent of the Borrowers, the Lenders named therein and Credit Suisse First Boston, as Administrative Agent; previously filed as Exhibit 4.6 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .7 | Amendment No. 1 to the Credit Agreement, dated August 26, 1998; previously filed as Exhibit 4.7 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .8 | Indemnity, Subrogation and Contribution Agreement, dated April 30, 1998, among Jafra Cosmetics International, S.A. de C.V. (JCISA), each Subsidiary of JCSI listed on Schedule I thereto and Credit Suisse First Boston; previously filed as Exhibit 4.8 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. |
120
Exhibit | ||||
Number | Description of Document | |||
4 | .9 | JCI Guarantee Agreement, dated April 30, 1998, between CDRJ Acquisition Corporation and Credit Suisse First Boston; previously filed as Exhibit 4.9 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .10 | JCISA Guarantee Agreement, dated April 30, 1998, between Jafra Cosmetics International, S.A. de C.V. and Credit Suisse First Boston; previously filed as Exhibit 4.10 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .11 | JCISA Subsidiary Guarantee Agreement, dated April 30, 1998, among each of the subsidiaries of Jafra Cosmetics International, S.A. de C.V. listed on Schedule I thereto, and Credit Suisse First Boston; previously filed as Exhibit 4.11 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .12 | Parent Guarantee Agreement, dated April 30, 1998, between CDRJ Investments (Lux) S.A. and Credit Suisse First Boston; previously filed as Exhibit 4.12 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .13 | Pledge Agreement, dated April 30, 1998 among CDRJ Investments (Lux) S.A., CDRJ North Atlantic Sarl, CDRJ Latin America Holding Company B.V., Latin Cosmetics Holdings B.V., Regional Cosmetics Holding B.V., Southern Cosmetics Holdings B.V., and CDRJ Mexico Holding Company B.V., CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V. and Credit Suisse First Boston; previously filed as Exhibit 4.13 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .14 | Security Agreement, dated April 30, 1998, among CDRJ Acquisition Corporation (JCI), each subsidiary of JCI listed on Schedule I thereto and Credit Suisse First Boston; previously filed as Exhibit 4.14 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .15 | Deed of Trust, with Assignment of Leases and Rents, Fixture Filing and Security Agreement, dated April 30, 1998, by Jafra Cosmetics International, Inc. to TitleServ Agency of New York City, Inc., as trustee for the Benefit of Credit Suisse First Boston; previously filed as Exhibit 4.15 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .16 | Acknowledgment of Obligations and Mortgage, dated April 30, 1998, granted by Reday, S.A. de C.V. in favor of Credit Suisse First Boston, together with an unofficial English translation thereof; previously filed as Exhibit 4.16 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
4 | .17 | Notarial Deed of Pledge, dated April 30, 1998, with respect to the pledge to Credit Suisse First Boston of (i) 24 ordinary shares of the capital stock of CDRJ Europe Holding Company B.V. by Jafra Cosmetics International, Inc., and (ii) 40 ordinary shares of the capital stock of CDRJ Latin America Holding B.V. by CDRJ North Atlantic (Lux) Sarl; previously filed as Exhibit 4.17 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. |
121
Exhibit | ||||
Number | Description of Document | |||
4 | .18 | Consent and Waiver, dated as of November 19, 1999, to the Credit Agreement dated as of April 30, 1998, as amended by Amendment No. 1 thereto dated as of August 26, 1998, among Jafra Cosmetics International Inc., Jafra Cosmetics International S.A. de C.V., CDRJ Investments (Lux) S.A., the several banks and financial institutions party to the Credit Agreement, the Issuing Bank and Credit Suisse First Boston, as Administrative Agent; previously filed as Exhibit 4.18 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | ||
4 | .19 | Substitution of Trustee and Partial Reconveyance of Deed of Trust, Assignment of Leases and Rents, Fixture Filing and Security Agreement, and Release of Financing Statement, dated November 29, 1999, which amends the Deed of Trust filed as Exhibit 4.15 above; previously filed as Exhibit 4.19 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | ||
4 | .20 | Partial Reconveyance of Deed of Trust, Assignment of Leases and Rents, Fixture Filing and Security Agreement and Release of Financing Statement, dated November 29, 1999, which amends the Deed of Trust filed as Exhibit 4.15 above; previously filed as Exhibit 4.20 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | ||
4 | .21 | Consent and Waiver, dated as of June 30, 2001, to the Credit Agreement dated as of April 30, 1998, as amended by Amendment No. 1 thereto dated as of August 26, 1998, among Jafra Cosmetics International Inc., Jafra Cosmetics International S.A. de C.V., CDRJ Investments (Lux) S.A., the several banks and financial institutions party to the Credit Agreement, the Issuing Bank and Credit Suisse First Boston, as Administrative Agent, previously filed as Exhibit 4.21 to the Companys Annual Report of Form 10-K for the fiscal year ended 2001, filed on April 1, 2002, and incorporated herein by reference. | ||
10 | .1 | Indemnification Agreement, dated April 30, 1998, among CDRJ Investments (Lux) S.A., CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V., Clayton, Dubilier & Rice, Inc., Clayton, Dubilier & Rice Fund V Limited Partnership; previously filed as Exhibit 10.1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
10 | .2 | Consulting Agreement, dated April 30, 1998, by and among CDRJ Investments (Lux) S.A., Jafra Cosmetics International, Inc. and Jafra Cosmetics, S.A. de C.V., and Clayton, Dubilier & Rice, Inc.; previously filed as Exhibit 10.2 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
10 | .3 | Form of Employment Agreement for Messrs. Clark, Rubio, Mason, Guirao and DiGregorio; previously filed as Exhibit 10.3 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
10 | .4 | Amended and Restated Jafra Cosmetics International, Inc. Stock Incentive Plan, as adopted September 3, 1998; previously filed as Exhibit 10.4 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | ||
10 | .5 | CDRJ Investments (Lux) S.A. Form of Management Stock Option Agreement; previously filed as Exhibit 10.5 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | ||
10 | .6 | Amended and Restated Stock Purchase Warrant, dated September 30, 1998, by and between CDRJ Investments (Lux) S.A. and Jafra Cosmetics International, Inc.; previously filed as Exhibit 10.6 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. |
122
Exhibit | ||||
Number | Description of Document | |||
10 | .7 | Registration and Participation Agreement, dated April 30, 1998, among CDRJ Investments (Lux) S.A. and Clayton, Dubilier & Rice Fund V Limited Partnership and the other parties thereto; previously filed as Exhibit 10.7 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | ||
10 | .8 | CDRJ Investments (Lux) S.A. Form of Management Stock Subscription Agreement; previously filed as Exhibit 10.8 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | ||
10 | .9 | CDRJ Investments (Lux) S.A. Form of Individual Investor Stock Subscription Agreement; previously filed as Exhibit 10.9 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | ||
10 | .10 | Jafra Cosmetics International, Inc. Supplemental Savings Plan, dated October 27, 1998; previously filed as Exhibit 10.1 to the Companys Quarterly Report on Form 10-Q for the first quarter ended March 31, 1999, filed May 17, 1999, and incorporated herein by reference. | ||
10 | .11 | Jafra Cosmetics International, Inc. Special Supplemental Savings Plan for Non-United States-Source Income, dated January 20, 1999; previously filed as Exhibit 10.2 to the Companys Quarterly Report on Form 10-Q for the first quarter ended March 31, 1999, filed May 17, 1999, and incorporated herein by reference. | ||
10 | .12 | Asset Purchase Agreement, dated as of June 10, 1999, as amended by Amendment No. 1, dated as of June 10, 1999; by and between the Company and the Contractor, previously filed as Exhibit 10.1 to Form 8-K, filed on June 10, 1999, and incorporated herein by reference (portions of which were filed under a confidentiality request). | ||
10 | .13 | Amendment No. 1 to Asset Purchase Agreement, dated as of June 10, 1999; previously filed as Exhibit 10.2 to Form 8-K, filed on June 10, 1999, and incorporated herein by reference (portions of which were filed under a confidentiality request). | ||
10 | .14 | Manufacturing Agreement, dated as of June 10, 1999, by and between the Company and the Contractor, as amended by Amendment No. 1, dated as of June 22, 1999; previously filed as Exhibit 10.3 to Form 8-K, filed on June 10, 1999, and incorporated herein by reference (portions of which were filed under a confidentiality request). | ||
10 | .15 | Form of Amendment No. 1 to Manufacturing Agreement, dated as of June 10, 1999; previously filed as Exhibit 10.4 to Form 8-K, filed on June 10, 1999 and incorporated herein by reference (portions of which were filed under a confidentiality request). | ||
10 | .16 | Form of Secured Note for the Assets, dated June 10, 1999, made by the Contractor in favor of the Company; previously filed as Exhibit 10.5 to Form 8-K, filed on June 10, 1999 and incorporated herein by reference (portions of which were filed under a confidentiality request). | ||
10 | .17 | Form of Secured Note for the Inventory, dated June 10, 1999, made by the Contractor in favor of the Company; previously filed as Exhibit 10.6 to Form 8-K, filed on June 10, 1999 and incorporated herein by reference (portions of which were filed under a confidentiality request). | ||
10 | .18 | Trust Agreement dated May 20, 1999 by and between Jafra Cosmetics International, Inc. and Scudder Trust Company; previously filed as Exhibit 10.20 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | ||
10 | .19 | Amendment No. 1 to Consulting Agreement, dated as of March 15, 2000, by and among CDRJ Investments (Lux) S.A., Jafra Cosmetics International, Inc., Jafra Cosmetics International, S.A. de C.V., and Clayton, Dubilier & Rice, Inc.; previously filed as Exhibit 10.21 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. |
123
Exhibit | ||||
Number | Description of Document | |||
10 | .20 | First Amendment to Amended and Restated Jafra Cosmetics International, Inc. Stock Incentive Plan; previously filed as exhibit 10.22 to the Companys Annual Report on Form 10-K for the fiscal year ended 2000, filed on April 2, 2001, and incorporated herein by reference. | ||
10 | .21 | CDRJ Investments (Lux) S.A. Form of Management Stock Subscription Agreement, as amended; previously filed as exhibit 3.10 to the Companys Annual Report on Form 10-K for the fiscal year ended 2000, filed on April 2, 2001, and incorporated herein by reference. | ||
10 | .22 | Amended and Restated Consulting Agreement, dated as of January 1, 2001, by and among CDRJ Investments (Lux) S.A., Jafra Cosmetics International, Inc., Jafra Cosmetics International, S.A. de C.V., and Clayton, Dubilier & Rice, Inc; previously filed as Exhibit 10.1 to the Companys Quarterly Report on Form 10-Q for the first quarter ended March 31, 2001, filed May 15, 2001, and incorporated herein by reference. | ||
21 | .1 | Subsidiaries of the registrant. |
(b) | Reports on Form 8-K |
On November 13, 2002, the Company filed a Current Report on form 8-K, dated November 13, 2002, with the Securities and Exchange Commission regarding fair disclosure, which information was reported under Item 7, Financial Statements and Exhibits and Item 9, Regulation FD Disclosure.
124
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
CDRJ Investments (Lux) S.A. |
By: | /s/ RONALD B. CLARK |
|
|
Name: Ronald B. Clark |
Title: | Chief Executive Officer of the Advisory |
Committee and Director |
Date March 18, 2003
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of Registrant and in the capacities and on the dates indicated.
Signature | Title | Date | ||
/s/ RONALD B. CLARK Ronald B. Clark |
Chief Executive Officer of the Advisory Committee and Director (Principal executive officer) |
March 18, 2003 | ||
/s/ MICHAEL A. DIGREGORIO Michael A. DiGregorio |
Senior Vice President and Chief Financial Officer of the Advisory Committee (Principal financial officer, Principal accounting officer) |
March 18, 2003 | ||
/s/ RALPH S. MASON, III Ralph S. Mason, III |
Secretary and Executive Vice President of the Advisory Committee (Representative in the U.S.) |
March 18, 2003 | ||
/s/ DONALD J. GOGEL Donald J. Gogel |
Director | March 18, 2003 | ||
/s/ STEVEN D. GOLDSTEIN Steven D. Goldstein |
Director | March 18, 2003 | ||
/s/ THOMAS E. IRELAND Thomas E. Ireland |
Director | March 18, 2003 | ||
/s/ SIRI MARSHALL Siri Marshall |
Director | March 18, 2003 | ||
/s/ DAVID A. NOVAK David A. Novak |
Director | March 18, 2003 | ||
/s/ ANN REESE Ann Reese |
Director | March 18, 2003 | ||
/s/ EDWARD H. RENSI Edward H. Rensi |
Director | March 18, 2003 | ||
/s/ GONZALO RUBIO Gonzalo Rubio |
Director | March 18, 2003 | ||
/s/ KENNETH D. TAYLOR Kenneth D. Taylor |
Director | March 18, 2003 |
125
CERTIFICATIONS
I, Ronald B. Clark, certify that:
1. I have reviewed this annual report on Form 10-K of CDRJ Investments (Lux) S.A.;
2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report:
4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared; | |
b) evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the Evaluation Date); and | |
c) presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and | |
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
6. The registrants other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
/s/ RONALD B. CLARK |
|
Ronald B. Clark | |
Chief Executive Officer of the Advisory Committee and Director |
Date March 18, 2003
126
I, Michael A. DiGregorio, certify that:
1. I have reviewed this annual report on Form 10-k of CDRJ Investments (Lux) S.A.;
2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report:
4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared; | |
b) evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the Evaluation Date); and | |
c) presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and | |
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and |
6. The registrants other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
/s/ MICHAEL A. DIGREGORIO _______________________________________ Michael A. DiGregorio |
|
Senior Vice President and Chief Financial Officer of the Advisory Committee (Principal Financial Officer) |
Date March 18, 2003
127
Supplemental Information to be Furnished with Reports Filed Pursuant to Section 15(d) of the Act by Registrants Which Have Not Registered Securities Pursuant to Section 12 of the Act.
No annual report or proxy material has been sent to security holders.
128
EXHIBIT INDEX
Exhibit | ||||
Number | Description of Document | |||
3.1 | Articles of Association (Statuts Coordonnes) of CDRJ Investments (Lux) S.A., as restated on September 30, 1998; previously filed as Exhibit 3.1 to Amendment 2 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed December 23, 1998, and incorporated herein by reference. | |||
3.2 | Certificate of Incorporation of CDRJ Acquisition Corporation, dated March 31, 1998; previously filed as Exhibit 3.2 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
3.3 | Certificate of Merger of Jafra Cosmetics International, Inc. into CDRJ Acquisition Corporation, dated April 30, 1998; previously filed as Exhibit 3.3 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
3.4 | Amended and Restated By-laws of Jafra Cosmetics International, Inc. (formerly CDRJ Acquisition Corporation), as adopted on July 21, 1998; previously filed as Exhibit 3.4 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
3.5 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Jafra Cosmetics International, S.A. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.5 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
3.6 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Dirsamex, S.A. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.7 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | |||
3.7 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Jafra Cosmetics S.A. de C.V., formerly known as Jafra Cosmetics S. de R.L. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.9 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | |||
3.8 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Qualifax, S.A. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.10 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | |||
3.9 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Reday, S.A. de C.V., together with a unofficial summary thereof in English; previously filed as Exhibit 3.11 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | |||
3.10 | Deed of Incorporation (acta constitutiva), including all amendments thereto, and current by-laws (estatutos sociales) of Cosmeticos Y Fragrancias, S.A. de C.V., together with an unofficial summary thereof in English; previously filed as exhibit 3.10 to the Companys Annual Report on Form 10-K for the fiscal year ended 2000, filed on April 2, 2001, and incorporated herein by reference. |
129
Exhibit | ||||
Number | Description of Document | |||
3.11 | Notarial Deed and Resolutions, together with an unofficial summary thereof in English, for the transformation of Jafra Cosmetics S. de R.L. de C.V. into Jafra Cosmetics S.A. de C.V.; previously filed as Exhibit 3.12 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | |||
3.12 | Approval, dated as of April 17, 2000, by the Public Registry of Commerce of the United Mexican States of the merger of Consultoria Jafra S.A. de C.V. and Distribuidora Venus, S.A. de C.V. with and into Reday, S.A. de C.V., together with supporting shareholders resolutions and the unofficial English translation thereof; previously filed as Exhibit 3.1 to the Companys Quarterly Report on Form 10-Q for the second quarter ended June 30, 2000, filed on August 14, 2000, and incorporated herein by reference. | |||
3.13 | Notarial Deed and Resolutions, together with an unofficial summary thereof in English, for the changing of the corporate name from Reday, S.A. de C.V. to Distribuidora Venus, S.A. de C.V. as a consequence of the merger of Distribuidora Venus, S.A. de C.V. into Reday, S.A. de C.V.; previously filed as Exhibit 3.11 to the Companys Annual Report on Form 10-K for the fiscal year ended 2000, filed on April 2, 2001, and incorporated herein by reference. | |||
3.14 | Notarial Deed and Resolutions, together with an unofficial summary thereof in English, for the renaming of Qualifax, S.A. de C.V. as Serviday S.A. de C.V.; previously filed as Exhibit 3.1 to the Companys Quarterly Report on Form 10-Q for the second quarter ended June, 30, 2001, filed on August 14, 2001, and incorporated herein by reference. | |||
4.1 | Indenture, dated April 30, 1998, among CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V., CDRJ Investments (Lux) S.A., and State Street Bank and Trust Company; previously filed as Exhibit 4.1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.2 | First Supplemental Indenture, dated April 30, 1998, among Consultoria Jafra, S.A. de C.V., Distribuidora Venus, S.A. de C.V., Dirsamex, S.A. de C.V., Reday, S.A. de C.V., Qualifax S.A. de C.V., and Jafra Cosmetics S.R.L., CDRJ Acquisition Corporation and Jafra Cosmetics International, S.A. de C.V. and State Street Bank and Trust Company; previously filed as Exhibit 4.2 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.3 | Purchase Agreement, dated April 28, 1998, between Credit Suisse First Boston Corporation, Chase Securities Inc., CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V., and CDRJ Investments (Lux) S.A.; previously filed as Exhibit 4.3 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.4 | Purchase Agreement Amendment, dated April 30, 1998, executed on behalf of each of Reday, S.A. de C.V., Distribuidora Venus, S.A. de C.V., Dirsamex, S.A. de C.V., Qualifax, S.A. de C.V., Jafra Cosmetics, S.R.L., Consultoria Jafra, S.A. de C.V., Credit Suisse First Boston Corporation, and Chase Securities Inc.; previously filed as Exhibit 4.4 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.5 | Registration Rights Agreement, dated April 30, 1998, among CDRJ Acquisition Corporation, Jafra Cosmetics International, Inc., Jafra Cosmetics International, S.A. de C.V., CDRJ Investments (Lux) S.A., Reday, S.A. de C.V., Distribuidora, S.A. de C.V., Dirsamex, S.A. de C.V., Qualifax, S.A. de C.V., Jafra Cosmetics, S.A. de C.V., Consultoria Jafra, S.A. de C.V., and Credit Suisse First Boston Corporation; previously filed as Exhibit 4.5 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. |
130
Exhibit | ||||
Number | Description of Document | |||
4.6 | Credit Agreement, dated April 30, 1998, among CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V., CDRJ Investments (Lux) S.A., as Guarantor and Parent of the Borrowers, the Lenders named therein and Credit Suisse First Boston, as Administrative Agent; previously filed as Exhibit 4.6 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.7 | Amendment No. 1 to the Credit Agreement, dated August 26, 1998; previously filed as Exhibit 4.7 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.8 | Indemnity, Subrogation and Contribution Agreement, dated April 30, 1998, among Jafra Cosmetics International, S.A. de C.V. (JCISA), each Subsidiary of JCSI listed on Schedule I thereto and Credit Suisse First Boston; previously filed as Exhibit 4.8 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.9 | JCI Guarantee Agreement, dated April 30, 1998, between CDRJ Acquisition Corporation and Credit Suisse First Boston; previously filed as Exhibit 4.9 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.10 | JCISA Guarantee Agreement, dated April 30, 1998, between Jafra Cosmetics International, S.A. de C.V. and Credit Suisse First Boston; previously filed as Exhibit 4.10 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.11 | JCISA Subsidiary Guarantee Agreement, dated April 30, 1998, among each of the subsidiaries of Jafra Cosmetics International, S.A. de C.V. listed on Schedule I thereto, and Credit Suisse First Boston; previously filed as Exhibit 4.11 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.12 | Parent Guarantee Agreement, dated April 30, 1998, between CDRJ Investments (Lux) S.A. and Credit Suisse First Boston; previously filed as Exhibit 4.12 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.13 | Pledge Agreement, dated April 30, 1998 among CDRJ Investments (Lux) S.A., CDRJ North Atlantic Sarl, CDRJ Latin America Holding Company B.V., Latin Cosmetics Holdings B.V., Regional Cosmetics Holding B.V., Southern Cosmetics Holdings B.V., and CDRJ Mexico Holding Company B.V., CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V. and Credit Suisse First Boston; previously filed as Exhibit 4.13 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.14 | Security Agreement, dated April 30, 1998, among CDRJ Acquisition Corporation (JCI), each subsidiary of JCI listed on Schedule I thereto and Credit Suisse First Boston; previously filed as Exhibit 4.14 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.15 | Deed of Trust, with Assignment of Leases and Rents, Fixture Filing and Security Agreement, dated April 30, 1998, by Jafra Cosmetics International, Inc. to TitleServ Agency of New York City, Inc., as trustee for the Benefit of Credit Suisse First Boston; previously filed as Exhibit 4.15 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. |
131
Exhibit | ||||
Number | Description of Document | |||
4.16 | Acknowledgment of Obligations and Mortgage, dated April 30, 1998, granted by Reday, S.A. de C.V. in favor of Credit Suisse First Boston, together with an unofficial English translation thereof; previously filed as Exhibit 4.16 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.17 | Notarial Deed of Pledge, dated April 30, 1998, with respect to the pledge to Credit Suisse First Boston of (i) 24 ordinary shares of the capital stock of CDRJ Europe Holding Company B.V. by Jafra Cosmetics International, Inc., and (ii) 40 ordinary shares of the capital stock of CDRJ Latin America Holding B.V. by CDRJ North Atlantic (Lux) Sarl; previously filed as Exhibit 4.17 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
4.18 | Consent and Waiver, dated as of November 19, 1999, to the Credit Agreement dated as of April 30, 1998, as amended by Amendment No. 1 thereto dated as of August 26, 1998, among Jafra Cosmetics International Inc., Jafra Cosmetics International S.A. de C.V., CDRJ Investments (Lux) S.A., the several banks and financial institutions party to the Credit Agreement, the Issuing Bank and Credit Suisse First Boston, as Administrative Agent; previously filed as Exhibit 4.18 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | |||
4.19 | Substitution of Trustee and Partial Reconveyance of Deed of Trust, Assignment of Leases and Rents, Fixture Filing and Security Agreement, and Release of Financing Statement, dated November 29, 1999, which amends the Deed of Trust filed as Exhibit 4.15 above; previously filed as Exhibit 4.19 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | |||
4.20 | Partial Reconveyance of Deed of Trust, Assignment of Leases and Rents, Fixture Filing and Security Agreement and Release of Financing Statement, dated November 29, 1999, which amends the Deed of Trust filed as Exhibit 4.15 above; previously filed as Exhibit 4.20 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | |||
4.21 | Consent and Waiver, dated as of June 30, 2001, to the Credit Agreement dated as of April 30, 1998, as amended by Amendment No. 1 thereto dated as of August 26, 1998, among Jafra Cosmetics International Inc., Jafra Cosmetics International S.A. de C.V., CDRJ Investments (Lux) S.A., the several banks and financial institutions party to the Credit Agreement, the Issuing Bank and Credit Suisse First Boston, as Administrative Agent, previously filed as Exhibit 4.21 to the Companys Annual Report of Form 10-K for the fiscal year ended 2001, filed on April 1, 2002, and incorporated herein by reference. | |||
10.1 | Indemnification Agreement, dated April 30, 1998, among CDRJ Investments (Lux) S.A., CDRJ Acquisition Corporation, Jafra Cosmetics International, S.A. de C.V., Clayton, Dubilier & Rice, Inc., Clayton, Dubilier & Rice Fund V Limited Partnership; previously filed as Exhibit 10.1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
10.2 | Consulting Agreement, dated April 30, 1998, by and among CDRJ Investments (Lux) S.A., Jafra Cosmetics International, Inc. and Jafra Cosmetics, S.A. de C.V., and Clayton, Dubilier & Rice, Inc.; previously filed as Exhibit 10.2 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
10.3 | Form of Employment Agreement for Messrs. Clark, Rubio, Mason, Guirao and DiGregorio; previously filed as Exhibit 10.3 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. |
132
Exhibit | ||||
Number | Description of Document | |||
10.4 | Amended and Restated Jafra Cosmetics International, Inc. Stock Incentive Plan, as adopted September 3, 1998; previously filed as Exhibit 10.4 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | |||
10.5 | CDRJ Investments (Lux) S.A. Form of Management Stock Option Agreement; previously filed as Exhibit 10.5 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | |||
10.6 | Amended and Restated Stock Purchase Warrant, dated September 30, 1998, by and between CDRJ Investments (Lux) S.A. and Jafra Cosmetics International, Inc.; previously filed as Exhibit 10.6 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | |||
10.7 | Registration and Participation Agreement, dated April 30, 1998, among CDRJ Investments (Lux) S.A. and Clayton, Dubilier & Rice Fund V Limited Partnership and the other parties thereto; previously filed as Exhibit 10.7 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed September 4, 1998, and incorporated herein by reference. | |||
10.8 | CDRJ Investments (Lux) S.A. Form of Management Stock Subscription Agreement; previously filed as Exhibit 10.8 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | |||
10.9 | CDRJ Investments (Lux) S.A. Form of Individual Investor Stock Subscription Agreement; previously filed as Exhibit 10.9 to Amendment No. 1 to Registration Statement No. 333-62989 under the Securities Act of 1933, as amended, filed October 27, 1998, and incorporated herein by reference. | |||
10.10 | Jafra Cosmetics International, Inc. Supplemental Savings Plan, dated October 27, 1998; previously filed as Exhibit 10.1 to the Companys Quarterly Report on Form 10-Q for the first quarter ended March 31, 1999, filed May 17, 1999, and incorporated herein by reference. | |||
10.11 | Jafra Cosmetics International, Inc. Special Supplemental Savings Plan for Non-United States-Source Income, dated January 20, 1999; previously filed as Exhibit 10.2 to the Companys Quarterly Report on Form 10-Q for the first quarter ended March 31, 1999, filed May 17, 1999, and incorporated herein by reference. | |||
10.12 | Asset Purchase Agreement, dated as of June 10, 1999, as amended by Amendment No. 1, dated as of June 10, 1999; by and between the Company and the Contractor, previously filed as Exhibit 10.1 to Form 8-K, filed on June 10, 1999, and incorporated herein by reference (portions of which were filed under a confidentiality request). | |||
10.13 | Amendment No. 1 to Asset Purchase Agreement, dated as of June 10, 1999; previously filed as Exhibit 10.2 to Form 8-K, filed on June 10, 1999, and incorporated herein by reference (portions of which were filed under a confidentiality request). | |||
10.14 | Manufacturing Agreement, dated as of June 10, 1999, by and between the Company and the Contractor, as amended by Amendment No. 1, dated as of June 22, 1999; previously filed as Exhibit 10.3 to Form 8-K, filed on June 10, 1999, and incorporated herein by reference (portions of which were filed under a confidentiality request). | |||
10.15 | Form of Amendment No. 1 to Manufacturing Agreement, dated as of June 10, 1999; previously filed as Exhibit 10.4 to Form 8-K, filed on June 10, 1999 and incorporated herein by reference (portions of which were filed under a confidentiality request). |
133
Exhibit | ||||
Number | Description of Document | |||
10.16 | Form of Secured Note for the Assets, dated June 10, 1999, made by the Contractor in favor of the Company; previously filed as Exhibit 10.5 to Form 8-K, filed on June 10, 1999 and incorporated herein by reference (portions of which were filed under a confidentiality request). | |||
10.17 | Form of Secured Note for the Inventory, dated June 10, 1999, made by the Contractor in favor of the Company; previously filed as Exhibit 10.6 to Form 8-K, filed on June 10, 1999 and incorporated herein by reference (portions of which were filed under a confidentiality request). | |||
10.18 | Trust Agreement dated May 20, 1999 by and between Jafra Cosmetics International, Inc. and Scudder Trust Company; previously filed as Exhibit 10.20 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | |||
10.19 | Amendment No. 1 to Consulting Agreement, dated as of March 15, 2000, by and among CDRJ Investments (Lux) S.A., Jafra Cosmetics International, Inc., Jafra Cosmetics International, S.A. de C.V., and Clayton, Dubilier & Rice, Inc.; previously filed as Exhibit 10.21 to the Companys Annual Report on Form 10-K for the fiscal year ended 1999, filed on March 30, 2000, and incorporated herein by reference. | |||
10.20 | First Amendment to Amended and Restated Jafra Cosmetics International, Inc. Stock Incentive Plan; previously filed as exhibit 10.22 to the Companys Annual Report on Form 10-K for the fiscal year ended 2000, filed on April 2, 2001, and incorporated herein by reference. | |||
10.21 | CDRJ Investments (Lux) S.A. Form of Management Stock Subscription Agreement, as amended; previously filed as exhibit 3.10 to the Companys Annual Report on Form 10-K for the fiscal year ended 2000, filed on April 2, 2001, and incorporated herein by reference. | |||
10.22 | Amended and Restated Consulting Agreement, dated as of January 1, 2001, by and among CDRJ Investments (Lux) S.A., Jafra Cosmetics International, Inc., Jafra Cosmetics International, S.A. de C.V., and Clayton, Dubilier & Rice, Inc; previously filed as Exhibit 10.1 to the Companys Quarterly Report on Form 10-Q for the first quarter ended March 31, 2001, filed May 15, 2001, and incorporated herein by reference. | |||
21.1 | Subsidiaries of the registrant. |
134